KR20210099037A - 바실루스 메가테리움 속의 프로바이오틱 균주 및 다중불포화 지방산 성분을 포함하는 제제 - Google Patents
바실루스 메가테리움 속의 프로바이오틱 균주 및 다중불포화 지방산 성분을 포함하는 제제 Download PDFInfo
- Publication number
- KR20210099037A KR20210099037A KR1020217019791A KR20217019791A KR20210099037A KR 20210099037 A KR20210099037 A KR 20210099037A KR 1020217019791 A KR1020217019791 A KR 1020217019791A KR 20217019791 A KR20217019791 A KR 20217019791A KR 20210099037 A KR20210099037 A KR 20210099037A
- Authority
- KR
- South Korea
- Prior art keywords
- seq
- omega
- acid
- bacillus megaterium
- fatty acid
- Prior art date
Links
- 241000194107 Bacillus megaterium Species 0.000 title claims abstract description 88
- 239000006041 probiotic Substances 0.000 title claims abstract description 21
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 21
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title claims abstract description 20
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims description 18
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims abstract description 65
- 239000000203 mixture Substances 0.000 claims abstract description 64
- 238000009472 formulation Methods 0.000 claims abstract description 39
- 229940012843 omega-3 fatty acid Drugs 0.000 claims abstract description 32
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 30
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims abstract description 30
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract description 30
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 30
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 24
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 19
- 235000020665 omega-6 fatty acid Nutrition 0.000 claims abstract description 15
- 229940033080 omega-6 fatty acid Drugs 0.000 claims abstract description 15
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 12
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 12
- 235000013305 food Nutrition 0.000 claims abstract description 10
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 8
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 8
- 239000002253 acid Substances 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims abstract description 5
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims abstract description 5
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims abstract description 5
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 claims abstract description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims abstract description 4
- 235000021294 Docosapentaenoic acid Nutrition 0.000 claims abstract description 4
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 claims abstract description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 4
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims abstract description 4
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims abstract description 4
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims abstract description 4
- 229960002733 gamolenic acid Drugs 0.000 claims abstract description 4
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 4
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 3
- 229940127557 pharmaceutical product Drugs 0.000 claims abstract description 3
- 230000000699 topical effect Effects 0.000 claims abstract description 3
- 108091033319 polynucleotide Proteins 0.000 claims description 30
- 102000040430 polynucleotide Human genes 0.000 claims description 30
- 239000002157 polynucleotide Substances 0.000 claims description 30
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 28
- 239000006185 dispersion Substances 0.000 claims description 24
- 230000036541 health Effects 0.000 claims description 24
- -1 phospholipid esters Chemical class 0.000 claims description 20
- 229940024606 amino acid Drugs 0.000 claims description 19
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 18
- 239000000047 product Substances 0.000 claims description 17
- 150000001413 amino acids Chemical class 0.000 claims description 15
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical group C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 15
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 15
- 244000005700 microbiome Species 0.000 claims description 15
- 239000006014 omega-3 oil Substances 0.000 claims description 14
- 150000003904 phospholipids Chemical class 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 11
- 229930195729 fatty acid Natural products 0.000 claims description 11
- 239000000194 fatty acid Substances 0.000 claims description 11
- 229920001046 Nanocellulose Polymers 0.000 claims description 9
- 235000021323 fish oil Nutrition 0.000 claims description 9
- CRDZYJSQHCXHEG-SFVBTVKNSA-N protectin D1 Chemical compound CC\C=C/C[C@H](O)\C=C/C=C/C=C/[C@H](O)C\C=C/C\C=C/CCC(O)=O CRDZYJSQHCXHEG-SFVBTVKNSA-N 0.000 claims description 9
- SWTYBBUBEPPYCX-VIIQGJSXSA-N (4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosahexaenoic acid Chemical compound CC\C=C/CC(O)\C=C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O SWTYBBUBEPPYCX-VIIQGJSXSA-N 0.000 claims description 8
- HLHYXXBCQOUTGK-FHCQLJOMSA-N (7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid Chemical compound CC\C=C/C\C=C/C[C@H](O)\C=C/C=C/C=C/[C@H](O)C\C=C/CCC(O)=O HLHYXXBCQOUTGK-FHCQLJOMSA-N 0.000 claims description 8
- 229920002678 cellulose Polymers 0.000 claims description 8
- 239000001913 cellulose Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 235000018102 proteins Nutrition 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- AOPOCGPBAIARAV-OTBJXLELSA-N resolvin E1 Chemical compound CC[C@@H](O)\C=C\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O AOPOCGPBAIARAV-OTBJXLELSA-N 0.000 claims description 8
- 108020004465 16S ribosomal RNA Proteins 0.000 claims description 7
- 101100321034 Bacillus subtilis (strain 168) yqfD gene Proteins 0.000 claims description 7
- 101100439426 Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110) groEL4 gene Proteins 0.000 claims description 7
- 101100267109 Escherichia coli (strain K12) ygfF gene Proteins 0.000 claims description 7
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 7
- 239000004472 Lysine Substances 0.000 claims description 7
- 241001465754 Metazoa Species 0.000 claims description 7
- 101100038261 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) rpo2C gene Proteins 0.000 claims description 7
- 125000004494 ethyl ester group Chemical group 0.000 claims description 7
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- 101150077981 groEL gene Proteins 0.000 claims description 7
- 101150013736 gyrB gene Proteins 0.000 claims description 7
- 101150012629 parE gene Proteins 0.000 claims description 7
- 101150085857 rpo2 gene Proteins 0.000 claims description 7
- 101150090202 rpoB gene Proteins 0.000 claims description 7
- FTAGQROYQYQRHF-FCWZHQICSA-N 5-HEPE Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C=C/C(O)CCCC(O)=O FTAGQROYQYQRHF-FCWZHQICSA-N 0.000 claims description 6
- 230000002496 gastric effect Effects 0.000 claims description 6
- 230000001965 increasing effect Effects 0.000 claims description 6
- 150000002632 lipids Chemical class 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- MCRJLMXYVFDXLS-QGQBRVLBSA-N 12-HEPE Chemical compound CC\C=C/C\C=C/CC(O)\C=C\C=C/C\C=C/CCCC(O)=O MCRJLMXYVFDXLS-QGQBRVLBSA-N 0.000 claims description 5
- JSFATNQSLKRBCI-UHFFFAOYSA-N 15-Hydroxyeicosatetraenoic acid Chemical compound CCCCCC(O)C=CC=CCC=CCC=CCCCC(O)=O JSFATNQSLKRBCI-UHFFFAOYSA-N 0.000 claims description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
- KGIJOOYOSFUGPC-MSFIICATSA-N 5-Hydroxyeicosatetraenoic acid Chemical compound CCCCCC=CCC=CCC=C\C=C\[C@@H](O)CCCC(O)=O KGIJOOYOSFUGPC-MSFIICATSA-N 0.000 claims description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 5
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 5
- 229960003104 ornithine Drugs 0.000 claims description 5
- 235000013406 prebiotics Nutrition 0.000 claims description 5
- WYCMUVNNXSREQB-AZOGICFMSA-N resolvin E3 Chemical compound CC[C@H](O)C(O)\C=C\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O WYCMUVNNXSREQB-AZOGICFMSA-N 0.000 claims description 5
- 150000003626 triacylglycerols Chemical class 0.000 claims description 4
- GCZRCCHPLVMMJE-IBGZPJMESA-N 11-HETE Natural products CCCCCC=CC=C[C@H](O)CC=CCC=CCCCC(O)=O GCZRCCHPLVMMJE-IBGZPJMESA-N 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 229960003121 arginine Drugs 0.000 claims description 3
- 239000012620 biological material Substances 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 235000014633 carbohydrates Nutrition 0.000 claims description 3
- 230000036996 cardiovascular health Effects 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 235000012041 food component Nutrition 0.000 claims description 3
- 239000005417 food ingredient Substances 0.000 claims description 3
- 235000021588 free fatty acids Nutrition 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 230000007413 intestinal health Effects 0.000 claims description 3
- 230000037231 joint health Effects 0.000 claims description 3
- 210000004072 lung Anatomy 0.000 claims description 3
- 229960003646 lysine Drugs 0.000 claims description 3
- 230000004630 mental health Effects 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- GCZRCCHPLVMMJE-RLZWZWKOSA-N 11-HETE Chemical compound CCCCC\C=C/C=C/C(O)C\C=C/C\C=C/CCCC(O)=O GCZRCCHPLVMMJE-RLZWZWKOSA-N 0.000 claims description 2
- KGIJOOYOSFUGPC-CABOLEKPSA-N 5-HETE Natural products CCCCC\C=C/C\C=C/C\C=C/C=C/[C@H](O)CCCC(O)=O KGIJOOYOSFUGPC-CABOLEKPSA-N 0.000 claims description 2
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 claims description 2
- 229920003043 Cellulose fiber Polymers 0.000 claims description 2
- 229960002749 aminolevulinic acid Drugs 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 230000000112 colonic effect Effects 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- 230000003111 delayed effect Effects 0.000 claims description 2
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 claims description 2
- 239000003925 fat Substances 0.000 claims description 2
- 235000019197 fats Nutrition 0.000 claims description 2
- 239000002955 immunomodulating agent Substances 0.000 claims description 2
- 229940121354 immunomodulator Drugs 0.000 claims description 2
- VNYSSYRCGWBHLG-AMOLWHMGSA-N leukotriene B4 Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-AMOLWHMGSA-N 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- 235000013384 milk substitute Nutrition 0.000 claims description 2
- 210000000214 mouth Anatomy 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- ALWYOLKNLLFCAY-GYROAIJESA-N (13R,14S)-dihydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid Chemical compound CC\C=C/C\C=C/C[C@H](O)[C@H](O)\C=C\C=C\C=C/C\C=C/CCC(O)=O ALWYOLKNLLFCAY-GYROAIJESA-N 0.000 claims 1
- CRDZYJSQHCXHEG-XLBFCUQGSA-N (4Z,7Z,10S,11E,13Z,15E,17S,19Z)-10,17-dihydroxydocosahexaenoic acid Chemical compound CC\C=C/C[C@H](O)\C=C\C=C/C=C/[C@@H](O)C\C=C/C\C=C/CCC(O)=O CRDZYJSQHCXHEG-XLBFCUQGSA-N 0.000 claims 1
- SEVOKGDVLLIUMT-SKSHMZPZSA-N (4Z,7Z,10Z,14E,16Z,19Z)-13-hydroxydocosahexaenoic acid Chemical compound CC\C=C/C\C=C/C=C/C(O)C\C=C/C\C=C/C\C=C/CCC(O)=O SEVOKGDVLLIUMT-SKSHMZPZSA-N 0.000 claims 1
- OZXAIGIRPOOJTI-XJAVJPOHSA-N (4Z,8E,10Z,13Z,16Z,19Z)-7-hydroxydocosahexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C=C/C(O)C\C=C/CCC(O)=O OZXAIGIRPOOJTI-XJAVJPOHSA-N 0.000 claims 1
- IDEHSDHMEMMYIR-WSAGHCNZSA-N 11-HEPE Chemical compound CC\C=C/C\C=C/C=C/C(O)C\C=C/C\C=C/CCCC(O)=O IDEHSDHMEMMYIR-WSAGHCNZSA-N 0.000 claims 1
- ZNHVWPKMFKADKW-UHFFFAOYSA-N 12-HETE Chemical compound CCCCCC=CCC(O)C=CC=CCC=CCCCC(O)=O ZNHVWPKMFKADKW-UHFFFAOYSA-N 0.000 claims 1
- ZNHVWPKMFKADKW-ZYBDYUKJSA-N 12-HETE Natural products CCCCC\C=C/C[C@@H](O)\C=C\C=C/C\C=C/CCCC(O)=O ZNHVWPKMFKADKW-ZYBDYUKJSA-N 0.000 claims 1
- HNICUWMFWZBIFP-BSZOFBHHSA-N 13-HODE Chemical compound CCCCCC(O)\C=C\C=C/CCCCCCCC(O)=O HNICUWMFWZBIFP-BSZOFBHHSA-N 0.000 claims 1
- WLKCSMCLEKGITB-XWJJKCKWSA-N 15-HEPE Chemical compound CC\C=C/CC(O)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O WLKCSMCLEKGITB-XWJJKCKWSA-N 0.000 claims 1
- JSFATNQSLKRBCI-VAEKSGALSA-N 15-HETE Natural products CCCCC[C@H](O)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O JSFATNQSLKRBCI-VAEKSGALSA-N 0.000 claims 1
- LRWYBGFSVUBWMO-UAAZXLHOSA-N 18(R)-HEPE Chemical compound CC[C@@H](O)\C=C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O LRWYBGFSVUBWMO-UAAZXLHOSA-N 0.000 claims 1
- FTAGQROYQYQRHF-OTZRFASISA-N 5-HEPE Natural products CCC=C/CC=C/CC=C/CC=C/C=C/C(O)CCCC(=O)O FTAGQROYQYQRHF-OTZRFASISA-N 0.000 claims 1
- NLUNAYAEIJYXRB-HEJOTXCHSA-N 8-HETE Chemical compound CCCCC\C=C/C\C=C/C=C/C(O)C\C=C/CCCC(O)=O NLUNAYAEIJYXRB-HEJOTXCHSA-N 0.000 claims 1
- NPDSHTNEKLQQIJ-ZJHFMPGASA-N alpha-dimorphecolic acid Chemical compound CCCCC\C=C/C=C/C(O)CCCCCCCC(O)=O NPDSHTNEKLQQIJ-ZJHFMPGASA-N 0.000 claims 1
- CRDZYJSQHCXHEG-HBMALMRFSA-N aspirin-triggered protectin D1 Chemical compound CC\C=C/C[C@@H](O)\C=C/C=C/C=C/[C@H](O)C\C=C/C\C=C/CCC(O)=O CRDZYJSQHCXHEG-HBMALMRFSA-N 0.000 claims 1
- OIWTWACQMDFHJG-BJEBZIPWSA-N aspirin-triggered resolvin D1 Chemical compound CC\C=C/C[C@@H](O)\C=C\C=C/C=C/C=C/[C@@H](O)[C@@H](O)C\C=C/CCC(O)=O OIWTWACQMDFHJG-BJEBZIPWSA-N 0.000 claims 1
- NPDSHTNEKLQQIJ-UHFFFAOYSA-N dimorphecolic acid Natural products CCCCCC=CC=CC(O)CCCCCCCC(O)=O NPDSHTNEKLQQIJ-UHFFFAOYSA-N 0.000 claims 1
- LZINBAGZNCYRNQ-UHFFFAOYSA-N n-(1h-benzimidazol-2-ylmethyl)-2-methoxyacetamide Chemical compound C1=CC=C2NC(CNC(=O)COC)=NC2=C1 LZINBAGZNCYRNQ-UHFFFAOYSA-N 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 35
- 210000004027 cell Anatomy 0.000 description 34
- IVVBLUGHDNNLFF-UHFFFAOYSA-N 18-hydroxyicosa-2,4,6,8,10-pentaenoic acid Chemical compound CCC(O)CCCCCCC=CC=CC=CC=CC=CC(O)=O IVVBLUGHDNNLFF-UHFFFAOYSA-N 0.000 description 32
- 235000001014 amino acid Nutrition 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- 239000002775 capsule Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 8
- 239000002243 precursor Substances 0.000 description 8
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 7
- 238000006213 oxygenation reaction Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000013589 supplement Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- 101710198130 NADPH-cytochrome P450 reductase Proteins 0.000 description 5
- 102000004316 Oxidoreductases Human genes 0.000 description 5
- 108090000854 Oxidoreductases Proteins 0.000 description 5
- 102000004020 Oxygenases Human genes 0.000 description 5
- 108090000417 Oxygenases Proteins 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- RGBUEIHKUZWFQU-UHFFFAOYSA-N 11-hydroxyicosa-2,4,6,8,10-pentaenoic acid Chemical compound OC(=CC=CC=CC=CC=CC(=O)O)CCCCCCCCC RGBUEIHKUZWFQU-UHFFFAOYSA-N 0.000 description 4
- KGIJOOYOSFUGPC-XRXZHELTSA-N 5-hydroxyeicosatetraenoic acid Natural products CCCCCC=CCC=CCC=C\C=C\C(O)CCCC(O)=O KGIJOOYOSFUGPC-XRXZHELTSA-N 0.000 description 4
- KROOJMCNWRRPCC-UHFFFAOYSA-N 8-hydroxyeicosatetraenoic acid Natural products CCCCCC=CCC=CCC=C(O)CC=CCCCC(O)=O KROOJMCNWRRPCC-UHFFFAOYSA-N 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- ZNHVWPKMFKADKW-LQWMCKPYSA-N 12(S)-HETE Chemical compound CCCCC\C=C/C[C@H](O)\C=C\C=C/C\C=C/CCCC(O)=O ZNHVWPKMFKADKW-LQWMCKPYSA-N 0.000 description 3
- GPQVVJQEBXAKBJ-JPURVOHMSA-N 17(18)-EpETE Chemical compound CCC1OC1C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O GPQVVJQEBXAKBJ-JPURVOHMSA-N 0.000 description 3
- 150000000668 8-HETE derivatives Chemical class 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
- 241000194103 Bacillus pumilus Species 0.000 description 3
- 108010052832 Cytochromes Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- IXAQOQZEOGMIQS-ORRYEOPJSA-N Lipoxin A Natural products CCCCCC(O)C=CC=C/C=C/C=C/C(O)C(O)CCCC(=O)O IXAQOQZEOGMIQS-ORRYEOPJSA-N 0.000 description 3
- 102000003820 Lipoxygenases Human genes 0.000 description 3
- 108090000128 Lipoxygenases Proteins 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000003613 bile acid Substances 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 229960004232 linoleic acid Drugs 0.000 description 3
- IXAQOQZEOGMIQS-SSQFXEBMSA-N lipoxin A4 Chemical compound CCCCC[C@H](O)\C=C\C=C/C=C/C=C/[C@@H](O)[C@@H](O)CCCC(O)=O IXAQOQZEOGMIQS-SSQFXEBMSA-N 0.000 description 3
- 150000004668 long chain fatty acids Chemical class 0.000 description 3
- 235000018977 lysine Nutrition 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 239000006225 natural substrate Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 201000001245 periodontitis Diseases 0.000 description 3
- IKFAUGXNBOBQDM-XFMPMKITSA-N resolvin D2 Chemical compound CC\C=C/C[C@H](O)[C@H](O)\C=C\C=C\C=C/C=C/[C@@H](O)C\C=C/CCC(O)=O IKFAUGXNBOBQDM-XFMPMKITSA-N 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000019722 synbiotics Nutrition 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 2
- GCZRCCHPLVMMJE-JVNZAOJVSA-N (5e,8e,12e,14e)-11-hydroxyicosa-5,8,12,14-tetraenoic acid Chemical compound CCCCC\C=C\C=C\C(O)C\C=C\C\C=C\CCCC(O)=O GCZRCCHPLVMMJE-JVNZAOJVSA-N 0.000 description 2
- UXVRTOKOJOMENI-ICTGYCPSSA-N (6e,8e,10e,12e)-5,14,15-trihydroxyicosa-6,8,10,12-tetraenoic acid Chemical compound CCCCCC(O)C(O)\C=C\C=C\C=C\C=C\C(O)CCCC(O)=O UXVRTOKOJOMENI-ICTGYCPSSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010009900 Colitis ulcerative Diseases 0.000 description 2
- 208000011231 Crohn disease Diseases 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 244000008991 Curcuma longa Species 0.000 description 2
- 201000003883 Cystic fibrosis Diseases 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 229920002581 Glucomannan Polymers 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 235000019766 L-Lysine Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 229930064664 L-arginine Natural products 0.000 description 2
- 235000014852 L-arginine Nutrition 0.000 description 2
- 208000001145 Metabolic Syndrome Diseases 0.000 description 2
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 2
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 2
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 description 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 239000012867 bioactive agent Substances 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 238000002296 dynamic light scattering Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 2
- 229940107187 fructooligosaccharide Drugs 0.000 description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229940046240 glucomannan Drugs 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 244000005709 gut microbiome Species 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005706 microflora Species 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 210000004498 neuroglial cell Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- OIWTWACQMDFHJG-CCFUIAGSSA-N resolvin D1 Chemical compound CC\C=C/C[C@H](O)\C=C\C=C/C=C/C=C/[C@@H](O)[C@@H](O)C\C=C/CCC(O)=O OIWTWACQMDFHJG-CCFUIAGSSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- WBWWGRHZICKQGZ-HZAMXZRMSA-N taurocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 WBWWGRHZICKQGZ-HZAMXZRMSA-N 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- FPRKGXIOSIUDSE-SYACGTDESA-N (2z,4z,6z,8z)-docosa-2,4,6,8-tetraenoic acid Chemical compound CCCCCCCCCCCCC\C=C/C=C\C=C/C=C\C(O)=O FPRKGXIOSIUDSE-SYACGTDESA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OWFVSJHRFRIEAK-UHFFFAOYSA-N 15-hydroxyicosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCC(O)CCCC=CC=CC=CC=CC=CC(O)=O OWFVSJHRFRIEAK-UHFFFAOYSA-N 0.000 description 1
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 1
- IQMBFVPVALDBIC-UHFFFAOYSA-N 8-hydroxyicosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCCCCCC=CC=C(O)C=CC=CC=CC(O)=O IQMBFVPVALDBIC-UHFFFAOYSA-N 0.000 description 1
- LIBBWEZNMNXORM-UHFFFAOYSA-N 8-hydroxyicosa-2,4,6,8-tetraenoic acid Chemical compound CCCCCCCCCCCC=C(O)C=CC=CC=CC(O)=O LIBBWEZNMNXORM-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- CUHJQOVOXFVMSQ-UHFFFAOYSA-N 9-hydroxyoctadeca-2,4-dienoic acid Chemical compound CCCCCCCCCC(O)CCCC=CC=CC(O)=O CUHJQOVOXFVMSQ-UHFFFAOYSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 208000031873 Animal Disease Models Diseases 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 102000009515 Arachidonate 15-Lipoxygenase Human genes 0.000 description 1
- 108010048907 Arachidonate 15-lipoxygenase Proteins 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 229920002749 Bacterial cellulose Polymers 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 208000028006 Corneal injury Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 235000021292 Docosatetraenoic acid Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 101000741790 Homo sapiens Peroxisome proliferator-activated receptor gamma Proteins 0.000 description 1
- 101000620009 Homo sapiens Polyunsaturated fatty acid 5-lipoxygenase Proteins 0.000 description 1
- 101001064864 Homo sapiens Polyunsaturated fatty acid lipoxygenase ALOX12 Proteins 0.000 description 1
- 101001064853 Homo sapiens Polyunsaturated fatty acid lipoxygenase ALOX15 Proteins 0.000 description 1
- 101000935569 Homo sapiens Zinc finger protein basonuclin-1 Proteins 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 102000005298 Iron-Sulfur Proteins Human genes 0.000 description 1
- 108010081409 Iron-Sulfur Proteins Proteins 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- 241001136169 Komagataeibacter xylinus Species 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 229930184725 Lipoxin Natural products 0.000 description 1
- 241001625930 Luria Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 208000036110 Neuroinflammatory disease Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- XOJVVFBFDXDTEG-UHFFFAOYSA-N Norphytane Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- 102100022364 Polyunsaturated fatty acid 5-lipoxygenase Human genes 0.000 description 1
- 102100031949 Polyunsaturated fatty acid lipoxygenase ALOX12 Human genes 0.000 description 1
- 102100031950 Polyunsaturated fatty acid lipoxygenase ALOX15 Human genes 0.000 description 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 101000877889 Pseudomonas putida Flavin reductase Proteins 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 241000831652 Salinivibrio sharmensis Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000320380 Silybum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 238000010811 Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Methods 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 102100027904 Zinc finger protein basonuclin-1 Human genes 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000011558 animal model by disease Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229920000617 arabinoxylan Polymers 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 239000005016 bacterial cellulose Substances 0.000 description 1
- 229940098396 barley grain Drugs 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000013452 biotechnological production Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003293 cardioprotective effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229940106265 charcoal Drugs 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- ATNNLHXCRAAGJS-UHFFFAOYSA-N docos-2-enoic acid Chemical class CCCCCCCCCCCCCCCCCCCC=CC(O)=O ATNNLHXCRAAGJS-UHFFFAOYSA-N 0.000 description 1
- YFHUZNNPPBARJW-UHFFFAOYSA-N docosa-1,3,5,7,9-pentaene Chemical compound CCCCCCCCCCCCC=CC=CC=CC=CC=C YFHUZNNPPBARJW-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229940050549 fiber Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000014106 fortified food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000014168 granola/muesli bars Nutrition 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000007358 intestinal barrier function Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 229940106134 krill oil Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002639 lipoxins Chemical class 0.000 description 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 230000003959 neuroinflammation Effects 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 150000002888 oleic acid derivatives Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000003979 response to food Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229960005559 sulforaphane Drugs 0.000 description 1
- 235000015487 sulforaphane Nutrition 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229940005741 sunflower lecithin Drugs 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000013595 supernatant sample Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000001195 ultra high performance liquid chromatography Methods 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000021470 vitamin B5 (pantothenic acid) Nutrition 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1868—Docosahexaenoic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/187—Eicosapentaenoic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1872—Linoleic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1874—Linolenic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1882—Polyunsaturated fatty acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
본 발명은 바실루스 메가테리움 속에 속하는 적어도 하나의 프로바이오틱 균주, 및 에이코사펜타엔산(EPA), 도코사헥사엔산(DHA), 아라키돈산(ARA), 알파 리놀렌산, 스테아리돈산, 에이코사테트라엔산, 도코사펜타엔산, 리놀레산, γ-리놀렌산으로부터 선택된 적어도 하나의 오메가-3 또는 오메가-6 지방산을 포함하는 다중불포화 지방산 성분을 포함하며, 여기서 다중불포화 지방산 성분은 오메가-3 또는 오메가-6 지방산 염을 포함하는 것인 제제에 관한 것이다. 본 발명은 추가로 사료 또는 식품 보충제, 제약 제품, 사료- 또는 식품 조성물로서의 및 국소 적용을 위한 본 발명의 제제의 용도에 관한 것이다.
Description
본 발명은 바실루스 메가테리움(Bacillus megaterium) 속에 속하는 적어도 하나의 프로바이오틱 균주 또는 바실루스 메가테리움 추출물, 및 에이코사펜타엔산(EPA), 도코사헥사엔산(DHA), 아라키돈산(ARA), 알파 리놀렌산, 스테아리돈산, 에이코사테트라엔산, 도코사펜타엔산, 리놀레산, γ-리놀렌산 및/또는 그의 유도체로부터 선택되는 적어도 하나의 오메가-3 또는 오메가-6 지방산을 포함하는 다중불포화 지방산 성분을 포함하는 제제에 관한 것이다.
오메가-3 지방산, 즉 알파-리놀레산(ALA), EPA 및 DHA의 식이 섭취는, 특히 예를 들어 류마티스 관절염의 개선 및 심혈관 질환 위험 인자의 감소와 관련하여 인간 건강에 유익하다[1, 2]. 다양한 해산물 제품이 식이 EPA/DHA의 공급원이지만, 그의 소비는 종종 권장 식이 허용량(전형적으로 1 일에 500 mg EPA 및 DHA)을 충족시키기에 충분하지 않다[3]. 이러한 간극은 오메가-3 지방산을 함유하는 식이 보충제 또는 강화 식품의 광범위한 사용에 의해 좁혀진다[4]. 식이 보충제는 영양소 또는 영양 또는 생리학적 효과를 갖는 다른 물질의 농축된 공급원이며, 그의 목적은 정상 식사를 보충하는 것이다(www.efsa.europa.eu/en/topics/topic/food-supplements). 예를 들어, 오메가-3 지방산 보충제는 종종 어유, 크릴유 또는 조류로부터의 EPA/DHA의 트리글리세리드 또는 오메가-3 에틸 에스테르를 함유한다.
오메가-3 지방산은 일반적으로 항염증, 심장- 및 신경보호 효과를 갖는다[2, 5]. 그의 작용 방식은, 예를 들어 반응성 산소 종의 직접 스캐빈징, 세포 신호전달 사건에 후속적으로 영향을 미치는 세포 막 유동성의 변경, 염증유발 및 항염증 시토카인의 생합성을 조율하는 전사 인자, 예컨대 PPARG 및 NFKappaB의 활성의 조정, 및 시클로옥시게나제 및 리폭시게나제에 의해 염증유발 시토카인으로 전환되는 기질의 경쟁적 배제를 수반한다.
보다 최근에, 오메가-3 및 오메가-6 지방산의 여러 산소화 생성물이 확인되었고 특히 만성 염증 상태의 개선과 관련하여 그의 유익한 건강 효과의 중대한 매개인자로서 기능적으로 특성화되었다[6]. 이들 제품은 마레신(MaR), E- 및 D- 계열 레졸빈(RvE 및 RvD), 프로텍틴, 리폭신, 및 그의 전구체 예컨대 18-히드록시-에이코사펜타엔산(18-HEPE), 17-히드록시-도코사헥사엔산(17-HDHA), 및 17,18-에폭시에이코사테트라엔산(17,18-EEQ), 총칭하여 전문 해소-촉진 지질 매개인자(SPM)로 지칭되는 것을 포함한다. SPM은 리폭시게나제, 시클로옥시게나제-2, 및 시토크롬 P450 모노옥시게나제(CYP450)에 의해 내인성으로 형성되고, 나노몰 농도에서 G-단백질 커플링된 수용체를 통해 신호전달하는, 활성 염증 해소의 강력한 작용제로서 작용한다. 다수의 감염 및 염증 질환에 대한 SPM의 유효성은 설치류에 대한 연구에서 입증되었다[6]. 예를 들어, RvE1, RvD2, 프로텍틴 D1(PD1), 및 LXA4는 병원성 슈도모나스 깅기발리스(Pseudomonas gingivalis)[7], 이. 콜라이(E.coli)[8], 단순 포진(Herpes simples)[9], 칸디다(Candida)[10], H5N1 인플루엔자(Influenza)[11]의 제거를 증진시킨다.
LXA4, LXB4, RvE1, RvE3, RvD1-5, RvD2, PD1, MaR1, MaR2는 치주염, 낭포성 섬유증, 신경염증, 허혈성 뇌졸중, 알츠하이머 질환[12], 죽상동맥경화증[13], 비-알콜성 지방간 질환[14], 각막 손상[15], 망막병증[16], 녹내장[17], 대장염[18], 천식[19, 20], 인슐린 저항성[14], 관절염[21] 및 통증[22]의 모델에서 보호적이다. 또한, SPM의 몇몇 전구체는 그 자체가 해소-촉진 효과를 발휘하는 것으로 나타났다. 예를 들어, 18-히드록시-에이코사펜타엔산(18-HEPE)은 혈관 내피 세포에 대한 단핵구 부착을 억제하고[23] 압력 과부하-유도된 부적응 심장 리모델링을 억제함으로써[24] 심혈관 질환의 발생을 방해한다. 유사하게, 17,18-EEQ는 심장-보호, 항부정맥, 혈관확장 및 항염증 특성을 갖는다[5]. 장 신경교 세포에 의한 ARA-유래 15-HETE의 파라크린 분비는 예를 들어 크론 질환에서 손상되는 과정인 장 장벽 기능을 지지한다[25].
그러나, 이들 유망한 전임상 발견을 인간 건강의 개선으로 해석하는 것은 도전적인 것으로 나타났다. 실험 연구에서 수행된 바와 같이, 정맥내 또는 복강내 주사에 의한 SPM의 직접 전달은 인간에 대해 실현가능하지 않고, 특히 예방적 접근법의 맥락에서 실현가능하지 않다. SPM- 또는 SPM 전구체-함유 보충제 또는 식품의 경구 전달은 생물학적 유체에서 그의 상대적으로 짧은 반감기로 인해 합리적이지 않으며, 따라서 그의 표적 조직에 도달할 가능성이 없다. 이와 관련하여, WO 2017/041094에는 농축된 에스테르화 어유가 단지 ~ 0.0005 %의 18-HEPE 및 17-HDHA를 함유하고, 심지어 초임계 유체 추출에 의한 이들 SPM 전구체의 농축도 0.05 %(18-HEPE + 17-HDHA)/총 오메가-3 이하를 수득한다고 개시한다.
EPA/DHA를 사용한 임상 시험은 특히 염증 장 질환, 천식, 및 대사 증후군의 형질을 갖는 환자에 대해 결정적이지 않거나 무효한 결과를 수득하였다[2]. 인간에 대한 이익의 이러한 결여는 SPM에 의한 각각의 동물 질환 모델의 효과적인 치료와 대조적이다[6]. 우리는 오메가-3(및 오메가-6)의 SPM으로의 전환이 다중불포화 지방산(PUFA)을 사용하여 염증 질환을 예방, 치유, 또는 치료하는 것을 목표로 하는 임의의 개입으로부터의 성공적인 결과를 전달하는데 결정적인 중대한 단계라고 판단한다. 우리는 또한 SPM-제조 기구가 특정 조건 하에 제대로 기능을 하지 않는 것으로 생각한다. 이러한 아이디어는 당뇨병성 상처[26], 대사 증후군[27], 천식[19, 28], 궤양성 대장염[29], 크론 질환[25] 및 치주염[30]에서의 감소된(국부 또는 순환) SPM 수준, 뿐만 아니라 중증 천식[28], 궤양성 대장염[29], 낭포성 섬유증[31], 치주염[30] 및 알츠하이머 질환[12]에서의 SPM-제조 효소의 감소된 발현 또는 활성의 발견에 의해 지지된다.
따라서, 본 발명의 목적은 상기 언급된 상태를 앓고 있는 인간 및 동물에게 이익을 제공하기 위해 유기체 내부에서의 SPM 형성을 촉진하고 오메가-3 단독의 보충을 거의 또는 전혀 성공하지 못하는 이러한 및 유사한 상태를 예방, 개선 또는 치유하기 위한 신규 전략을 필요로 하는 기술을 제공하는 것이다.
이러한 목표는, 조합 기술이 오메가-3 공급원 단독과 비교하여 증진된 및/또는 표적화된 효능을 전달하도록, 적합한 제제에서 적합한 오메가-3 공급원을 새로 발견된 미생물 SPM-생산자와 조합하는 본 발명에 의해 달성된다. 적합한 제제는 소장에서 먼 위장 절편에서 성분의 동시 방출을 가능하게 하여, 오메가-3 공급원이 소장에서 흡수되는 것을 방지하고 미생물 SPM-생산자에 의한 대사에 보다 이용가능하게 한다.
SPM의 생합성은 진핵 세포, 특히 과립구 및 단핵구에 대해 상세하게 기재되어 있다. 대식세포는 SPM 생합성에 필요한 모든 효소를 발현할 수 있다; 선택된 효소만을 발현하는 다른 세포 유형은 상보성 세포와 함께 그렇게 할 수 있다. ALOX5는 비만 세포에서, ALOX12는 피부 및 상피 세포에서, ALOX15는 수지상 및 장 신경교 세포에서[25], 및 COX-2 및 CYP450 이소형은 상피 세포에서 발견된다.
장 미생물총이 식품 성분에 대한 개체의 반응을 결정하고 후속적으로 건강 결과를 변형시킨다는 것을 고려하여, 우리는 이를 촉진된 내인성 SPM 제조의 우리의 기술적 접근법에 대한 표적으로서 확인하였다. 미생물총-표적화 전략은 일반적으로 미생물총의 조성 및 활성을 변형시키기 위한 의도로 프리바이오틱스 및 프로바이오틱스의 적용을 포함한다. 프로바이오틱스는 살아있는 미생물이며, 이는 적절한 양으로 투여될 때 숙주에 건강상 이익을 부여한다(FAO-WHO; Probiotics in food. Health and nutritional properties and guidelines for evaluation; FAO Food and Nutritional Paper 85, 2006). 프리바이오틱스는 유익한 미생물의 성장을 지지한다. 오메가-3 지방산의 프리바이오틱 효과가 기재되어 있지만[32, 33], 그 반대의 경우, 오메가-3에 대한 장 미생물의 가능한 대사 영향이 결정되어야 하는 것으로 남아있고, 본 발명에 개시되어 있다. 장-거주 미생물에서의 산소-소모 효소의 발생은 제한적이며; 병원성 슈도모나스 아에루기노사(Pseudomonas aeruginosa)에 의해 발현되는 15-리폭시게나제를 제외하고는, 시클로옥시게나제 및 리폭시게나제는 위장 박테리아 및 고세균에 존재하지 않는 것으로 보인다[34]. CYP450 모노옥시게나제는 바실루스 속(Genus Bacillus)에서 검출되었다[35]. CYP450BM-3으로 또한 명명되는 CYP102A1은 연속적인 옥시게나제 및 리덕타제 활성을 통해 다중불포화 지방산의 NADPH-의존성 히드록실화를 촉매하는 바실루스 메가테리움 종에서 발견되는 이관능성 효소이다. 이 P450 시스템은 하나는 헤모단백질을 함유하고 다른 하나는 FAD-리덕타제를 함유하는 2개의 상이한 도메인을 갖는 폴리펩티드 쇄로 이루어진다. 이 박테리아 시토크롬 P450 군은 가용성이고 [2Fe-2S] 유형의 철-황 단백질을 통해 NADH-의존성 FAD-함유 리덕타제로부터 반응 메카니즘에 필요한 전자를 수득한다[36]. 발현 벡터 구축물로부터 유래된 정제된 CYP450BM-3은 무세포 반응에서 EPA로부터 18-HEPE를 생성하는 것으로 나타났다[37]. 그러나, 야생형 프로바이오틱 균주가 세포 외 EPA/DHA의 18-HEPE 또는 다른 SPM으로의 활성화를 위한 "촉매"인 프로바이오틱 또는 신바이오틱 전략에서의 이러한 반응의 가능한 적용은, 보다 중요하게는 이들 분자를 숙주에게 이용가능하게 하는 것으로 기재되지 않았다. 또한, 임의의 다른 프로바이오틱 미생물에 의한 오메가-3 또는 오메가-6 화합물의 임의의 다른 SPM 또는 생물활성 지질 매개인자로의 산소화는 지금까지 기재되지 않았다.
본 발명은 바실루스 메가테리움 속에 속하는 적어도 하나의 프로바이오틱 균주, 및 에이코사펜타엔산(EPA), 도코사헥사엔산(DHA), 아라키돈산(ARA), 알파 리놀렌산, 스테아리돈산, 에이코사테트라엔산, 도코사펜타엔산, 리놀레산, γ-리놀렌산으로부터 선택된 적어도 하나의 오메가-3 또는 오메가-6 지방산을 포함하는 다중불포화 지방산 성분을 포함하며, 여기서 다중불포화 지방산 성분은 오메가-3 또는 오메가-6 지방산 염을 포함하는 것인 제제에 관한 것이다.
이러한 새로운 제제는 장 내강에서의 다양한 SPM의 형성을 촉진하고, 이에 의해 이들은 숙주에게 이용가능하게 되고 그 안에서 생리학적 기능을 발휘한다. EPA/DHA로부터 SPM의 생합성에 필요한 산소는 장 내강에서 이용가능하다: 인간 직장 내의 기체는 보고에 따르면 0.3 - 1.8 % 산소를 함유한다[38]. 또한, (혈관화) 맹장 점막을 향해 1에서 40 mmHg pO2로 증가하는 관강내 산소의 방사상 분배가 쥐에 대해 기재되었으며[39], 이는 점막과 연관된 내기성 미생물이 산소-의존성 생화학적 반응을 허용하는 상대적으로 산소-풍부한 환경에 직면함을 나타낸다.
바실루스 메가테리움 종의 박테리아는 이러한 효과에 특히 적합한 것으로 밝혀졌다. 따라서, 프로바이오틱 균주는 이 종의 균주를 포함한다. 본 발명의 중대한 특징은 균주가 숙주에 대한 생리학적 효과를 도출하기 위한 필수 조건인 SPM의 세포 외 양을 초래한다는 것이다. 우리는 나노몰 수준에서 세포 외 SPM의 바실루스 메가테리움-의존성 제조를 개시하고 -여기서 일부 SPM은 인간 혈장에 대해 보고된 것[27, 40, 41] 및 부분적으로 모유에 대해 보고된 것[42]을 초과하는 피코몰 수준[6]에서 생리학적으로 활성이다.- 본 발명에 따르면, 박테리아 세포의 모든 성분을 포함하는 전체 세포 및 용해된 박테리아 세포 둘 다를 사용하는 것이 실현가능하다. 세포 추출물이 또한 사용될 수 있다.
바실루스 메가테리움은 최근에 인간 분변[43] 및 타액[44] 샘플에서 검출되었으며, 이는 이들 박테리아가 인간 장의 거주물임을 나타낸다. 따라서 본 발명은 또한 천연 발생 장 거주물로서, 예를 들어 바실루스 메가테리움 종의 균주를 통한 위장 미생물총에 의한 위장관에서의 다양한 SPM의 형성을 촉진하기 위한 오메가-3 또는 오메가-6 성분의 용도를 포함한다.
본 발명의 균주의 세포는, 특히 본 발명의 조성물에, 포자(휴면상태임)로서, 영양 세포(성장 중임)로서, 전이 상태 세포(성장기에서 포자형성기로 전이 중임)로서, 또는 이들 유형의 세포 중 적어도 2종, 특히 모두의 조합으로서 존재할 수 있다. 따라서, 바람직한 실시양태에서, 프로바이오틱 균주는 휴면 형태로 또는 영양 세포로서 존재한다.
바람직한 실시양태에서, 오메가-3 또는 오메가-6 지방산은 유리 지방산, 염, 천연 트리글리세리드, 어유, 인지질 에스테르 또는 에틸 에스테르의 형태이다.
추가의 바람직한 구성에서, 지방산은 오메가-3 지방산 EPA 및 DHA로부터 선택되거나 또는 여기서 오메가-6 지방산 성분은 ARA이다.
본 발명의 추가적인 구성은 상기-언급된 조성물들 중 임의의 것과 헴 생합성을 증진함으로써[45] 바실루스 메가테리움의 옥시제나제 활성을 촉발할 수 있는 화합물인 5-아미노레불린산의 조합이다.
바람직한 실시양태에서, 프로바이오틱 균주는 하기 중 하나 이상으로부터 선택된다: 바실루스 메가테리움 DSM 32963, DSM 33296 또는 DSM 33299.
바실루스 메가테리움 DSM 32963, DSM 33296 및 DSM 33299는 자연 발생 단리물의 스크리닝에 의해 확인되었다. 이들은 2018 년 11 월 27 일(DSM 32963) 및 2019 년 10 월 17 일에 에보닉 데구사 게엠베하(Evonik Degussa GmbH)의 명칭으로 이전에 언급된 수탁 번호 하에 특허 절차상 목적을 위해 미생물 기탁의 국제적 승인에 대한 부다페스트 조약의 규정 하에 DSMZ에 기탁되었다.
따라서, 본 발명에 따른 제제에 사용되는 바실루스 메가테리움 균주는 하기 군으로부터 선택된다:
a) DSMZ에 DSM 32963, DSM 33296 및 DSM 33299 하에 기탁된 바실루스 메가테리움 균주 중 하나;
b) 균주 DSM 32963의 모든 식별 특성을 갖는 DSM 32963 하에 기탁된 바실루스 메가테리움 균주의 돌연변이체, 여기서 상기 돌연변이체는 바람직하게는 균주 DSM 32963에 대해 적어도 95 %, 바람직하게는 적어도 96, 97 또는 98 %, 보다 바람직하게는 적어도 99 또는 99.5 %의 DNA 서열 동일성을 갖는다;
c) (a) 또는 (b)의 제제;
d) (a), (b) 또는 (c)에 함유된 대사물의 유효 혼합물을 함유하는 제제.
DSMZ에 DSM 32963 하에 기탁된 바실루스 메가테리움 균주는 하기 특징화 서열을 나타낸다:
a) 서열식별번호(SEQ ID NO): 1 또는 서열식별번호: 2에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 16S rDNA 서열;
b) 서열식별번호: 3에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 yqfD 서열;
c) 서열식별번호: 4에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 gyrB 서열;
d) 서열식별번호: 5에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 rpoB 서열;
e) 서열식별번호: 6에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 groEL 서열.
DSM 33296 하에 DSMZ에 기탁된 바실루스 메가테리움 균주는 하기 특징화 서열을 나타낸다:
a) 서열식별번호: 13 또는 서열식별번호: 14에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 16S rDNA 서열;
b) 서열식별번호: 15에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 yqfD 서열;
c) 서열식별번호: 16에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 gyrB 서열;
d) 서열식별번호: 17에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 rpoB 서열;
e) 서열식별번호: 18에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 groEL 서열.
DSM 33299 하에 DSMZ에 기탁된 바실루스 메가테리움 균주는 하기 특징화 서열을 나타낸다:
a) 서열식별번호: 25 또는 서열식별번호: 26에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 16S rDNA 서열;
b) 서열식별번호: 27에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 yqfD 서열;
c) 서열식별번호: 28에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 gyrB 서열;
d) 서열식별번호: 29에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 rpoB 서열;
e) 서열식별번호: 30에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 groEL 서열.
따라서, 본 발명의 추가 대상은 바실루스 메가테리움 균주, 특히 상기 언급된 바와 같은 비. 메가테리움 균주이며, 하기 특징 중 적어도 하나, 바람직하게는 모두를 나타낸다:
a) 서열식별번호: 1 또는 서열식별번호: 2, 서열식별번호: 13 또는 서열식별번호: 14 또는 서열식별번호: 25 또는 서열식별번호: 26에 따른 폴리뉴클레오티드 서열에 대해 적어도 99 %, 바람직하게는 적어도 99.5 %, 보다 바람직하게는 적어도 99.8 또는 99.9 %, 특히 100 %의 서열 동일성을 갖는 16S rDNA 서열;
b) 서열식별번호: 3, 서열식별번호: 15 또는 서열식별번호: 27에 따른 폴리뉴클레오티드 서열에 대해 적어도 99 %, 바람직하게는 적어도 99.5 %, 보다 바람직하게는 적어도 99.8 또는 99.9 %, 특히 100 %의 서열 동일성을 갖는 yqfD 서열;
c) 서열식별번호: 4, 서열식별번호: 16 또는 서열식별번호: 28에 따른 폴리뉴클레오티드 서열에 대해 적어도 99 %, 바람직하게는 적어도 99.5 %, 보다 바람직하게는 적어도 99.8 또는 99.9 %, 특히 100 %의 서열 동일성을 갖는 gyrB 서열.
바람직하게는, 이러한 비. 메가테리움 균주는 하기 추가의 특징 중 적어도 하나, 보다 바람직하게는 모두를 나타낸다:
d) 서열식별번호: 5, 서열식별번호: 17 또는 서열식별번호: 29에 따른 폴리뉴클레오티드 서열에 대해 적어도 99 %, 바람직하게는 적어도 99.5 %, 보다 바람직하게는 적어도 99.8 또는 99.9 %, 특히 100 %의 서열 동일성을 갖는 rpoB 서열;
e) 서열식별번호: 6, 서열식별번호: 18 또는 서열식별번호: 30에 따른 폴리뉴클레오티드 서열에 대해 적어도 99 %, 바람직하게는 적어도 99.5 %, 보다 바람직하게는 적어도 99.8 또는 99.9 %, 특히 100 %의 서열 동일성을 갖는 groEL 서열.
따라서, 본 발명의 특정 대상은 또한 하기 특징을 나타내는 바실루스 메가테리움 균주이다:
a) 서열식별번호: 1 또는 서열식별번호: 2, 서열식별번호: 13 또는 서열식별번호: 14 또는 서열식별번호: 25 또는 서열식별번호: 26에 따른 16S rDNA 서열;
b) 서열식별번호: 3, 서열식별번호: 15 또는 서열식별번호: 27에 따른 yqfD 서열;
c) 서열식별번호: 4, 서열식별번호: 16 또는 서열식별번호: 28에 따른 gyrB 서열.
바람직하게는, 이러한 비. 메가테리움 균주는 하기 추가의 특징을 나타낸다:
d) 서열식별번호: 5, 서열식별번호: 17 또는 서열식별번호: 29에 따른 rpoB 서열;
e) 서열식별번호: 6, 서열식별번호: 18 또는 서열식별번호: 30에 따른 groEL 서열.
유리한 구성에서, EPA 및 DHA는 유리 지방산, 염, 천연 트리글리세리드, 어유, 인지질 에스테르 또는 오메가-3 에틸 에스테르의 형태이다.
EPA 및 DHA는 이들이 지방산 염으로서 첨가되었을 때 프로바이오틱 균주에 의해 SPM으로 효과적으로 형질전환되었고, 그의 제조 및 적용은 이전에 개시되었다. WO2016102323A1에는 산화에 대해 안정화될 수 있는 다중불포화 오메가-3 지방산 염을 포함하는 조성물이 기재되어 있다. WO2017202935A1은 오메가-3 지방산 염 및 아민을 포함하는 조성물의 제조 방법을 개시하며, 여기서 하나 이상의 오메가-3 지방산(들), 하나 이상의 염기성 아민(들) 및 페이스트의 총 중량을 기준으로 20 중량% 이하의 물을 포함하는 페이스트를 균질 페이스트가 수득될 때까지 혼련한다.
따라서, 본 발명의 바람직한 구성에서 오메가-3 성분은 아미노산이 리신, 아르기닌, 오르니틴, 히스티딘, 시트룰린, 콜린 및 그의 혼합물로부터 선택된 염기성 아미노산으로부터 선택된 것인 오메가-3 지방산 아미노산 염을 포함한다.
추가의 바람직한 구성에서, 아미노산은 리신, 아르기닌, 오르니틴, 콜린 및 이들의 혼합물로부터 선택된 염기성 아미노산으로부터 선택된다.
리신의 아미노산 염을 사용하는 것이 가장 바람직하다.
본 발명의 또 다른 바람직한 구성은 프로바이오틱 균주에 대한 생체이용률을 추가로 개선시키기 위한 오메가-3 분산액(아마도 리포솜)의 제제이다. 이러한 분산액 제제는 바람직하게는 인지질 혼합물(예를 들어, 탈유 해바라기 레시틴) 또는 한정된 인지질, 예를 들어 디올레일포스파티딜콜린(DOPC)으로 이루어진다. 이러한 분산액 제제의 가장 바람직한 형태는 유리 오메가-3 지방산 염 또는 유리 오메가-3 지방산을 함유한다.
따라서, 이러한 바람직한 실시양태에서 다중불포화 지방산 성분은 적어도 하나의 인지질 및 적어도 하나의 오메가-3 지방산의 분산액을 포함하는 제제를 포함한다.
추가의 바람직한 실시양태에서, 다중불포화 지방산 성분은 적어도 하나의 인지질의 분산액 및 오메가-3 또는 오메가-6 지방산으로부터 유래된 음이온과 양이온의 적어도 하나의 지방산 염을 포함하는 제제를 포함한다. 오메가-3 지방산을 사용하는 것이 특히 바람직하다.
본 발명의 대안적 구성에서 인지질은 40 중량% 초과, 바람직하게는 70 중량%, 보다 바람직하게는 90 중량% 초과의 포스파티딜콜린 함량 및 5 중량% 미만, 바람직하게는 1 중량% 미만의 포스파티딜에탄올아민 함량을 포함하는 탈유 인지질이다.
대안적 실시양태에서 인지질은 총 지방산의 70 중량% 초과의 올레산 및/또는 리놀레산 함량을 갖는 비-수소화 인지질이다.
본 발명의 추가의 바람직한 구성에서 지방산 염에 대한 인지질의 질량비는 0.001 초과, 바람직하게는 0.05 초과, 보다 바람직하게는 0.01 초과, 보다 바람직하게는 0.09 초과, 가장 바람직하게는 0.39 초과이다.
대안적 실시양태에서 제제는 pH 6.5 내지 7.5의 pH 값에서 물과 혼합되는 경우에 1μm 미만, 바람직하게는 500 nm 미만, 가장 바람직하게는 250 nm 미만의 평균 입자 크기를 갖는 콜로이드성 분산액을 생성하는 분말 또는 액체의 형태이다.
또 다른 실시양태에서 성분은 인지질 및 지방산 염 둘 다가 100 μg 이하의 양으로 존재하고 검출가능하도록 서로 미세하게 분산된다.
본 발명의 제제의 장내 전달을 위한 바람직한 제제는 위 상태에 대한 보호를 제공하는 제제, 또는 소장에서 제제의 표적화 방출을 제공하는 제제 또는 대장에서 제제의 표적화 방출을 제공하는 제제이다. 따라서, 바람직한 실시양태에서, 제제는 지연 방출 또는 장 또는 결장 방출을 위한 코팅을 포함한다.
본 발명의 한 대상은 사료 또는 식품 보충제로서의 본 발명에 따른 제제의 용도 또는 식품에서의 그의 용도이다. 본 발명에 따른 바람직한 식품은 초콜릿 제품, 젤리, 뮤즐리, 뮤즐리 바 및 유제품이다.
본 발명의 추가의 대상은 또한 사료 또는 식품 제품의 신바이오틱 성분으로서의 본 발명의 제제의 용도이다.
본 발명의 추가의 대상은 본 발명에 따른 제제 및 바람직하게는 단백질, 탄수화물, 지방, 추가의 프로바이오틱스, 프리바이오틱스, 효소, 비타민, 면역 조절제, 우유 대체품, 미네랄, 아미노산, 항 콕시듐증 제제, 산-기재 제품, 의약, 및 그의 조합으로부터 선택된 적어도 하나의 추가의 사료 또는 식품 성분을 함유하는 사료- 또는 식품 조성물이다.
본 발명에 따른 사료- 또는 식품 조성물은 또한 환제, 캡슐, 정제 또는 액체 형태의 식이 보충제를 포함한다.
본 발명의 추가의 대상은 본 발명에 따른 제제 및 제약상 허용되는 담체를 함유하는 제약 조성물이다.
본 발명의 추가의 대상은 제약 제품의 제조를 위한 제제의 용도이다.
본 발명에 따른 제제는, 동물 또는 인간에게 투여되는 경우에, 바람직하게는 동물 또는 인간의 건강 상태, 특히 장 건강, 심혈관 건강, 심장-대사 건강, 폐 건강, 관절 건강, 눈 건강, 정신 건강, 구강 건강 또는 면역 건강을 개선시킨다.
따라서, 본 발명의 추가의 대상은 동물 또는 인간의 건강 상태, 특히 장 건강, 심혈관 건강, 심장-대사 건강, 폐 건강, 관절 건강, 눈 건강, 정신 건강, 구강 건강 또는 면역 건강을 개선시키기 위한 본 발명에 따른 조성물이고, 본 발명의 일부이다.
본 발명에 따른 유리한 구성은 하기 중 하나 이상에 의해 동물 또는 인간의 건강 상태를 개선시키기 위한 조성물이다:
- 위장 미생물에 의한 그의 제조를 통해 숙주에서 하기 지질 매개인자의 총량을 증가시키는 것:
17-히드록시-DHA(17-HDHA), 14-히드록시-DHA(14-HDHA), 13-히드록시-DHA(13-HDHA), 7-히드록시-DHA(7-HDHA), 4-히드록시-DHA(4-HDHA), 18-히드록시-에이코사펜타엔산(18-HEPE), 15-히드록시-에이코사펜타엔산(15-HEPE), 12-히드록시-에이코사펜타엔산(12-HEPE), 11-히드록시-에이코사펜타엔산(11-HEPE), 8-히드록시-에이코사펜타엔산(8-HEPE), 5-히드록시-에이코사펜타엔산(5-HEPE), 15-히드록시-에이코사테트라엔산(15-HETE), 12-히드록시-에이코사테트라엔산(12-HETE), 11-히드록시-에이코사테트라엔산(11-HETE), 8-히드록시-에이코사테트라엔산(8-HETE), 5-히드록시-에이코사테트라엔산(5-HETE), 9-히드록시옥타데카디엔산(9-HODE), 13-히드록시옥타데카디엔산(13-HODE), 19Z-도코사헥사엔산(PDX), 프로텍틴 D1(PD1), 아스피린-촉발 PD1(AT-PD1), 마레신 1(MaR1), 마레신 2(MaR2), 류코트리엔 B4(LTB4), t-LTB4, 레졸빈 D1-5(RvD1-5), 아스피린-촉발 RvD1(AT-RvD1), 레졸빈 E1(RvE1), 레졸빈 E3(RvE3), 리폭신 A4(LXA4), 리폭신 A5(LXA5), 리폭신 B4(LXB4), 리폭신 B5(LXB5),
- 숙주에서 EPA의 총량을 증가시키는 것,
- 숙주에서 DHA의 총량을 증가시키는 것.
본 발명의 추가의 대상은 또한 적합한 매트릭스 또는 담체를 사용하여 피부, 눈 및 구강 공동 상에 국소 적용하기 위한 본 발명의 제제의 용도이다.
바람직한 구성에서, 제제는 나노셀룰로스를 포함하는 사전-합성된 다상 생체물질 상에 및/또는 내에 로딩되며, 여기서 나노셀룰로스는 하기로부터 선택된 박테리아 합성된 나노셀룰로스(BNC)이다:
- 셀룰로스 섬유 또는 나노위스커의 네트워크를 포함하는 BNC,
- 셀룰로스 피브릴의 2개 이상의 상이한 층을 포함하며, 여기서 각각의 층은 상이한 미생물로부터의 또는 상이한 조건 하에 배양된 미생물로부터의 BNC로 이루어진 것인 BNC,
- 적어도 2종의 상이한 셀룰로스 네트워크를 포함하는 BNC 또는
- 중합체를 추가로 포함하는 BNC 복합 물질.
나노셀룰로스는 나노-구조화 셀룰로스를 지칭하는 용어이다. 이는 셀룰로스 나노결정(CNC 또는 NCC), 마이크로피브릴화 셀룰로스(MFC)로도 불리는 셀룰로스 나노섬유(CNF), 또는 박테리아에 의해 제조된 나노-구조화 셀룰로스를 지칭하는 박테리아 나노셀룰로스(BNC)일 수 있다. BNC는 셀룰로스 제조에서 가장 높은 효율을 제공하는 최상의 박테리아 종 중 하나인 코마가타에이박터 크실리누스(Komagataeibacter xylinus)와 같은 균주에 의해 제조된 나노피브릴 중합체이다. BNC는 독특한 특성, 예컨대 화학적 순도, 탁월한 기계적 강도, 높은 가요성, 높은 흡수성, 뛰어난 성형성 및 연성 및 많은 다른 것으로 인한 임의의 형상 및 크기의 형성 가능성을 갖는 생체물질이다. 또한, 상기 물질은 채식이고 높은 수분 함량을 포함한다.
박테리아 셀룰로스는 3-차원 네트워크이고 미생물 및 추가의 물질을 고정하고 포획하기 위한 담체이다. 고정화된 생물제제(미생물 포함)는 계 내/생체 내 생물활성 대사물(예를 들어 항미생물제, 대사 생물활성제)의 생합성, 미생물 및 생물활성제의 촉발된 방출을 위해 사용되고/거나 발효 공정을 위한 고정화된 초소형공장으로서 사용된다.
본 발명의 추가의 대상은 또한 SPM의 생명공학적 제조를 위한, 하기 특징을 나타내는, 휴면 형태의 또는 영양 세포로서의 바실루스 메가테리움 균주의 용도이다:
a) 서열식별번호: 1 또는 서열식별번호: 2, 서열식별번호: 13 또는 서열식별번호: 14, 서열식별번호: 25 또는 서열식별번호: 26에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 16S rDNA 서열; 및/또는
b) 서열식별번호: 3, 서열식별번호: 15 또는 서열식별번호: 27에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 yqfD 서열; 및/또는
c) 서열식별번호: 4, 서열식별번호: 16, 서열식별번호: 28에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 gyrB 서열; 및/또는
d) 서열식별번호: 5, 서열식별번호: 17, 서열식별번호: 29에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 rpoB 서열; 및/또는
e) 서열식별번호: 6, 서열식별번호: 18, 서열식별번호: 30에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 groEL 서열.
작업 실시예
실시예 1: 균주 바실루스 메가테리움 DSM 32963, DSM 33296 및 DSM 33299는 각각 시토크롬 P450 모노옥시게나제(CYP450)에 대한 유전자 서열을 보유한다
균주 바실루스 메가테리움 DSM 32963, DSM 33296 및 DSM 33299를 각각 웨스트팔리아(Westphalia) 동부의 깨끗한 정원으로부터의 토양 샘플로부터 단리하였다. 이들은 2018 년 11 월 27 일(DSM 32963) 및 2019 년 10 월 17 일에 에보닉 데구사 게엠베하의 명칭으로 이전에 언급된 수탁 번호 하에 특허 절차상 목적을 위해 미생물 기탁의 국제적 승인에 대한 부다페스트 조약의 규정 하에 DSMZ에 기탁되었다.
비. 메가테리움 DSM 32963의 게놈 서열은 비. 메가테리움 ATCC 14581(AAA87602.1)의 P450 BM3(CYP102A1)에 대해 아미노산 수준에서 97.9 %의 동일성을 갖는 단백질을 코딩하는 유전자 [서열식별번호: 7]를 함유한다. 이 효소는 P450 옥시게나제 및 NADPH:P-450 리덕타제 둘 다를 혼입한다[46]. P450 BM3의 천연 기질은 장쇄 지방산(C12 내지 C20)인 것으로 분석되었고, 이는 오로지 말단하 위치(ω-1 내지ω-3)에서 히드록실화된다[47].
P450 BM3에 비해 비. 메가테리움 DSM 32963의 게놈 서열 내에서 확인된 서열에 대해 부분 서열 히트 상의 21.1 % 내지 30.5 % 범위의 아미노산 수준에 대한 보다 낮은 서열 유사성이 관찰되었다. 이들 추가의 잠재적인 시토크롬 유전자는 P450 BM3[서열식별번호: 8 - 12]에 비해 유사한 기능을 가질 수 있다(표 1 참조).
표 1: 바실루스 메가테리움 DSM 32963의 단백질 서열에 대한 P450 BM3의 BLASTp(히트 열에서의 SEQ ID 는 상응하는 뉴클레오티드 서열을 지칭함)
비. 메가테리움 DSM 33296의 게놈 서열은 비. 메가테리움 ATCC 14581(AAA87602.1)의 P450 BM3(CYP102A1)에 대해 아미노산 수준에서 98.9 %의 동일성을 갖는 단백질을 코딩하는 유전자[서열식별번호: 19]를 함유한다. 이 효소는 P450 옥시게나제 및 NADPH:P-450 리덕타제 둘 다를 혼입한다[46]. P450 BM3의 천연 기질은 장쇄 지방산(C12 내지 C20)인 것으로 분석되었고, 이는 오직 말단하 위치(ω-1 내지ω-3)에서 히드록실화된다[47].
P450 BM3에 비해 비. 메가테리움 DSM 33296의 게놈 서열 내에서 확인된 서열에 대해 부분 서열 히트 상의 21.5 % 내지 30.7 % 범위의 아미노산 수준에 대한 보다 낮은 서열 유사성이 관찰되었다. 이들 추가의 잠재적인 시토크롬 유전자는 P450 BM3[서열 20 - 24]에 비해 유사한 기능을 가질 수 있다(표 2 참조).
표 2: 바실루스 메가테리움 DSM 33296의 단백질 서열에 대한 P450 BM3의 BLASTp(히트 열에서의 서열은 상응하는 뉴클레오티드 서열을 지칭함)
비. 메가테리움 DSM 33299의 게놈 서열은 비. 메가테리움 ATCC 14581(AAA87602.1)의 P450 BM3(CYP102A1)에 대해 아미노산 수준에서 96.1 %의 동일성을 갖는 단백질을 코딩하는 유전자[서열식별번호: 31]를 함유한다. 이 효소는 P450 옥시게나제 및 NADPH:P-450 리덕타제 둘 다를 혼입한다[46]. P450 BM3의 천연 기질은 장쇄 지방산(C12 내지 C20)인 것으로 분석되었고, 이는 오직 말단하 위치(ω-1 내지ω-3)에서 히드록실화된다[47].
P450 BM3에 비해 비. 메가테리움 DSM 33299의 게놈 서열 내에서 확인된 서열에 대해 부분 서열 히트 상의 20.9 % 내지 30.5 % 범위의 아미노산 수준에 대한 보다 낮은 서열 유사성이 관찰되었다. 이들 추가의 잠재적인 시토크롬 유전자는 P450 BM3[서열식별번호: 32 - 37]에 비해 유사한 기능을 가질 수 있다(표 3 참조).
표 3: 바실루스 메가테리움 DSM 33299의 단백질 서열에 대한 P450 BM3의 BLASTp(히트 열에서의 서열은 상응하는 뉴클레오티드 서열을 지칭함)
실시예 2: 포스페이트 완충액 중 디올레일포스파티딜콜린(DOPC)을 갖는 오메가-3 지방산 분산액의 제조
오메가-3 지방산 분산액의 제제를 제조하기 위해 0.8 g의 디올레일포스파티딜콜린(DOPC, 리포이드 게엠베하(Lipoid GmbH))을 1 ml 에탄올 중에 용해시켰다. 0.2 g의 어유(오메가-3 1400, 도펠헤르츠(Doppelherz)®), 오메가-3 에틸 에스테르(프로노바퓨어(PronovaPure)® 500:200 EE, 바스프(BASF)) 또는 오메가-3 리신 염 형태의 유리 오메가-3 지방산의 리신 염(아배일옴(AvailOm)®, 에보닉)을 첨가하고 용해시켰다. 유리 오메가-3 지방산 염의 경우에, 증류수 20 μl를 첨가하여 생성물을 완전히 용해시켰다.
오메가-3 리신 염 형태의 유리 오메가-3 지방산의 리신 염(아배일옴®, 에보닉)은 약 67 %의 지방산 및 다량의 오메가-3 지방산 EPA 및 DHA 및 소량의 오메가-3 지방산 도코사펜타엔산 및 오메가-6 지방산 아라키돈산, 도코사테트라엔산 및 도코사엔산 이성질체를 함유한다.
1 ml의 각각의 용액을 45 ℃의 온도에서 강하게 교반하면서 20 ml의 0.1 M 포스페이트 완충액, pH = 8에 적가하였다. 그 후, 분산액을 얼음 상에 놓고 15 분 동안 초음파 처리하여 나노미터 규모 분산액, 아마도 리포솜(브랜슨 소니파이어(Branson Sonifier), 100 % 진폭, 50 % 임펄스)을 생성하였다. 최종적으로, 분산액을 0.2 μm 주사기 필터를 통해 멸균 여과하였다. 생성된 분산액을 동적 광 산란(DLS) 측정(제타사이저 나노(Zetasizer Nano) ZS, 말번(Malvern))을 통해 입자 크기와 관련하여 특성화되었다. 분산액은 40 g/l 인지질 및 10 g/l 오메가-3 지방산 또는 에스테르를 함유하였다.
실시예 3: 균주 비. 메가테리움 DSM 32963은 세포 내 18-히드록시-에이코사펜타엔산(18-HEPE)을 제조할 수 있다
비. 메가테리움 DSM 32963에 대해 SPM-제조 효소(들)의 연관된 세포 내 활성이 입증될 수 있다. 0.1 % 글루코스(LBG)를 함유하는 10 ml 루리아 베르타미 브로쓰(Luria Bertami broth)(LB, 써모 피셔 사이언티픽(Thermo Fisher Scientific))로부터 비. 메가테리움 DSM 32963의 배양물을 100 ml 플라스크에서 24 시간 동안 30 ℃ 및 200 rpm에서 성장시켰다. 완전 배양물을 LBG 중 200 ml 주 배양물로 옮겼다. 주 배양물을 2 l 플라스크에서 30 ℃ 및 200 rpm에서 6 시간 동안 성장시켰다. 이어서 세포 배양물을 10 ml 부분으로 수확하고, 상등액을 원심분리(15 분, 4000 rpm, 실온)에 의해 제거하고, 세포 펠렛을 각각 10 ml LBG 및 2 ml의 보충제 중에 재현탁시켰다(표 2). 이들 배양물을 100 ml 진탕 플라스크에서 16 시간 동안 30 ℃ 및 200 rpm에서 인큐베이션하였다.
상이한 형태의 에이코사펜타엔산(EPA) 및 도코사헥사엔산(DHA) 공급원을 비. 메가테리움 DSM 32963 세포 배양물에 0.4 g/l의 최종 농도로 오메가-3 리신 염(에보닉의 아배일옴®), 어유(도펠헤르츠®의 오메가-3 1400), 및 오메가-3 에틸 에스테르(바스프의 프로노바퓨어® 500:200 EE)의 형태로 첨가하였다. 이들 물질을 초음파 처리된 에멀젼 및 분산액 제제(실시예 2에 기재된 제제)로서 각각 첨가하였다.
오메가-3 지방산 함량이 없는 DOPC 제제, 및 PBS 완충액을 EPA가 없는 대조군으로서 사용하였다.
표 2: 보충제, 저장 용액의 제제, 및 그의 계산된 EPA 함량(g/l)
상등액을 원심분리(15 분, 4000 rpm, 실온)에 의해 분리한 다음, 세포 배양물을 각각 수확하였다. 그 후, 상등액을 물/아세토니트릴 혼합물로 이루어진 용매로 희석하였다(상등액:용매 비는 1:2, 용매 조성: 65 % H2O, pH 8 및 35 % MeCN). 펠렛을 밤새 동결 건조시키고 물/아세토니트릴 혼합물로 이루어진 용매(펠렛:용매 비는 1:2였음, 용매 조성: 65 % H2O, pH 8 및 35 % MeCN) 중에 재현탁시켰다. 세포 파괴를 리보라이저(Ribolyser)에서 용해 매트릭스(Lysing Matrix) 튜브(0.1 mm 실리카 구체)에서 수행하였다.
세포 균질화액(및 희석된 상등액)을 여과한 다음 m/z 318에서의 양성 SIM-모드 뿐만 아니라 m/z 302에서의 전구체 화합물 EPA에서의 LC/ESI-MS 분석(애질런트(Agilent) QQQ 6420, 제미니(Gemini) 3μ C6-페닐)에 의한 18-히드록시-에이코사펜타엔산(18-HEPE)의 검출에 사용하였다.
비. 메가테리움 세포에 오메가-3 리신 염, 오메가-3 에틸 에스테르, DOPC를 갖는 오메가-3 리신 염 분산액, 또는 DOPC를 갖는 어유 분산액의 형태로의 EPA의 첨가는 18-HEPE의 세포 연관된(= 세포 내 + 세포 외 흡착된) 축적을 초래하였다(표 3). 단연코 세포 내 18-HEPE의 가장 높은 값은 오메가-3 리신 염의 첨가에 의해 달성되었다; 다른 접근법에서보다 10배 더 높았다.
표 3: 바실루스 메가테리움 DSM 32963 세포의 세포 추출물 중 세포 연관된 18-HEPE의 농도(mg/ml)
실시예 4: 바실루스 메가테리움 DSM 32963과 오메가-3 지방산 염 아배일옴®의 분산액 제제의 신바이오틱 조합은 세포 외 양의 18-HEPE를 초래한다
세포 외 출현 18-HEPE의 양을 조사하기 위해, 비. 메가테리움 DSM 32963 세포를 실시예 1에 기재된 바와 같이 배양하였다. 세포를 타우로콜레이트, 인지질 및 담즙 계면활성제를 모의하도록 설계된 다른 성분의 혼합물인 9.76 g/l FeSSIF-V2(biorelevant.com)를 함유하는 LBG 또는 10 ml LBG 중에 재현탁시키고, 2 ml의 보충제(표 2)를 각각 첨가하였다. 추가로, 보충제를 또한 세포가 없는 진탕 플라스크 내의 상이한 배지에 각각 첨가하고 동일한 조건 하에 처리하였다(대조군). 배양 상등액 및 대조군의 18-HEPE 농도를 16 시간, 30 ℃ 및 200 rpm에서의 인큐베이션 후에 측정하였다(표 4). 바실루스 메가테리움 DSM 32963 세포는 세포 외에서 검출가능한 오메가-3 리신 염(아배일옴®) 분산액으로부터 18-HEPE를 합성할 수 있는 것으로 나타날 수 있다. 주목할 만하게, 이 방법에 의해 검출된 오메가-3 → 18-HEPE 전환율은 0.075 이하이며, 이는 WO 2017/041094에 개시된 에스테르화 어유 중 18-HEPE의 기초 함량을 0.0005 % 초과한다. 보다 중요하게는, 우리는 오메가-3 리신 염이 바실루스 메가테리움 균주에 의해 생리학적 관련성을 갖는 18-HEPE보다 훨씬 더 높은 농도에서 다수의 (최종) SPM 생성물로 전환된다는 것을 발견하였다(실시예 6 참조).
표 4: 배양물 상등액 및 대조군의 측정된 18-HEPE 농도(mg/l)
실시예 5: 상이한 바실루스 종에 의한 EPA의 생체변환
상이한 바실루스 종이 세포 내 18-HEPE를 제조하는 능력을 조사하기 위해, 상이한 종의 세포를 실시예 1에 기재된 바와 같이 배양하였다. 세포를 담즙 계면활성제를 모의하도록 설계된 타우로콜레이트, 인지질 및 다른 성분의 혼합물인 9.76 g/l FeSSIF-V2(biorelevant.com)를 함유하는 10 ml LBG 중에 재현탁시키고, 1.2 ml의 오메가-3 리신 염 분산액과 DOPC를 각각 첨가하였다. 30 ℃ 및 200 rpm에서 16 시간 동안 인큐베이션한 후 세포의 내부 18-HEPE 농도를 실시예 3에 기재된 바와 같이 측정하였다.
오직 바실루스 메가테리움 세포만이 오메가-3 리신 염(아배일옴®) 분산액으로부터 내부적으로 18-HEPE를 합성할 수 있었으며, 비. 서브틸리스(B.subtilis), 비. 아밀로리퀘파시엔스(B. amyloliquefaciens), 비. 푸밀루스(B. pumilus) 및 비. 리케니포르미스(B. licheniformis)는 그렇지 않았다.
표 5: 비. 메가테리움 DSM 32963 세포의 세포 내 측정된 18-HEPE 함량(mg/ml)
실시예 6: 상이한 배양 조건 하에 오메가-3 지방산 염 아배일옴®으로부터 바실루스 메가테리움 DSM 32963에 의한 SPM의 제조
지질대사체:
박테리아 상등액 샘플을 RP-상 고체 상 추출을 사용하여 지질 추출에 적용하고 후속적으로 공개된 절차에 따라 초고성능 액체 크로마토그래피 ESI 탠덤 질량 분광법(UPLC-MS/MS)에 의해 분석하였다[48]. 이들 조건 하에 5-히드록시-에이코사펜타엔산 5-HEPE, 8-HEPE, 11-HEPE, 12-HEPE, 15-HEPE, 18-HEPE, 5-히드록시-에이코사테트라엔산(5-HETE), 8-HETE, 11-HETE, 12-HETE, 15-HETE, 4-히드록시-DHA(4-HDHA), 7-HDHA, 13-HDHA, 14-HDHA, 17-HDHA, 리폭신 A4(LXA4), LXB4, 레졸빈 E1(RvE1), RvE3, 레졸빈 D1-5(RvD1-5), AT-RvD1, RvD2, 프로텍틴 D1(PD1), AT-PD1, 마레신 1(MaR1), MaR2, 4개의 지방산 기질을 포함한 대략 40종의 상이한 LM이 1 pg의 검출 하한치로 검출될 수 있다.
바실루스 메가테리움이 18-HEPE에 추가로 다른 PUFA 산소화 생성물을 제조할 수 있는지를 조사하기 위해, 실시예 4에서와 같이 아배일옴®과 함께 배양된 바실루스 메가테리움 균주 32963으로부터의 상등액의 지질대사체 스크리닝을 담즙산과 함께 또는 없이 용해되어 또는 분산액 제제 중에서 수행하였다. 아배일옴® 제제의 세포가 없는 제제를 처리하고 동시에 분석하였고 이는 산소화 생성물의 비-효소적, 자발적 형성에 대한 대조군으로서의 역할을 하였다. 표 6에 주어진 값은 형성된 생성물의 순 농도, 즉 대조군 값의 차감 후를 나타낸다. 볼 수 있는 바와 같이, SPM을 포함한 수많은 산소화 생성물이 박테리아에 의해 형성되었다. 여러 SPM의 농도는 인간 혈장 샘플에서 발견되는 SPM의 농도를 훨씬 초과하며, 이는 전형적으로 ~ 20-100 pg/ml의 범위이다[27, 40, 41]. 비교를 위해, 인간 모유는 ~ 6.000 pg/ml RvE1 및 ~ 10.000 pg/ml RvD1을 함유한다[42]. SPM이 설치류에 대해 시험관 내 및 생체 내에서 nM 또는 심지어 pM 범위로 수용체-매개 효과를 발휘한다는 사실을 고려하면[6], 표 6에 나타낸 발견은 본 발명의 생리학적 및 치료적 중요성을 강하게 암시한다.
PUFA 제제의 유형은 생성물 수준에 큰 영향을 미쳤고, 이는 일반적으로 PUFA 분산액 제제의 존재 및/또는 가용화제로서의 담즙산의 첨가에서 더 높았다. 동시에, 모노-히드록실화 SPM 전구체 5-HEPE, 11-HEPE, 12-HEPE, 15-HEPE, 18-HEPE, 5-HETE, 8-HETE, 및 9-HODE의 풍부함은 분산액 제제 및 담즙산의 부재 하에 아배일옴으로 처리된 샘플에 비해 이들 샘플에서 더 낮았다. 이는 이들 전구체의 디- 및 트리히드록실화 지방산으로의 증가된 전환에 의해 설명될 수 있다.
표 6: 바실루스 메가테리움 DSM 32963 세포의 PUFA 산소화 생성물의 세포 외 농도
실시예 7: 다른 바실루스 메가테리움 균주에 의한 오메가-3 지방산 염 아배일옴®의 분산액 제제로부터의 SPM의 제조
다양한 서식지로부터 공급된 47개의 추가의 바실루스 메가테리움 균주를 그의 SPM 제조 능력에 대해 스크리닝하여 이것이 바실루스 메가테리움 종의 일반적인 현상인지 측정하고 제조되는 SPM의 유형 및 양에서 균주-특이적 차이를 검출하였다. 오메가-3 지방산 공급원으로서의 역할을 하는 아배일옴®의 분산액 제제와 함께, 세포를 실시예 4에 상술된 바와 같이 배양하였다. 아배일옴®의 세포가 없는 제제를 처리하고 동시에 분석하였고 이는 산소화 생성물의 비-효소적, 자발적 형성에 대한 대조군으로서의 역할을 하였다. 모든 시험된 균주는 측정가능한(> 1 pg/ml) 양의 다양한 SPM 및 그의 전구체를 제조하였고, 이들의 양은 균주 사이에서 크게 상이하였고(최대 2.000배), RvE3의 농도는 대부분의 균주에서 특히 높은 것(최대 1.3 μg/ml)이 관찰되었다.
표 7에 주어진 값은 최고 성능 균주, 바실루스 메가테리움 DSM 33296 및 바실루스 메가테리움 DSM 33299 중 2종에 의해 형성된 PUFA 산소화 생성물의 순 농도를 나타낸다.
표 7: 바실루스 메가테리움 DSM 33296 및 바실루스 메가테리움 DSM 33299 세포의 PUFA 산소화 생성물의 세포 외 농도.
실시예 8: 식품 보충제로서 또는 약물로서 EPA-DHA 아미노산 염 및 바실루스 메가테리움 균주(들)를 포함하는 캡슐
하기 성분을 HPMC 캡슐(크기 00)에 충전하였다.
표 7: HPMC 캡슐에 충전하기 위한 제제 *아미노산은 L-오르니틴, L-리신 및 L-아르기닌으로부터 선택된다. #바실루스 메가테리움 DSM 32963, DSM 33296, DSM 33299로부터 선택된 균주.
캡슐은 L-오르니틴, L-아스파르테이트, L-리신 및 L-아르기닌으로부터 선택된 아미노산을 추가로 함유할 수 있다.
캡슐은 아라비녹실란, 보리 곡물 섬유, 귀리 곡물 섬유, 호밀 섬유, 밀겨 섬유, 이눌린, 프룩토올리고사카라이드(FOS), 갈락토올리고사카라이드(GOS), 저항성 전분, 베타-글루칸, 글루코만난, 갈락토글루코만난, 구아 검 및 크실로올리고사카라이드로부터 선택된 추가의 탄수화물 성분을 추가로 함유할 수 있다.
캡슐은 생강, 계피, 자몽, 파슬리, 심황, 강황, 올리브 과일, 파낙스 인삼, 양고추냉이, 마늘, 브로콜리, 스피룰리나, 석류, 콜리플라워, 케일, 실란트로, 녹차, 양파, 및 밀크시슬로부터 선택된 1종 이상의 식물 추출물을 추가로 함유할 수 있다.
캡슐은 아스타잔틴, 목탄, 키토산, 글루타티온, 모나콜린 K, 식물 스테롤, 식물 스타놀, 술포라판, 콜라겐, 히알루론, 포스파티딜콜린을 추가로 함유할 수 있다.
캡슐은 비오틴, 비타민 A, 비타민 B1(티아민), 비타민 B2(리보플라빈), 비타민 B3(니아신), 비타민 B5(판토텐산), 비타민 B9(폴산 또는 폴레이트), 비타민 C(아스코르브산), 비타민 D(칼시페롤), 비타민 E(토코페롤 및 토코트리에놀) 및 비타민 K(퀴논)로부터 선택된 비타민 또는 황, 철, 염소, 칼슘, 크로뮴, 코발트, 구리, 마그네슘, 망가니즈, 몰리브덴, 아이오딘, 셀레늄, 및 아연으로부터 선택된 미네랄을 추가로 포함할 수 있다.
참고문헌
1. 문헌 [Balk EM, Lichtenstein AH: Omega-3 Fatty Acids and Cardiovascular Disease: Summary of the 2016 Agency of Healthcare Research and Quality Evidence Review. Nutrients 2017, 9(8).]
2. 문헌 [Calder PC: Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta 2015, 1851(4):469-484.]
3. 문헌 [Papanikolaou Y, Brooks J, Reider C, Fulgoni VL, 3rd: U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008. Nutr J 2014, 13:31.]
4. 문헌 [Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL: Trends in the use of complementary health approaches among adults: United States, 2002-2012. Natl Health Stat Report 2015(79):1-16.]
5. 문헌 [Schunck WH, Konkel A, Fischer R, Weylandt KH: Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases. Pharmacol Ther 2018, 183:177-204.]
6. 문헌 [Serhan CN, Krishnamoorthy S, Recchiuti A, Chiang N: Novel anti-inflammatory--pro-resolving mediators and their receptors. Curr Top Med Chem 2011, 11(6):629-647.]
7. 문헌 [Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA et al: Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003, 171(12):6856-6865.]
8. 문헌 [Prescott D, McKay DM: Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production. Am J Physiol Gastrointest Liver Physiol 2011, 301(3):G487-497.]
9. 문헌 [Rajasagi NK, Reddy PB, Mulik S, Gjorstrup P, Rouse BT: Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology. Invest Ophthalmol Vis Sci 2013, 54(9):6269-6279.]
10. 문헌 [Baillie JK, Digard P: Influenza--time to target the host? N Engl J Med 2013, 369(2):191-193.]
11. 문헌 [Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, Watanebe T, Sakabe S, Daidoji T, Nakamura S et al: The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 2013, 153(1):112-125.]
12. 문헌 [Zhu M, Wang X, Sun L, Schultzberg M, Hjorth E: Can inflammation be resolved in Alzheimer's disease? Ther Adv Neurol Disord 2018, 11:1756286418791107.]
13. 문헌 [Kasikara C, Doran AC, Cai B, Tabas I: The role of non-resolving inflammation in atherosclerosis. J Clin Invest 2018, 128(7):2713-2723.]
14. 문헌 [Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Moran-Salvador E, Titos E, Martinez-Clemente M, Lopez-Parra M, Arroyo V et al: Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 2009, 23(6):1946-1957.]
15. 문헌 [Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, Serhan CN, Dana R: Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci 2009, 50(10):4743-4752.
16. 문헌 [Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, Hong S, Pravda EA, Majchrzak S, Carper D et al: Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 2007, 13(7):868-873.]
17. 문헌 [Livne-Bar I, Wei J, Liu HH, Alqawlaq S, Won GJ, Tuccitto A, Gronert K, Flanagan JG, Sivak JM: Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury. J Clin Invest 2017, 127(12):4403-4414.]
18. 문헌 [Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN: Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci U S A 2005, 102(21):7671-7676.]
19. 문헌 [Barnig C, Frossard N, Levy BD: Towards targeting resolution pathways of airway inflammation in asthma. Pharmacol Ther 2018, 186:98-113.]
20. 문헌 [Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y, Okajima F, Dobashi K, Mori M: Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun 2008, 367(2):509-515.]
21. 문헌 [Perretti M, Norling LV: Actions of SPM in regulating host responses in arthritis. Mol Aspects Med 2017, 58:57-64.]
22. 문헌 [Dalli J, Zhu M, Vlasenko NA, Deng B, Haeggstrom JZ, Petasis NA, Serhan CN: The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype. FASEB J 2013, 27(7):2573-2583.]
23. 문헌 [Liu Y, Fang X, Zhang X, Huang J, He J, Peng L, Ye C, Wang Y, Xue F, Ai D et al: Metabolic profiling of murine plasma reveals eicosapentaenoic acid metabolites protecting against endothelial activation and atherosclerosis. Br J Pharmacol 2018, 175(8):1190-1204.]
24. 문헌 [Endo J, Sano M, Isobe Y, Fukuda K, Kang JX, Arai H, Arita M: 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling. J Exp Med 2014, 211(8):1673-1687.]
25. 문헌 [Pochard C, Coquenlorge S, Jaulin J, Cenac N, Vergnolle N, Meurette G, Freyssinet M, Neunlist M, Rolli-Derkinderen M: Defects in 15-HETE Production and Control of Epithelial Permeability by Human Enteric Glial Cells From Patients With Crohn's Disease. Gastroenterology 2016, 150(1):168-180.]
26. 문헌 [Tang Y, Zhang MJ, Hellmann J, Kosuri M, Bhatnagar A, Spite M: Proresolution therapy for the treatment of delayed healing of diabetic wounds. Diabetes 2013, 62(2):618-627.]
27. 문헌 [Barden AE, Mas E, Croft KD, Phillips M, Mori TA: Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin. Am J Clin Nutr 2015, 102(6):1357-1364.]
28. 문헌 [Miyata J, Arita M: Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases. Allergol Int 2015, 64(1):27-34.]
29. 문헌 [Mangino MJ, Brounts L, Harms B, Heise C: Lipoxin biosynthesis in inflammatory bowel disease. Prostaglandins Other Lipid Mediat 2006, 79(1-2):84-92.]
30. 문헌 [Wang CW, Colas RA, Dalli J, Arnardottir HH, Nguyen D, Hasturk H, Chiang N, Van Dyke TE, Serhan CN: Maresin 1 Biosynthesis and Proresolving Anti-infective Functions with Human-Localized Aggressive Periodontitis Leukocytes. Infect Immun 2015, 84(3):658-665.]
31. 문헌 [Ringholz FC, Buchanan PJ, Clarke DT, Millar RG, McDermott M, Linnane B, Harvey BJ, McNally P, Urbach V: Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis. Eur Respir J 2014, 44(2):394-404.]
32. 문헌 [Robertson RC, Seira Oriach C, Murphy K, Moloney GM, Cryan JF, Dinan TG, Paul Ross R, Stanton C: Omega-3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav Immun 2017, 59:21-37.]
33. 문헌 [Mujico JR, Baccan GC, Gheorghe A, Diaz LE, Marcos A: Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice. Br J Nutr 2013, 110(4):711-720.]
34. 문헌 [Vance RE, Hong S, Gronert K, Serhan CN, Mekalanos JJ: The opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase. Proc Natl Acad Sci U S A 2004, 101(7):2135-2139.]
35. 문헌 [Furuya T, Shibata D, Kino K: Phylogenetic analysis of Bacillus P450 monooxygenases and evaluation of their activity towards steroids. Steroids 2009, 74(12):906-912.]
36. 문헌 [Bernhardt R: Cytochromes P450 as versatile biocatalysts. J Biotechnol 2006, 124(1):128-145.]
37. 문헌 [Capdevila JH, Wei S, Helvig C, Falck JR, Belosludtsev Y, Truan G, Graham-Lorence SE, Peterson JA: The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3. J Biol Chem 1996, 271(37):22663-22671.]
38. 문헌 [Levitt MD: Volume and composition of human intestinal gas determined by means of an intestinal washout technic. N Engl J Med 1971, 284(25):1394-1398.]
39. 문헌 [Albenberg L, Esipova TV, Judge CP, Bittinger K, Chen J, Laughlin A, Grunberg S, Baldassano RN, Lewis JD, Li H et al: Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology 2014, 147(5):1055-1063 e1058.]
40. 문헌 [Polus A, Zapala B, Razny U, Gielicz A, Kiec-Wilk B, Malczewska-Malec M, Sanak M, Childs CE, Calder PC, Dembinska-Kiec A: Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production. Biochim Biophys Acta 2016, 1861(11):1746-1755.]
41. 문헌 [See VHL, Mas E, Prescott SL, Beilin LJ, Burrows S, Barden AE, Huang RC, Mori TA: Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial. Br J Nutr 2017, 118(11):971-980.]
42. 문헌 [Weiss GA, Troxler H, Klinke G, Rogler D, Braegger C, Hersberger M: High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health Dis 2013, 12:89.]
43. 문헌 [Piewngam P, Zheng Y, Nguyen TH, Dickey SW, Joo HS, Villaruz AE, Glose KA, Fisher EL, Hunt RL, Li B et al: Pathogen elimination by probiotic Bacillus via signalling interference. Nature 2018, 562(7728):532-537.]
44. 문헌 [Al-Thubiani ASA, Maher YA, Fathi A, Abourehab MAS, Alarjah M, Khan MSA, Al-Ghamdi SB: Identification and characterization of a novel antimicrobial peptide compound produced by Bacillus megaterium strain isolated from oral microflora. Saudi Pharm J 2018, 26(8):1089-1097.]
45. 문헌 [Miura M, Ito K, Hayashi M, Nakajima M, Tanaka T, Ogura S: The Effect of 5-Aminolevulinic Acid on Cytochrome P450-Mediated Prodrug Activation. PLoS One 2015, 10(7):e0131793.]
46. 문헌 [Ruettinger RT, Wen LP, Fulco AJ: Coding nucleotide, 5' regulatory, and deduced amino acid sequences of P-450BM-3, a single peptide cytochrome P-450:NADPH-P-450 reductase from Bacillus megaterium. J Biol Chem 1989, 264(19):10987-10995.]
47. 문헌 [Kang JY, Kim SY, Kim D, Kim DH, Shin SM, Park SH, Kim KH, Jung HC, Pan JG, Joung YH et al: Characterization of diverse natural variants of CYP102A1 found within a species of Bacillus megaterium. AMB Express 2011, 1(1):1.]
48. 문헌 [Werz O, Gerstmeier J, Libreros S, De la Rosa X, Werner M, Norris PC, Chiang N, Serhan CN: Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity. Nat Commun 2018, 9(1):59.]
SEQUENCE LISTING
<110> Evonik Operations GmbH
<120> Preparation comprising a probiotic strain and a polyunsaturated fatty acid component
<130> file number: 201800212
<160> 37
<170> PatentIn version 3.5
<210> 1
<211> 1549
<212> DNA
<213> Bacillus megaterium DSM 32963
<400> 1
tcggagagtt tgatcctggc tcaggatgaa cgctggcggc gtgcctaata catgcaagtc 60
gagcgaactg attagaagct tgcttctatg acgttagcgg cggacgggtg agtaacacgt 120
gggcaacctg cctgtaagac tgggataact tcgggaaacc gaagctaata ccggatagga 180
tcttctcctt catgggagat gattgaaaga tggtttcggc tatcacttac agatgggccc 240
gcggtgcatt agctagttgg tgaggtaacg gctcaccaag gcaacgatgc atagccgacc 300
tgagagggtg atcggccaca ctgggactga gacacggccc agactcctac gggaggcagc 360
agtagggaat cttccgcaat ggacgaaagt ctgacggagc aacgccgcgt gagtgatgaa 420
ggctttcggg tcgtaaaact ctgttgttag ggaagaacaa gtacaagagt aactgcttgt 480
accttgacgg tacctaacca gaaagccacg gctaactacg tgccagcagc cgcggtaata 540
cgtaggtggc aagcgttatc cggaattatt gggcgtaaag cgcgcgcagg cggtttctta 600
agtctgatgt gaaagcccac ggctcaaccg tggagggtca ttggaaactg gggaacttga 660
gtgcagaaga gaaaagcgga attccacgtg tagcggtgaa atgcgtagag atgtggagga 720
acaccagtgg cgaaggcggc tttttggtct gtaactgacg ctgaggcgcg aaagcgtggg 780
gagcaaacag gattagatac cctggtagtc cacgccgtaa acgatgagtg ctaagtgtta 840
gagggtttcc gccctttagt gctgcagcta acgcattaag cactccgcct ggggagtacg 900
gtcgcaagac tgaaactcaa aggaattgac gggggcccgc acaagcggtg gagcatgtgg 960
tttaattcga agcaacgcga agaaccttac caggtcttga catcctctga caactctaga 1020
gatagagcgt tccccttcgg gggacagagt gacaggtggt gcatggttgt cgtcagctcg 1080
tgtcgtgaga tgttgggtta agtcccgcaa cgagcgcaac ccttgatctt agttgccagc 1140
attcagttgg gcactctaag gtgactgccg gtgacaaacc ggaggaaggt ggggatgacg 1200
tcaaatcatc atgcccctta tgacctgggc tacacacgtg ctacaatgga tggtacaaag 1260
ggctgcaaga ccgcgaggtc aagccaatcc cataaaacca ttctcagttc ggattgtagg 1320
ctgcaactcg cctacatgaa gctggaatcg ctagtaatcg cggatcagca tgccgcggtg 1380
aatacgttcc cgggccttgt acacaccgcc cgtcacacca cgagagtttg taacacccga 1440
agtcggtgga gtaaccgtaa ggagctagcc gcctaaggtg ggacagatga ttggggtgaa 1500
gtcgtaacaa ggtagccgta tcggaaggtg cggctggatc acctccttt 1549
<210> 2
<211> 1549
<212> DNA
<213> Bacillus megaterium DSM 32963
<400> 2
tcggagagtt tgatcctggc tcaggatgaa cgctggcggc gtgcctaata catgcaagtc 60
gagcgaactg attagaagct tgcttctatg acgttagcgg cggacgggtg agtaacacgt 120
gggcaacctg cctgtaagac tgggataact tcgggaaacc gaagctaata ccggatagga 180
tcttctcctt catgggagat gattgaaaga tggtttcggc tatcacttac agatgggccc 240
gcggtgcatt agctagttgg tgaggtaacg gctcaccaag gcaacgatgc atagccgacc 300
tgagagggtg atcggccaca ctgggactga gacacggccc agactcctac gggaggcagc 360
agtagggaat cttccgcaat ggacgaaagt ctgacggagc aacgccgcgt gagtgatgaa 420
ggctttcggg tcgtaaaact ctgttgttag ggaagaacaa gtacaagagt aactgcttgt 480
accttgacgg tacctaacca gaaagccacg gctaactacg tgccagcagc cgcggtaata 540
cgtaggtggc aagcgttatc cggaattatt gggcgtaaag cgcgcgcagg cggtttctta 600
agtctgatgt gaaagcccac ggctcaaccg tggagggtca ttggaaactg gggaacttga 660
gtgcagaaga gaaaagcgga attccacgtg tagcggtgaa atgcgtagag atgtggagga 720
acaccagtgg cgaaggcggc tttttggtct gtaactgacg ctgaggcgcg aaagcgtggg 780
gagcaaacag gattagatac cctggtagtc cacgccgtaa acgatgagtg ctaagtgtta 840
gagggtttcc gccctttagt gctgcagcta acgcattaag cactccgcct ggggagtacg 900
gtcgcaagac tgaaactcaa aggaattgac gggggcccgc acaagcggtg gagcatgtgg 960
tttaattcga agcaacgcga agaaccttac caggtcttga catcctctga caactctaga 1020
gatagagcgt tccccttcgg gggacagagt gacaggtggt gcatggttgt cgtcagctcg 1080
tgtcgtgaga tgttgggtta agtcccgcaa cgagcgcaac ccttgatctt agttgccagc 1140
atttagttgg gcactctaag gtgactgccg gtgacaaacc ggaggaaggt ggggatgacg 1200
tcaaatcatc atgcccctta tgacctgggc tacacacgtg ctacaatgga tggtacaaag 1260
ggctgcaaga ccgcgaggtc aagccaatcc cataaaacca ttctcagttc ggattgtagg 1320
ctgcaactcg cctacatgaa gctggaatcg ctagtaatcg cggatcagca tgccgcggtg 1380
aatacgttcc cgggccttgt acacaccgcc cgtcacacca cgagagtttg taacacccga 1440
agtcggtgga gtaaccgtaa ggagctagcc gcctaaggtg ggacagatga ttggggtgaa 1500
gtcgtaacaa ggtagccgta tcggaaggtg cggctggatc acctccttt 1549
<210> 3
<211> 1188
<212> DNA
<213> Bacillus megaterium DSM 32963
<400> 3
atgaagaatg gatggacaaa ctttgttatt ggtaccgtac gtattcgaat tgttggaaaa 60
ggaattgaac gttttttaaa taattgtgtg agacaacaga ttatgatttc gaatgtccat 120
aaagttgacg gtcaactagc aacagcaacg atattattga aagatgtaaa gaaaattcgt 180
atactaattc gcaacgcaga ttgtaaaatt tattttataa gaggcagagg ttttcctttt 240
ttaacaaaac gagtgatcaa aaatagtgga tttgctttag gttttctttc tttttttatt 300
attcttggtt tgctttccaa catggtgtgg aaagtggaaa ttagcggtgc agaaccacaa 360
acagaacatc aaatgactaa gcagcttgcc aaaataggtg taaaaagagg agagtttcaa 420
tttctgttag aaagtcctga aaaaattcag cgctatttaa cggataatat gaacaatatt 480
acctgggtgg gagtagaagt gcgcggcact tcttatcact tccaagtggt tgaaaaaaat 540
gagcccaagc ctcagcaaaa aacaccttac caacatttga ttgctaaaaa gaaagccatt 600
attacgaatt tgtttgtcga aaaaggacaa cctttagtca aggttaatga ttttgtcaat 660
gaaggcgagg tcctagtttc cggtattatt ggaaacgaaa aaaataaaaa ggtagtagct 720
gctaaaggga aagtctacgg tgaaacatgg tataagtctg aggtggaagt gcctttaaaa 780
actgattttc aggtattaac gggtaatgga tatacgaagc actatttaga ttttcaagct 840
tttaaaatgc ctctttgggc ttttaacaaa gaaaaatacg cctcaaaggt gacagaaaaa 900
gtggagcatc cactctattt tttaaaatgg aaattacctc tgtcgtatga gaaagttgct 960
gtacgagaag aacaaaactc gcagcgcgtc tattctaaac aagaggcggt ggaaaaagct 1020
ttggaaatcg gtcgaaaaaa attactatca actttaggtg aggattctaa aataaaaggt 1080
gaaaaagttt tgcaccaaga acaggacaat ggtaaagtta gattatcaat acattaccaa 1140
gttatagaaa atattgcgaa cactcaacca attattcaag gagattga 1188
<210> 4
<211> 1932
<212> DNA
<213> Bacillus megaterium DSM 32963
<400> 4
gtgatacatt tgacgatgga acaaaaagaa gtacaagcat atgaagctga tcagatacaa 60
gtattagaag gattagaggc tgttcgtaaa cgtccgggga tgtatattgg atcgacgagc 120
gcaaagggtt tacatcatct tgtatgggaa attgtagata atagtattga tgaagcgctg 180
gccggctatt gcgatgaaat taatgttatt atcgaaaagg ataatagtat tacagtcaaa 240
gataacggtc gtggaattcc ggttggtatt caagaaaaaa tgggcagacc tgccgttgaa 300
gttatcttaa cggttcttca tgccggaggt aaatttggcg gcggcggcta taaagtatcc 360
ggtggattac atggtgtagg tgcctcagtt gttaacgcac tttctacctc tttggaagtg 420
tacgtacatc gtgatggtaa agttcattat caaaaatatg aacgaggtgt accggctgct 480
gacttaaaag tagttggaga aacagataaa acaggtactg ttattcaatt ccatccagac 540
ggtgaaattt ttacagaaac gcttgaatac gattttgata cgttagctaa tcgtctgcgt 600
gagttagctt tcttaaatcg cggtattaaa attacgattg aagacaaacg tgaagaagat 660
aaaagacgtg agtatcacta tgaaggcgga attaagtctt acgttgaaca cttaaaccgt 720
gcaaaagaag taattcacga agagccgatc tatattgaag gtaatcgaga caacatttct 780
gtagaaattg ctattcaata taacgatagc tatacaagta atttatattc ttttgcaaac 840
aacattcaca catatgaagg tggaacgcac gaagcaggat ttaaaacagc gttaacgcgt 900
gtaattaacg actatgcacg taaaaacagc gtatttaaag acagtgatgc caatctaacg 960
ggtgaagatg ttcgtgaagg aattacagct atcatctcta ttaagcaccc agatccgcag 1020
tttgaaggac aaacaaaaac aaagctggga aatagtgaag caagaacaat tactgactct 1080
gtgtttgcag aacacttaga aacgtacttg ctagagaacc ctattgtggc gaaaaaggta 1140
attgaaaaag gtttaatggc tgcaagagca agaatggcag ctaaaaaagc tcgtgagctt 1200
acaagacgta aaagcgcgct tgaaatctca aacttaccgg gtaaattagc agattgttca 1260
tcaaaagatc cttctattag cgaactctat gtagtagagg gtgactctgc gggaggatca 1320
gctaagcagg gaagaagccg tcatttccaa gctattttgc ctttacgtgg taaaattatc 1380
aacgtagaga aagcccgttt agataaaatt ttatctaata acgaaattcg tacaatcatt 1440
accgctctag gaacgggtat tggtgacgat tttgatatct cgaaagcacg ctaccataaa 1500
attgtgatca tgacagatgc agacgtggac ggtgcgcata ttcgtacgct tcttctaacg 1560
ttcttctatc gctatatgag acagattatt gagcatggat atgtgtacat tgcccagccg 1620
cctctttaca aagtttcaca aggtaaaaaa gtggagtacg cgtacaacga tcgtcaatta 1680
gaagaggtat tagcttcttt ccctgaaggc gcaaaaccaa accttcagcg ttacaaaggt 1740
ttaggagaga tgaatcctga acaattatgg gaaacaacaa tggatccaga gttccgtacc 1800
cttcttcaag tgaacttgca agatgcaatt gaagctgatg agacatttga aattttaatg 1860
ggcgacaaag tagaaccacg ccgtaatttc attgaagaaa atgctcagta cgtaaaaaat 1920
cttgatattt aa 1932
<210> 5
<211> 3573
<212> DNA
<213> Bacillus megaterium DSM 32963
<400> 5
gtgaatcagt tgacaggtca actagttcag tatggacgcc accgccaacg cagaagttat 60
gctcgtatta gtgaagtttt agagttaccg aacttaatcg agattcaaac ggcttcatac 120
caatggtttt tagatgaagg tttacgagaa atgttccaag atatttctcc gattgatgat 180
tttacaggta acttatcact agaatttatt gattacagct taggtgagcc aaagtattca 240
gtaggagagt ccaaagaacg tgatgtaact tatgcagcac ctcttcgtgt taaggtgcgg 300
ttaattaata aagaaacagg tgaagtaaaa gaccaagatg tgttcatggg agatttccca 360
ttgatgaccg aaacaggtac ctttgtgatt aatggtgctg agcgtgttat cgtatcacag 420
ttggttcgtt caccaagtgt ttactatagt ggaaagcttg ataaaaacgg taaaaaagga 480
tatacagcaa ctgttatccc taaccgtggt gcatggctag aatatgaaac tgatgcaaaa 540
gatgtagtat acgtgcgtat tgatcgtact cgtaaactgc cagtaacagt gctgttacgc 600
gcgctaggtt tcggttctga ccaagagatt atcgatttaa tcggtgataa tgaatacatc 660
cgtaatacgc ttgaaaaaga taatacggaa acaacggaaa aagcgctatt agaaatctat 720
gagcgtttac gtccgggtga accaccgaca gttgagaatg cgaagtctct attagtatct 780
cgcttctttg atccaaaacg atatgactta gcgaacgtag gtcgctataa aattaataaa 840
aagcttcata tcaaacatcg cttatttaat caaaagctag ctgaaacatt agttgatcct 900
gaaacaggtg aaattattgc agaaaaaggc gcaatgattg accgccgtct gctagatcgc 960
ttgattccga tgcttgaagg tggagtaaac ttcaaaactt atagtccggt tggtggagta 1020
gtagaagacg atgttacatt acaatctatt aagatttatg cgccaaatga tccagaaggt 1080
gaaaaaatca tcactgtatc aggtaacgca tatgtaacag aagaagttaa aaatatcaca 1140
cctgctgata ttttagcatc aattagttac ttctttaact tgcttcatca agtaggagac 1200
acagatgata tcgaccactt aggtaaccgt cgtctgcgtt ctgtaggtga attgttacaa 1260
aaccaattcc gtatcggttt atctcgtatg gaacgtgttg ttcgtgaaag aatgtcaatt 1320
caagacacga atacaatcac acctcaacaa ttaattaata ttcgcccagt tattgcggcg 1380
attaaagagt tctttggaag ttctcaatta tcacagttca tggatcaaac gaatccatta 1440
ggcgaattga cgcacaaacg tcgtctttca gctctaggac ctggtggttt aacgcgtgag 1500
cgcgctggtt ttgaagtgcg tgacgttcac tactcccact atggccgtat gtgtccgatt 1560
gaaactccag agggtccgaa tatcgggtta atcaactcac tatcttctta tgcaaaagta 1620
aacaaattcg gtttcatcga aacaccttac cgtcgtatcg atcctgaaac aggtaaagtg 1680
acagagcgaa ttgactactt aacagctgat gaagaagata actatgttgt agcccaagcg 1740
aacgctcgtc taggcgatga tggttcattc ttagatgaaa atgtcgttgc acgtttccgt 1800
ggagaaaaca cggttatccg tcgcgatcgt ttagattata tggatgtatc accaaaacaa 1860
gttgtatctg ccgctacagc atgtatccca ttcttagaga acgatgactc taaccgtgca 1920
ttaatgggtg cgaacatgca acgtcaagca gtacctttat taaatcctga agcaccaatc 1980
gtaggtacag gtatggaata cgtatctggt aaagactctg gtgcagccgt gatttgtaaa 2040
tatcctggcg ttgtagagcg cgtagaagca aaacaaattt ttgttcgccg ctatgaagaa 2100
gtagacggac aaaaagttaa aggtaactta gatcaataca aattattaaa atttgttcgt 2160
tctaaccaag gtacttgtta caaccagcgt ccaattgttt cagttggcga cgaagtagta 2220
aaaggtgaga tcttagccga cggtccttca atggaaaaag gtgagcttgc tttaggacga 2280
aacgtaatgg ttggtttcat gacatgggat ggttacaact atgaggatgc catcatcatg 2340
agtgaacgcc ttgtgaaaga tgatgtatat acgtctgttc atattgaaga atatgaatct 2400
gagtctcgtg atacgaagct tggacctgaa gaaattacgc gtgacattcc aaacgtaggt 2460
gaagatgcgc ttcgcaactt agatgagcgt ggaatcatcc gcattggtgc agaagtaaaa 2520
gacggagatc ttttagttgg taaagtaacg ccaaaaggtg taacagaact aacagctgaa 2580
gaacgtcttc tacacgctat tttcggtgaa aaagcgcgtg aagttcgtga tacttctctt 2640
cgtgtaccgc acggcggcgg tggaatcatt cttgatgtta aagtcttcaa ccgtgaagat 2700
ggcgacgaat taccaccagg tgtaaaccaa ttagtccgtg tatatattgt tcagaagcgt 2760
aaaatttctg aaggtgacaa aatggccggt cgtcacggta acaaaggtgt aatttcacgt 2820
attttacctg aagaagatat gccttatcta ccagacggta cgccaattga catcatgtta 2880
aacccattag gggtaccatc tcgtatgaac atcggtcagg tgctagagct tcatttaggt 2940
atggctgctc gtaagcttgg cattcacgtt gcgtctccag tatttgatgg tgcgcgtgag 3000
gaagatgtgt gggcaacaat cgaagaagct ggcatgtctc gtgatgctaa aacagttcta 3060
tatgatggtc gaacaggtga accattcgat aaccgtgtat cagtaggaat catgtacatg 3120
atcaaacttg ctcacatggt agacgataaa cttcacgctc gttctactgg accatactca 3180
cttgttacac aacaaccact tggtggtaaa gcgcagttcg gtggacagcg ttttggtgag 3240
atggaggtat gggcacttga agcatacggt gctgcttaca cattacaaga gatcttaaca 3300
gtgaaatcag atgacgtagt aggtcgtgtg aaaacatacg aagcaattgt taaaggtgaa 3360
aacattccag aacctggcat acctgaatcg ttcaaagtat taattaaaga actacaaagt 3420
ttaggtatgg atgtgaagat gctttctgct gacgagcaag aaattgatat catggactca 3480
gaagaggacc atgagcaacc aacagaatca attattgctg ataacgaaga aagcctttct 3540
gaaggacaaa aagatcctgt cacaaaagag taa 3573
<210> 6
<211> 1632
<212> DNA
<213> Bacillus megaterium DSM 32963
<400> 6
atggcaaaag acattaaatt tagcgaagaa gcacgtcgcg caatgctacg tggtgtagac 60
acattggcaa atgctgtaaa agtaacgctt ggaccaaaag gtcgtaacgt tgtattagaa 120
aagaaattcg gttcaccgct tattacaaat gacggtgtaa caattgcaaa agaaatcgaa 180
ttagaagacg catttgaaaa tatgggtgct aaattagtag ccgaagttgc tagcaaaaca 240
aacgacgtcg ctggtgacgg tacaactact gcaacagttt tagcgcaagc aatgatcaga 300
gaaggtctta aaaacgtaac ggctggtgct aacccaatgg gtatccgtaa aggtatggaa 360
aaagcagtag ctgtagcggt tgaagaacta aaagcaatct ctaaaccaat tcaaggtaaa 420
gattcaattg ctcaagtagc ggctatctca gcagctgacg aagaagtagg tcaattaatt 480
gctgaagcaa tggagcgcgt tggtaacgac ggcgttatca cacttgaaga atcaaaaggt 540
ttcacaactg aattagaagt ggtagaaggt atgcagtttg accgtggata tgcatctcct 600
tacatggtaa ctgattcaga taaaatggaa gctgtattag atgatccata catcttaatc 660
acagacaaaa aaatcggtaa cattcaagaa atcttaccgg tattagagca agttgttcaa 720
caaggcaagc ccctattaat catcgctgaa gacgtagaag gcgaagcttt agcaacatta 780
gttgtgaaca aacttcgtgg tacattcaca gctgtagctg ttaaagctcc tggtttcggt 840
gatcgtcgta aagcaatgct acaagacgtt gcgatcttaa caggcggaga agtaatcact 900
gaagagcttg gtctcgacct aaaaacagca agcattgatc aattaggtcg cgcttctaaa 960
attgttgtaa caaaagaaaa tacaacggtt gtaaacggtg caggaaacgc agaagacatc 1020
ctagcacgcg taaaccaaat caaagctcag cttgaagaaa caacttcaga gtttgaccgt 1080
gaaaaattac aagagcgctt agcaaaactt gctggtggcg tagctgtaat taaagtgggt 1140
gcggcaactg aaactgagtt aaaagaacgt aaattacgta ttgaagatgc attaaactct 1200
acgcgtgctg cggttgaaga aggtatcgta gctggtggtg gtactgcatt agtaaatatc 1260
tataataaag tagcaagcat cgaagctgac ggtgacactg ctacaggtat caacattgta 1320
ttacgtgcga tcgaagagcc tgtacgtcaa atcgctcaca atgctggttt agaaggatca 1380
gtaatcgttg agcgtctaaa aggcgaagca gttggaactg gattcaatgc tgcaactggc 1440
gagtgggtaa acatgctaga cactggtatc gttgacccaa caaaagtaac gcgttcagct 1500
cttcaaaatg cttcttctgt agcggctatg ttcttaacaa ctgaagcagt tgttgctgac 1560
aagccagaag aaggcggagc acctgcaatg cctgacatgg gcggcatggg tggaatgggc 1620
ggcatgatgt aa 1632
<210> 7
<211> 3150
<212> DNA
<213> Bacillus megaterium DSM 32963
<400> 7
atgacaatta aagaaatgcc tcagccaaaa acgtttggag agcttaaaaa tttaccgtta 60
ttaaacacag ataaaccggt tcaagctttg atgaaaattg cggatgaatt aggagaaatc 120
tttaaattcg aggcgcctgg tcgtgtaacg cgctacttat caagtcagcg tctaattaaa 180
gaagcatgcg atgaatcacg ctttgataaa aacttaagtc aagcgcttaa atttgtacgt 240
gattttgcag gagacgggtt atttacaagc tggacgcacg aaaaaaattg gaaaaaagcg 300
cataatatct tacttccaag cttcagtcag caggcaatga aaggctatca tgcgatgatg 360
gtcgatatcg ccgtgcagct tgttcaaaag tgggagcgtc taaatgcaga tgagcatatt 420
gaagtaccgg aagacatgac acgtttaacg cttgatacaa ttggtctttg cggctttaac 480
tatcgcttta acagctttta ccgagatcag cctcatccat ttattacaag tatggtccgt 540
gcactggatg aagcaatgaa caagctgcag cgagcaaatc cagacgaccc agcttatgat 600
gaaaacaagc gccagtttca agaagatatc aaggtgatga acgacctagt agataaaatt 660
attgcagatc gcaaagcaag cggtgaacaa agcgatgatt tattaacgcg tatgctaaac 720
ggaaaagatc cagaaacggg tgagccgctt gatgacgaga acattcgcta tcaaattatt 780
acattcttaa ttgcgggaca cgaaacaaca agcggtcttt tatcatttgc gctgtatttc 840
ttagtgaaaa atccacatgt attacaaaaa gcagcagaag aagcagcacg agttctagta 900
gatcctgttc caagctacaa acaagtcaaa cagcttaaat atgtcggcat ggtcttaaac 960
gaagcgctgc gcttatggcc aactgctcct gcgttttccc tatatgcaaa agaagatacg 1020
gtgcttggag gagaatatcc tttagaaaaa ggcgacgaac taatggttct gattcctcag 1080
cttcaccgtg ataaaacaat ttggggagac gatgtagaag agttccgccc agagcgtttt 1140
gaaaacccaa gcgcaattcc gcagcatgcg tttaaaccat ttggaaacgg gcagcgcgcg 1200
tgtatcggtc agcagttcgc tcttcatgaa gcaacgcttg tacttggtat gatgctaaaa 1260
cactttgatt ttgaagatca tacaaactac gagctggatg ttaaagaaac tttaacgtta 1320
aaacctgaag gctttgtggt aaaagcaaaa tcgaaacaaa ttccgcttgg cggtattcct 1380
tcacctagca ctgaacagtc tgttaaaaaa gtacgcaaaa aggtagaaaa cgctcataat 1440
acgccgctgc ttgtgctata cggttcgaac atgggaacag ccgaaggaac ggcgcgtgat 1500
ttagcggata ttgcgatgag caaaggattc gcaccgcagg tcgcagcgct tgattcccac 1560
gcaggaaatc ttccgcgcga aggagctgta ttaattgtaa cggcgtctta taacggacac 1620
ccgcctgata acgcaaagca atttgtcgac tggttagacc aagcgtctgc tgatgaagta 1680
aaaggcgttc gctactccgt atttggatgc ggcgataaaa actgggctac tacgtatcaa 1740
aaagtgcctg cttttattga tgaaacgctt gccgctaaag gagcagaaaa catcgctgaa 1800
cgcggtgaag cagatgcaag cgacgacttt gaaggcacat atgaagaatg gcgtgaacac 1860
atgtggagtg acgtagcagc ctactttaac ctcgacattg aaaacagtga agataataaa 1920
tctacgcttt cacttcaatt tgtcgacagc gctgcggaca tgccgcttgc taaaatgcac 1980
ggtgcgtttt cagcaaacgt cgtagcaagc aaagaacttc aacagccagg cagtgaacga 2040
agcacgcgtc atcttgaaat tgaacttcca aaagaaactt cttatcaaga aggagatcat 2100
ttaggcgtta ttcctcgcaa ctatgaagga atagtaaatc gtgtgacgac aagatttggt 2160
ctagatgtat cacagcaaat ccgcttggaa gcagaagaag aaaaattagc gcatttgcca 2220
ctcggtaaaa cagtatcagt agaagagctt ctgcaatacg tagagcttca agaccctgtt 2280
acgcgcacgc agcttcgcgc aatggctgct aaaacggtct gcccgccgca taaagtagag 2340
cttgaagcct tgcttgaaaa gcaagcctac aaagaacaag tgctggcaaa acgtttaaca 2400
atgcttgaac tgcttgaaaa atacccggcg tgtgaaatgg aattcagcga atttatcgcc 2460
cttctgccaa gcatacgccc gcgctattat tcaatttcat cttcacctcg tgtcgatgaa 2520
aaacaagcaa gcattacggt cagcgttgtc tcaggagaag cgtggagcgg atacggagaa 2580
tacaaaggaa ttgcgtcaaa ctaccttgcc gagctgcaag aaggagatac gattacgtgc 2640
tttgtttcta caccgcagtc aggatttacg ctgccaaaag accctaaaac gccgcttatc 2700
atggtcggac cgggaacagg cgttgcaccg tttagaggct ttgtgcaggc tcgcaagcag 2760
ctaaaagaac aagaagagtc gcttggagaa gcgcatttat actttggctg ccgttcacct 2820
catgaagact atctgtatca agaagagctt gaaaacgccc aaaatgaagg catcattacg 2880
cttcataccg ctttttctcg cgtaccaaat cagccgaaaa catacgttca gcacgtaatg 2940
gaacaagacg gcaagaaatt gattgaactt cttgaccaag gagcgcactt ctatatttgc 3000
ggagacggaa gccaaatggc acctgacgtt gaagcaacgc ttatgaaaag ctatgctgac 3060
gttcaccaag tgagtgaagc agacgctcgc ttatggctgc agcagctaga agaaaagggc 3120
cgatacgcaa aagacgtgtg ggctgggtaa 3150
<210> 8
<211> 1812
<212> DNA
<213> Bacillus megaterium DSM 32963
<400> 8
gtgttgcaac ttaaggtagt aaacagccct tttaatcaag aacaagcaga tttgcttaat 60
cgccttctgc cgacattaac agaagcacaa aaaatgtggt tgagcggtta tttaacagca 120
gctcaatcta cgtctgccga aggaacgcca gacgtttcta cagcagcgcc tgctcaaacg 180
aaacagacag tttcaaaaga cgtaacgatt ctttatggat cacaaacagg aaatgctcaa 240
ggacttgctg aaaatacagg caaaacgctt gaagcaaaag gctttaatgt aactgtatct 300
tctatgaatg atttcaaacc aaataattta aagaaacttg aaaatttatt aattgtcgta 360
agtacacatg gagaaggaga gccgcctgat aatgcgctat ctttccatga atttcttcac 420
ggccgtcgag cgccaaaact tgagaacttc cgtttctctg ttttatcgct tggagacagc 480
tcatacgaat ttttctgtca aacaggaaaa gaatttgatg tgcgcttagc agaacttggc 540
ggtgaaagac tgtatccgcg cgttgactgt gatttagatt ttgaagagcc cgcaaataaa 600
tggcttaaag gtgttattga cggattaagc gaagcgaaag gacacagcgc ttcggcagct 660
gttccagcgg aagctcctgc aggaacttca ccatattcaa gaacaaaccc ttttaaagca 720
gaagtgcttg agaacttaaa cttaaacggc cgcggatcaa ataaagaaac gcgacactta 780
gaactatctc tagaaggttc aggtttgacg tatgaaccag gagacagttt aggtatttat 840
cctgaaaatg acccggagct tgttgatctt cttcttaacg aattcaagtg ggatgcaagt 900
gaaagtgtaa cggttaataa agaaggagaa acgcgtcctc ttagagaagc gctaatctct 960
aattttgaaa ttaccgtttt aacaaagccg cttttaaagc aagcagctga gcttactgga 1020
aacgataagt taaaagcgct tgtagaaaat cgcgaggaat taaaagcata cacacaaggc 1080
cgtgatgtaa ttgacttagt tcgtgacttc ggtccatgga acgtatcggc acaagagttt 1140
gtagccattc tacgtaaaat gccagcgcgt ctttactcga ttgcaagcag cttatcagca 1200
aaccctgatg aagttcatct aacaatcgga gcggtacgct acgaagcgca tggacgcgag 1260
cgtaaaggtg tttgttcagt cctttgttca gaacgtttgc agccaggcga tacgattcct 1320
gtataccttc aaagcaataa aaactttaag cttcctcaag atcaagaaac gccaattatt 1380
atggtaggac ctggtacagg tgtggctccg ttccgctcat ttatgcaaga gcgtgaagaa 1440
acaggggcaa aaggaaagtc atggatgttc tttggagatc agcacttcgt aacagacttc 1500
ctttaccaaa cagaatggca aaagtggtta aaagatggcg tactgacaaa aatggacgtg 1560
gcgttttcac gcgatacaga agaaaaagta tacgtacaaa accgtatgct cgaacatagt 1620
aaagaattat tccaatggtt agaagaaggc gcatcttttt atgtgtgcgg agataaaaca 1680
aatatggcac gcgacgtgca caacacgcta gttgaaatta tcgaaacaga aggcaagatg 1740
agccgtgaac aggcggaagg ttaccttgct gaaatgaaga aacaaaaacg ttatcagcgt 1800
gatgtatact ga 1812
<210> 9
<211> 1278
<212> DNA
<213> Bacillus megaterium DSM 32963
<400> 9
ttgccggtta tacagggccc ctcgtcgtat aagcttaccg gtcacctgca aaagtttaga 60
gagaaccccc tgggtttttt ggaaaacttg actcagtatg gagaaattgc aacatttaga 120
gttgcgcaca aacgctttta tgtaacgaga gaccctcaac ttattaaaga tgtagtcatt 180
acaaacagca aggcgtttca aaaaattaaa ctaacgcata tgtttaaaac gctgctaggc 240
gaagaaatgt tatggacaga tgaagcatta tatatgagcc ccattcaacc ctcacaacta 300
aaacaacatc taacttttaa taaggaagca atcgcaaaaa taattgaaaa gcatacggaa 360
acgtgggaag aagggcagct tcgaacaata gtaaaagaca taagacagat agtcatagct 420
gtactccttc aacttgtatt tggcatttcg attgaggaga aagataaaat tcactatgtt 480
caagcgctta tgagaaaaaa agaaaagtta ggcaaaattt atattcgtct acctttgcac 540
cagcctgact cagatgagca gctagaacaa ctcctttttg aacgcgttca aatgcgtgtt 600
caaaacaaaa ccgcaggaaa tgatttactg cagtatatat tgaattctta cggagaagac 660
agcgatgaaa gagaaatata cgaacagcta aattctatat tcctttcgat gtatgaaatg 720
attacgcacg tatgcagctg gtctattcat ttactatctc aaaatactag ggagcacctt 780
cagctgcata aagaaattca agcctatgct agcggcgaat cactttcaac caaaaatctg 840
acctatatgc gcaaaataat tgctgaaagc atgaggttgt atccgcctct ttggctattt 900
gggcgtcaag cacgtgaaga tatacaaata gatggctaca gtattaagaa aggggagatt 960
atgttaatta gcccttatat gatgcatcgc catgaagatt attttttaga gccaagtgaa 1020
tttttacctg accgttttga aaaaggaggg tccattgatg tcccaagcta tatgtatatg 1080
ccacttggga ttgagcatca agcggaaagg ggcatggact atatcactga aatagtcacc 1140
atttttctgt cagaaatgac aaagcgcttt ttatttcagc tgactaagcc cgaatctatt 1200
gctccgatgg cgggcgtaat gctgaatatg aaagaagaac tgaaggtgaa tgttcacaaa 1260
gttcacgcgc agtcttga 1278
<210> 10
<211> 1215
<212> DNA
<213> Bacillus megaterium DSM 32963
<400> 10
atgaaaacag aaagagaaaa cggaattgtc cgtcaagtga atacgattca aacaaaagaa 60
gaacgcttta atcctttttc atggtatgaa gagatgagaa acaccgagcc tgtgcaatgg 120
gatgaaaaaa ggcaggtatg ggatgttttt cactatgacg gggtcaaaga agtgctagaa 180
caaaagaata ttttttcttc tgatcgaaga cctccacaaa accaaagaca aactgctcta 240
ggaacgagcc taattaatat tgatccgcct aagcatgctg aaatgagagc gcttgttaat 300
aaagctttta cgcctaaagc aatgaaagca tgggagccta aaattgcgcg tattacaaat 360
gaattattac aagaagttga gcatcttgaa gatattgata tagtcgagca tctgtcctat 420
ccgcttccgg ttatggtaat tgccgatatt ttaggggtgc cgatagaaga tcagcgtcag 480
tttaaagatt ggtcggatat tatcgtagcc ggtccttcta ataacgaacg tgaaacgctc 540
gaaaaactcc agcaagagaa aatgaaagca aatgatgagc tagaaactta cttttatcga 600
atcattgaag aaaaacgcac gcgtccagga gatgatatta tctccctgct tcttcaggca 660
aaagaagaag ggaaacagct aacggatgaa gagatcgtcg gtttttctat tttgctactg 720
attgctggaa acgaaacaac cacaaattta atttcaaata cgatttattg tttaatggaa 780
gataaagctt cttttgaacg actcaaacga gagaaagaac ttttgccttc tgcgattgaa 840
gaagttcttc gctatcgttc acccgttcag gctcttcacc gaatcgtaaa agaagatgtg 900
actcttgcag gcaagaaact aaaagcgggc gaacacgtcg ttccatggat gggatctgcg 960
catcgagacg cggagtattt tgaagatccg gatgtattta aaatcgatcg aaagccaaat 1020
gtgcacatgg catttggaag aggcattcat ttttgcttag gagcacccct tgctcgaata 1080
gaagcaaaaa ttatgctggc cgagctgatt gaccgctatc cgcagatgga ctggagcccg 1140
tcatttgagt taaagccaat tgaaagcacg tttgtgtacg ggttaaaaga attattgatt 1200
cgtaaaaacg tataa 1215
<210> 11
<211> 1212
<212> DNA
<213> Bacillus megaterium DSM 32963
<400> 11
atgaatccaa aagcagtgaa aagagaaaat cgttatgcta atttaattcc tatgcaagaa 60
attaaatctg ttgaacagca gctttaccca tttgatattt ataatagcct gcgtcaagag 120
gcacctattc gttatgatga aagccgaaac tgctgggatg tatttgatta tgaaacagta 180
aagtatattt taaaaaaccc gtcgcttttt tcatccaaac gagcaatgga agaacgccaa 240
gaaagtattt taatgatgga tcctccaaaa catacaaagt tacgaaattt agtaaacaaa 300
gcttttacgc caagagctat tcagcacttg gagggtcata ttgaagagat tgcagattat 360
ttattagatg aagtaagcag caaagaaaag tttgatatag tagaagactt tgctggacca 420
ctgccgatta ttgtaatagc agagctgcta ggagtaccaa tacaagaccg agcactgttt 480
aaaaagtact ccgatgactt agtgagcggt gccgaaaata attcagacga agcttttgcg 540
aaaatgatgc aaaagcgtaa tgaaggcgtg atttttttac aagggtattt taaagaaatt 600
atcgcggagc gtcagcaaaa taaacaagaa gatctcattt cgcttctttt agaagcagaa 660
atcgacggcg agcatttaac agaagaggaa gtgctggggt tttgtatttt attgctagta 720
gcaggtaatg agacaacaac aaacttaatt acgaacggag ttcggtatat gacagaagat 780
gtagacgtgc agaatgaagt tcgtcgagac atatcgctag ttccgaacct ggtagaagaa 840
acgcttcgct attatcctcc tattcaagcg attggacgca tagctactga agatgtagaa 900
cttggagagt gtaagattaa aagaggacag caggtaatta gctgggcagc gagtgcaaat 960
agagattcag ctaagtttga atggcctgac acttttgtcg tgcatcgtaa aacaaatcct 1020
cacgtgagct ttggatttgg catccatttt tgcttaggag caccactagc aagaatggaa 1080
gggaaaattg cttttactaa gttactagaa aaagggggat tttccaaagt tcagaatcag 1140
tctttaaagc caatagatag cccttttgtt tttggtgtaa aaaaatatga aattgctttt 1200
aataacgcct ga 1212
<210> 12
<211> 1233
<212> DNA
<213> Bacillus megaterium DSM 32963
<400> 12
atgaacaaag aagtcattcc cgttacagaa attccaaaat ttcaatcacg tgcagaagag 60
tttttcccta tccaatggta taaagaaatg ttgaacaact cccccgttta ttttcatgaa 120
gaaacaaaca catggaatgt attccaatac gaacatgtta aacaagtctt gagcaactac 180
gatttttttt caagcgatgg acagagaacc actatttttg ttggagataa tagtaagaaa 240
aaaagcacat ctccaatcac caaccttaca aacttagatc ctcctgacca ccggaaagcg 300
cgatctttgc ttgctgcagc ctttactcct cgcagtttaa ggaactggga accgcgaatc 360
aaacaaattg cagcagaact tgtagaagcg atacaaaaga attcaactat taatattgtg 420
gacgatttat cttctccttt tcctagtcta gttatagcag atctattcgg cgtaccggta 480
aaagaccgat atcagtttaa aaaatgggta gacattctgt ttcagcctta tgatcaagaa 540
agattagaag agattgaaca agaaaagcaa cgtgcaggag ctgaatattt tcaatacctc 600
tacccgattg tcattgaaaa gcgctccaac ctttctgatg atattatctc agacttaatt 660
caagctgaag ttgatggtga aacattcaca gataaagaaa ttgtacacgc taccatgttg 720
cttctaggtg caggcgttga aaccacaagt cacgccattg caaatatgtt ttattctttt 780
ttatatgacg acaagtcgtt atacagcgag ctgagaaaca atagagaatt agctccaaaa 840
gcagtagaag aaatgcttcg atatcggttt catatctcca gacgagatcg cacggttaaa 900
caagataacg agctattagg cgttaagcta aaaaaaggag atgtcgttat tgcgtggatg 960
agtgcatgta atatggatga aactatgttt gaaaaccctt tttctgtaga cattcatcgt 1020
ccaactaata aaaagcactt aacattcgga aacggacctc atttttgttt gggcgcccct 1080
cttgcccgac ttgaaatgaa aattatctta gaagcatttt tagaggcctt ttctcatatt 1140
gaaccatttg aagactttga attagaaccg catttaacag cttcagctac gggtcaatct 1200
ttaacatact tgcccatgac ggtgtacaaa taa 1233
<210> 13
<211> 1549
<212> DNA
<213> Bacillus megaterium strain DSM 33296
<400> 13
tcggagagtt tgatcctggc tcaggatgaa cgctggcggc gtgcctaata catgcaagtc 60
gagcgaactg attagaagct tgcttctatg acgttagcgg cggacgggtg agtaacacgt 120
gggcaacctg cctgtaagac tgggataact tcgggaaacc gaagctaata ccggatagga 180
tcttctcctt catgggagat gattgaaaga tggtttcggc tatcacttac agatgggccc 240
gcggtgcatt agctagttgg tgaggtaacg gctcaccaag gccacgatgc atagccgacc 300
tgagagggtg atcggccaca ctgggactga gacacggccc agactcctac gggaggcagc 360
agtagggaat cttccgcaat ggacgaaagt ctgacggagc aacgccgcgt gagtgatgaa 420
ggctttcggg tcgtaaaact ctgttgttag ggaagaacaa gtacaagagt aactgcttgt 480
accttgacgg tacctaacca gaaagccacg gctaactacg tgccagcagc cgcggtaata 540
cgtaggtggc aagcgttatc cggaattatt gggcgtaaag cgcgcgcagg cggtttctta 600
agtctgatgt gaaagcccac ggctcaaccg tggagggtca ttggaaactg gggaacttga 660
gtgcagaaga gaaaagcgga attccacgtg tagcggtgaa atgcgtagag atgtggagga 720
acaccagtgg cgaaggcggc tttttggtct gtaactgacg ctgaggcgcg aaagcgtggg 780
gagcaaacag gattagatac cctggtagtc cacgccgtaa acgatgagtg ctaagtgtta 840
gagggtttcc gccctttagt gctgcagcta acgcattaag cactccgcct ggggagtacg 900
gtcgcaagac tgaaactcaa aggaattgac gggggcccgc acaagcggtg gagcatgtgg 960
tttaattcga agcaacgcga agaaccttac caggtcttga catcctctga caactctaga 1020
gatagagcgt tccccttcgg gggacagagt gacaggtggt gcatggttgt cgtcagctcg 1080
tgtcgtgaga tgttgggtta agtcccgcaa cgagcgcaac ccttgatctt agttgccagc 1140
atttagttgg gcactctaag gtgactgccg gtgacaaacc ggaggaaggt ggggatgacg 1200
tcaaatcatc atgcccctta tgacctgggc tacacacgtg ctacaatgga tggtacaaag 1260
ggctgcaaga ccgcgaggtc aagccaatcc cataaaacca ttctcagttc ggattgtagg 1320
ctgcaactcg cctacatgaa gctggaatcg ctagtaatcg cggatcagca tgccgcggtg 1380
aatacgttcc cgggccttgt acacaccgcc cgtcacacca cgagagtttg taacacccga 1440
agtcggtgga gtaaccgtaa ggagctagcc gcctaaggtg ggacagatga ttggggtgaa 1500
gtcgtaacaa ggtagccgta tcggaaggtg cggctggatc acctccttt 1549
<210> 14
<211> 1549
<212> DNA
<213> Bacillus megaterium strain DSM 33296
<400> 14
tcggagagtt tgatcctggc tcaggatgaa cgctggcggc gtgcctaata catgcaagtc 60
gagcgaactg attagaagct tgcttctatg acgttagcgg cggacgggtg agtaacacgt 120
gggcaacctg cctgtaagac tgggataact tcgggaaacc gaagctaata ccggatagga 180
tcttctcctt catgggagat gattgaaaga tggtttcggc tatcacttac agatgggccc 240
gcggtgcatt agctagttgg tgaggtaacg gctcaccaag gccacgatgc atagccgacc 300
tgagagggtg atcggccaca ctgggactga gacacggccc agactcctac gggaggcagc 360
agtagggaat cttccgcaat ggacgaaagt ctgacggagc aacgccgcgt gagtgatgaa 420
ggctttcggg tcgtaaaact ctgttgttag ggaagaacaa gtacaagagt aactgcttgt 480
accttgacgg tacctaacca gaaagccacg gctaactacg tgccagcagc cgcggtaata 540
cgtaggtggc aagcgttatc cggaattatt gggcgtaaag cgcgcgcagg cggtttctta 600
agtctgatgt gaaagcccac ggctcaaccg tggagggtca ttggaaactg gggaacttga 660
gtgcagaaga gaaaagcgga attccacgtg tagcggtgaa atgcgtagag atgtggagga 720
acaccagtgg cgaaggcggc tttttggtct gtaactgacg ctgaggcgcg aaagcgtggg 780
gagcaaacag gattagatac cctggtagtc cacgccgtaa acgatgagtg ctaagtgtta 840
gagggtttcc gccctttagt gctgcagcta acgcattaag cactccgcct ggggagtacg 900
gtcgcaagac tgaaactcaa aggaattgac gggggcccgc acaagcggtg gagcatgtgg 960
tttaattcga agcaacgcga agaaccttac caggtcttga catcctctga caactctaga 1020
gatagagcgt tccccttcgg gggacagagt gacaggtggt gcatggttgt cgtcagctcg 1080
tgtcgtgaga tgttgggtta agtcccgcaa cgagcgcaac ccttgatctt agttgccagc 1140
atttagttgg gcactctaag gtgactgccg gtgacaaacc ggaggaaggt ggggatgacg 1200
tcaaatcatc atgcccctta tgacctgggc tacacacgtg ctacaatgga tggtacaaag 1260
ggctgcaaga ccgcgaggtc aagccaatcc cataaaacca ttctcagttc ggattgtagg 1320
ctgcaactcg cctacatgaa gctggaatcg ctagtaatcg cggatcagca tgccgcggtg 1380
aatacgttcc cgggccttgt acacaccgcc cgtcacacca cgagagtttg taacacccga 1440
agtcggtgga gtaaccgtaa ggagctagcc gcctaaggtg ggacagatga ttggggtgaa 1500
gtcgtaacaa ggtagccgta tcggaaggtg cggctggatc acctccttt 1549
<210> 15
<211> 1188
<212> DNA
<213> Bacillus megaterium strain DSM 33296
<400> 15
atgaagaatg gatggacaaa ctttgttatt ggtaccgtac gtattcgaat tgttggaaaa 60
ggaattgaac gttttttaaa taattgtgtg agacaacaga ttatgatttc gaatgtccat 120
aaagttgacg gtcagctagc gacagcaacg atattattga aagatgtaaa aaaaattcgt 180
atactaattc gcaacgcaga ttgtaaaatt tattttataa gaggcagagg ttttcctttt 240
ttaacaaaac gagtaatcaa aaatagtgga tttgctttag gttttctttc tttttttatt 300
attcttggtt tgctttccaa catggtgtgg aaagtggaaa ttagcggtgc agaaccacaa 360
acagaacatc aaatgactaa gcagcttgcc aaaataggtg taaaaagagg agagtttcaa 420
tttctgttag agagtcctga aaaaattcag cgctatttaa cagataatat gaacaatatt 480
acctgggtgg gagtagaagt gcgcggcact tcttatcact tccaagtggt tgaaaaaaat 540
gagcccaagc ctcagcaaaa aacaccttac caacatttaa ttgctaaaaa gaaagccatt 600
attacgaatt tgtttgtcga aaaaggacaa cctttagtca aggttaatga ttttgtcaac 660
gaaggcgagg tcctagtttc cggtattatt ggaaacgaaa aaaataaaaa agtagtagct 720
gctaaaggga aagtctacgg tgaaacatgg tataagtctg aggtggaagt gcctttaaaa 780
actgattttc aggtattaac gggtaatgga tatacgaagc actatttaga ttttcaagct 840
tttaaaatgc ctctttgggc ttttaacaaa gaaaaatacg cctcaaaggt gacagaaaaa 900
gtggagcatc cactctattt ttttaaatgg aaattacctc tgtcgtatga gaaagttgct 960
gtacgagaag aacagaactc gcagcgcgtc tattctaaac aagaggcggt ggaaaaagct 1020
ttggaaatcg gtcgaaaaaa attactatca actttaggtg aggatgctaa aataaaaggt 1080
gaaaaagttt tgcaccaaga acaggacaat ggtaaagtta gattatcaat acattaccaa 1140
gttatagaaa atattgcgaa cactcaacca attattcaag gagattga 1188
<210> 16
<211> 1923
<212> DNA
<213> Bacillus megaterium strain DSM 33296
<400> 16
ttgacgatgg aacaaaaaga agtacaagca tatgaagctg atcagataca agtattagaa 60
ggattagaag ctgttcgtaa acgtccgggg atgtatattg gatcgacgag cgcaaagggt 120
ttacatcatc ttgtatggga aattgtagat aatagtattg atgaagcgct ggccggctat 180
tgcgatgaaa ttaatgttat tatcgaaaag gataatagta ttacagtcaa agataacggt 240
cgtggaattc cggttggtat tcaagaaaaa atgggcagac ctgccgttga agttatctta 300
acggttcttc atgccggagg taaatttggc ggcggcggct ataaagtatc tggtggatta 360
cacggtgtag gtgcctcagt tgttaacgca ctttctacct ctttggaagt gcacgtacat 420
cgtgacggta aagttcatta tcaaaaatat gaacgaggtg taccggctgc tgacttaaaa 480
gtagttggag aaacagataa aacaggtact gttattcaat tccgtccaga cagtgaaatt 540
tttacagaaa cgcttgaata cgattttgac acgttagcta atcgtctgcg tgagttagct 600
ttcttaaatc gcggcattaa aattacgatt gaagacaaac gtgaagaaga taaaagacgt 660
gaatatcact atgaaggcgg aattaagtct tacgttgaac acttgaaccg ttcgaaagaa 720
gtgattcacg aagagcccat ctatattgaa ggtaatcgag acaacatttc tgtagaaatt 780
gctattcaat ataacgatag ctatacaagt aatttatatt cttttgcaaa caacattcac 840
acatatgaag gtggaacgca cgaagcagga tttaaaacag cgttaacgcg tgtaattaac 900
gactatgcac gtaaaaacag cgtatttaaa gacagtgacg ccaatctaac gggtgaagat 960
gttcgtgaag gaattacagc tatcatctct attaagcacc cagatccgca gttcgaagga 1020
caaacaaaaa caaagctggg aaatagtgaa gcaagaacaa ttactgactc tgtgtttgca 1080
gaacacttag aaacttactt gctagagaac cctattgtgg cgaaaaaggt aattgaaaaa 1140
ggtttaatgg ctgcaagagc aagaatggcg gctaaaaaag ctcgtgagct tacacgccgt 1200
aaaagcgcgc ttgaaatttc aaacttaccg ggtaaattag cagattgttc atcaaaagat 1260
ccttctatta gcgaacttta tgtagtagag ggtgactctg caggaggttc agctaagcag 1320
ggaagaagcc gtcatttcca agctattttg cctttacgtg gtaaaattat caacgtagag 1380
aaagcgcgtt tagataaaat tttatctaat aacgaaattc gtacaatcat taccgctcta 1440
ggaacgggta ttggtgacga ttttgatatt tcgaaagccc gctaccataa aattgtgatt 1500
atgacagatg cagacgtaga cggtgcgcat attcgtacgc ttcttctaac gttcttctat 1560
cgctatatga gacagattat tgagcacgga tatgtttaca ttgcccagcc gcctctttac 1620
aaagttacac agggtaaaaa agtggagtac gcgtacaacg atcgtcaatt agaagaggta 1680
ttagcttctt tccctgaagg cgcaaaacca aaccttcagc gttacaaagg tttaggagag 1740
atgaatcctg aacaattatg ggaaacaaca atggatccag agttccgtac ccttcttcag 1800
gtgaacttgc aagatgcaat tgaagctgat gagacatttg aaattttaat gggcgacaaa 1860
gtagaaccac gccgtaattt cattgaagaa aatgctcagt acgtaaaaaa tcttgatatt 1920
taa 1923
<210> 17
<211> 3564
<212> DNA
<213> Bacillus megaterium strain DSM 33296
<400> 17
ttgacaggtc aactagttca gtatggacgc caccgccaac gcagaagtta tgctcgtatt 60
agtgaagttt tagagttacc gaacttaatc gagattcaaa cggcttcata ccaatggttt 120
ttagatgaag gtttacgaga aatgttccaa gatatttctc caattgatga ttttacaggt 180
aacttatcac tagaatttat tgattacagc ttaggtgagc caaagtattc agtaggagag 240
tccaaagaac gtgatgtaac ttatgcagca cctcttcgtg ttaaggtgcg gttaattaat 300
aaagaaacag gtgaagtaaa agaccaagat gtgttcatgg gagatttccc attgatgacc 360
gaaacaggta cctttgtaat taatggtgct gagcgtgtta tcgtatcaca gttggttcgt 420
tcaccaagtg tttactatag tggaaagctt gataaaaacg gtaaaaaagg atatacagca 480
actgttatcc ctaaccgtgg tgcatggcta gaatatgaaa ctgatgcaaa agatgtagta 540
tacgtgcgta ttgatcgtac tcgtaaactg ccagtaacag tgctgttacg cgcgctaggt 600
ttcggttctg accaagagat tatcgattta atcggtgata atgaatacat ccgtaatacg 660
cttgaaaaag ataatacgga aacaacggaa aaagcgctat tagaaatcta tgagcgttta 720
cgtccaggtg aaccaccgac agttgagaat gcgaagtctc tattagtatc tcgcttcttt 780
gatccaaaac gatatgactt agcgaacgta ggtcgctata aaattaataa aaagcttcat 840
atcaaacatc gcttatttaa tcaaaagcta gctgaaacat tagttgatcc tgaaacaggt 900
gaaattattg cagaaaaagg cgcaatgatt gaccgccgtc tgctagatcg cttgattccg 960
atgcttgaag gtggagtaaa cttcaaaact tatagtccgg ttggtggagt agtagaagac 1020
gatgttacat tacaatctat taagatttat gcgccaaatg atccagaagg tgaaaaaatc 1080
atcactgtat caggtaacgc gtatgtaaca gaagaagtta aaaatatcac gcctgctgat 1140
attttagcat caatcagtta cttctttaac ttgcttcatc aagtaggaga cacagatgat 1200
atcgaccact taggtaaccg tcgtctgcgt tctgtaggtg aattgttaca aaaccaattc 1260
cgtatcggtt tatctcgtat ggaacgtgtt gttcgtgaaa gaatgtcaat tcaagacacg 1320
aatacaatca cacctcaaca attaattaat attcgcccag ttattgcggc gattaaagag 1380
ttctttggaa gttctcaatt atcacagttc atggatcaaa cgaatccatt aggcgaattg 1440
acgcacaaac gtcgtctttc agctctagga cctggtggtt taacgcgtga gcgcgctggt 1500
tttgaagtgc gtgacgttca ctactcccac tatggacgta tgtgtccgat tgaaacgcca 1560
gagggtccga atatcgggtt aatcaactca ctatcttctt atgcaaaagt aaacaaattc 1620
ggtttcatcg aaacacctta ccgtcgtatc gatcctgaaa caggtaaagt gacagagcga 1680
attgactact taacagctga tgaagaagat aactatgttg tagcccaagc gaacgctcgt 1740
ctaggtgatg atggttcatt cttagatgaa aatgtcgttg cacgtttccg tggagaaaac 1800
acggttatcc gtcgcgatcg tttagattat atggatgtat caccaaaaca agttgtatct 1860
gccgctacag catgtattcc attcttagag aacgatgact ctaaccgtgc attaatgggt 1920
gcgaacatgc aacgtcaagc agtaccttta ttaaatcctg aagcaccaat cgtaggtaca 1980
ggtatggaat acgtatctgg taaagactct ggtgcagccg tgatttgtaa atatcctggt 2040
gttgtagagc gcgtagaagc aaaacaaatt tttgttcgcc gctatgaaga agtagacgga 2100
caaaaagtta aaggtaactt agatcaatac aaattattaa aatttgttcg ttctaaccaa 2160
ggtacttgtt acaaccagcg tccaattgtt tcagttggcg acgaagtagt aaaaggtgag 2220
atcttagccg acggtccttc aatggaaaaa ggtgagcttg ctttaggacg aaacgtaatg 2280
gttggtttca tgacatggga tggttacaac tatgaggatg ccatcatcat gagtgaacgc 2340
cttgtgaaag acgatgtata tacgtctgtt catattgaag aatatgaatc tgagtctcgt 2400
gatacgaagc ttggacctga agaaattacg cgtgacattc caaacgtagg tgaagatgcg 2460
cttcgtaact tagatgagcg tggaatcatc cgcattggtg cagaagtaaa agacggagat 2520
cttttagttg gtaaagtaac gccaaaaggt gtaacagaac taacagctga agaacgtctt 2580
ctacacgcta ttttcggtga aaaagcgcgt gaagttcgtg atacttctct tcgtgtaccg 2640
cacggcggcg gtggaatcat tcttgatgtt aaagtcttca accgtgaaga tggcgacgaa 2700
ttaccaccag gtgtaaacca attagtccgt gtatatattg ttcagaagcg taaaatttct 2760
gaaggtgaca aaatggccgg tcgtcacggt aacaaaggtg taatttcacg tattttacct 2820
gaagaagata tgccttatct accagacggt acgccaattg acatcatgtt aaacccatta 2880
ggggtaccat ctcgtatgaa catcggtcag gtgctagagc ttcatttagg tatggctgct 2940
cgtaagcttg gcattcacgt tgcgtctcca gtatttgatg gtgcgcgtga ggaagatgtt 3000
tgggcaacaa tcgaagaagc tggcatgtct cgtgatgcta aaacagttct atatgatggt 3060
cgaacaggtg aaccattcga taaccgtgta tcagtaggaa tcatgtacat gatcaaactt 3120
gctcacatgg tagacgataa acttcacgct cgttctactg gaccatactc acttgttaca 3180
caacaaccac ttggtggtaa agcgcagttc ggtggacagc gttttggtga gatggaggta 3240
tgggcacttg aagcatacgg tgctgcttac acattacaag agatcttaac agtgaaatca 3300
gatgacgtag taggtcgtgt gaaaacatac gaagcaattg ttaaaggtga aaacattcca 3360
gaacctggca tacctgaatc gttcaaagta ttaattaaag aactgcaaag tttaggtatg 3420
gatgtgaaga tgctttctgc tgacgagcaa gaaattgata tcatggactc agaagaggac 3480
catgagcaac caacagaatc aattattgct gataacgaag aaagcctttc tgaaggacaa 3540
aaagatcctg tcacaaaaga gtaa 3564
<210> 18
<211> 1632
<212> DNA
<213> Bacillus megaterium strain DSM 33296
<400> 18
atggcaaaag acattaaatt tagcgaagaa gcacgtcgcg caatgctacg tggtgtagat 60
acattagcaa atgctgtaaa agtaacgctt ggaccaaaag gtcgtaacgt tgtattagaa 120
aagaaattcg gttcaccgct tattacaaat gacggtgtaa caattgcaaa agaaatcgaa 180
ttagaagacg catttgaaaa tatgggtgct aaattagtag ccgaagttgc tagcaaaaca 240
aacgacgttg ctggtgacgg tacaactact gcaacagttt tagcgcaagc aatgatcaga 300
gaaggtctta aaaacgtaac ggctggtgct aacccaatgg gtatccgtaa aggtatggaa 360
aaagcagtag ctgtagcggt tgaagaacta aaagcaatct ctaaaccaat tcaaggtaaa 420
gattcaattg ctcaagtagc ggctatctca gcagctgacg aagaagtagg tcaattaatt 480
gctgaagcaa tggagcgcgt tggtaacgac ggcgttatca cacttgaaga atcaaaaggt 540
ttcacaactg aattagaagt ggtagaaggt atgcagtttg accgtgggta tgcatctcct 600
tacatggtaa ctgattcaga taaaatggaa gctgtattag atgatccata catcttaatc 660
acagacaaaa aaatcggtaa cattcaagaa atcttaccgg tattagagca agttgttcaa 720
caaggcaagc ctctattaat catcgctgaa gacgtagaag gcgaagcttt agcaacatta 780
gttgtgaaca aacttcgtgg tacattcaca gctgtagctg ttaaagctcc tggtttcggt 840
gatcgtcgta aagcaatgct acaagacgtt gcgatcttaa caggcggaga agtaatcact 900
gaagagcttg gtcttgactt aaaaacagca agcatcgatc aattaggtcg cgcttctaaa 960
attgtcgtaa caaaagaaaa tacaacagtt gtaaacggtg caggaaacgc agaagacatc 1020
ctagcacgcg taaaccaaat caaagctcag cttgaagaaa caacttcaga gtttgaccgt 1080
gaaaaattac aagagcgctt agcaaaactt gctggtggcg tagctgtaat taaagttggt 1140
gcggcaactg aaactgagtt aaaagaacgt aaattacgta ttgaagatgc attaaactct 1200
acgcgtgctg cggttgaaga aggtatcgta gctggtggtg gtactgcatt agtaaatatc 1260
tataataaag tagcaagcat cgaagctgat ggtgacactg ctacaggtat caacatcgta 1320
ttacgtgcga ttgaagagcc tgtacgccaa attgctcaca acgctggttt agaaggatca 1380
gtaatcgttg agcgtctaaa aggcgaagct gttggaactg gatttaacgc tgcaactggc 1440
gagtgggtaa atatgctaga cactggtatc gttgacccaa caaaagtaac gcgttcagct 1500
cttcaaaatg cttcttctgt agcggctatg ttcttaacaa ctgaagcagt tgttgctgac 1560
aagccagaag aaggcggagc acctgcaatg cctgacatgg gcggcatggg tggaatgggc 1620
ggcatgatgt aa 1632
<210> 19
<211> 3150
<212> DNA
<213> Bacillus megaterium strain DSM 33296
<400> 19
atgacaatta aagaaatgcc tcagccaaaa acgtttggag agcttaaaaa tttaccgtta 60
ttaaacacag ataaaccggt tcaagctttg atgaaaattg cggatgaatt aggagaaatc 120
tttaaattcg aggcgcctgg ccgtgtaacg cgttacttat caagtcagcg tctaattaaa 180
gaagcatgcg atgaatcacg ttttgataaa aacttaagtc aagcgcttaa atttgtacgt 240
gattttgcag gagacgggtt atttacaagc tggacgcacg aaaaaaattg gaaaaaagcg 300
cataatatct tacttccaag cttcagtcag caggcgatga aaggctatca tgcgatgatg 360
gtcgatatcg ccgtgcagct tattcaaaag tgggagcgtc taaatgcaga tgagcatatt 420
gaagtaccgg aagatatgac gcgtttaacg cttgatacaa tcggtctttg cggctttaac 480
taccgcttta acagctttta ccgagatcag ccgcatccgt ttattacgag tatggtccgt 540
gcactggatg aatcgatgaa caagctgcag cgagcaaatc cagatgaccc agcttatgat 600
gaaaacaagc gccagtttca agaagatatc aaggtaatga acaacctagt agataaaatt 660
attgcagatc gcaaagcaag cggtgaacaa agcgatgatt tgttaacaca tatgctaaac 720
ggaaaagatc cagaaacagg tgagccgctt gatgacgaga acattcgcta tcaaattatt 780
acattcttaa ttgcgggaca cgaaacaaca agcggtcttt tatcatttgc gctgtatttc 840
ttagtgaaaa atccacatgt attacaaaaa gcagcagaag aagcagcacg agttctagta 900
gatcctgttc caagctacaa acaagtcaaa cagcttaaat atgtgggcat ggtcttaaac 960
gaagcgctgc gcttatggcc aacggctcct gcgttttccc tatatgcaaa agaagatacg 1020
gtgcttggag gagaatatcc tttagaaaaa ggcgacgaac taatggttct gattcctcag 1080
cttcaccgtg ataaaacaat ttggggagac gatgtggaag agttccgtcc agagcgtttt 1140
gaaaatccaa gtgcgattcc gcagcatgcg tttaaaccgt ttggaaacgg gcagcgtgcg 1200
tgtatcggtc agcagttcgc tcttcatgaa gcaacgctgg tacttggtat gatgctaaaa 1260
cactttgact ttgaagatca tacaaactac gagctggata ttaaagaaac tttaacgtta 1320
aaacctgaag gctttgtggt aaaagcaaaa tcgaaaaaaa ttccgcttgg cggtattcct 1380
tcacctagca ctgaacagtc tgctaaaaaa gtacgcaaaa aggcagaaaa cgctcataat 1440
acgccgctgc ttgtgctata cggttcaaat atgggaacag ctgaaggaac ggcgcgtgat 1500
ttagcagata ttgcaatgag caaaggattc gcaccacagg tcgctaccct tgattcgcac 1560
accggaaatc ttccccgcga aggagctgta ttaattgtaa cggcgtctta taacggacac 1620
ccgcctgata acgcaaagca atttgtcgac tggttagacc aagcgtctgc tgatgaagta 1680
aaaggcgttc gctattccgt atttggatgc ggtgataaaa actgggcgac aacgtatcaa 1740
aaagtgcctg cttttatcga tgaaacgctt gccgctaaag gggcagaaaa catcgctgac 1800
cgcggtgaag cagatgcaag cgacgacttt gaaggcacat atgaagaatg gcgtgaacat 1860
atgtggagtg atgtagcagc ctactttaac ctcgacattg aaaacagtga agataataaa 1920
tctacacttt cacttcaatt cgtcgacagc gccgcggata tgccgcttgc gaaaatgcac 1980
ggtgcgtttt cagcgaacgt cgtagcaagc aaagaacttc aacagccagg cagtgcacga 2040
agcacgcgtc atcttgaaat tgaacttcca aaagaagctt cttatcaaga aggagatcat 2100
ttaggcgtta ttcctcgcaa ctatgaagga atagtaaacc gtgtaacagc aaggttcggc 2160
ctagatgcat cacagcaaat ccatctggaa gcagaagaag aaaaattagc tcatttgcca 2220
ctcgctaaaa cagtatcagt agaagagctt ctgcaatacg tggagcttca agatcctgtt 2280
acgcgcacgc agcttcgcgc aatggctgct aaaacggtct gcccgccgca taaagtagag 2340
cttgaagcct tgcttgaaaa gcaagcctac aaagaacaag tgctggcaaa acgtttaaca 2400
atgcttgaac tgcttgaaaa atacccggcg tgtgaaatgg agttcagcga atttatcgcc 2460
cttctgccaa gcatacgccc gcgctattac tcaatttctt catcacctcg tgtcgatgaa 2520
aaacaagcaa gcatcacggt cagcgttgtc tcaggagaag cgtggagcgg atatggagaa 2580
tataaaggaa ttgcgtcgaa ctatcttgcc gagctgcaag aaggagatac gattacgtgc 2640
tttatttcca caccgcagtc aggatttacg ctgccaaaag accctgaaac gccgcttatc 2700
atggtcggac cgggaacagg cgtcgcgccg tttagaggtt tcgtgcaggc tcgcaaacag 2760
ctaaaagaac aaggacagtc gcttggagaa gcgcatttat acttcggctg ccgttcacct 2820
catgaagact atctgtacca agaagagctt gaaaacgccc aaaatgaagg catcattacg 2880
cttcataccg ctttttctcg cgtgccaaat cagccgaaaa catacgttca gcacgtgatg 2940
gaacaagacg gcaagaaatt gattgaactt cttgatcaag gagcgcactt ctatatttgc 3000
ggagacggag gccaaatggc acctgacgtt gaagcaacgc ttatgaaaag ctatgctgac 3060
gttcaccaag tgagtgaagc agacgctcgc ttatggctgc agcagctaga agaaaaaggc 3120
cgatacgcaa aagacgtgtg ggctgggtaa 3150
<210> 20
<211> 1812
<212> DNA
<213> Bacillus megaterium strain DSM 33296
<400> 20
gtgttgcaac ttaaggtagt aaacagccct tttaatcaag aacaagcaga tttgcttaat 60
cgccttctgc cgacattaac agaagcacaa aaaatgtggt tgagcggtta tttaacagca 120
tctcaatcta cgtctgccga aggaacgcca gacgtttcta cagcagcgcc tgctcaaacg 180
aagcagacag tttcaaaaga cgtaacgatt ctttacggat cacaaacagg aaatgctcaa 240
ggacttgctg aaaatacagg caaaacgctt gaagcaaaag gctttaatgt aactgtatct 300
tctatgaatg atttcaaacc aaataattta aagaaacttg aaaatttatt aattgtcgta 360
agtacacatg gagaaggaga gccgcctgat aatgcgctat ctttccatga atttcttcac 420
ggccgtcgag cgccaaaact tgagaacttc cgtttctctg ttttatcgct tggagacagc 480
tcatacgaat ttttctgtca aacaggaaaa gaatttgatg tgcgcttagc agaacttggg 540
ggtgaaagac tgtatccgcg cgttgactgt gatttagatt ttgaagagcc cgcaaataaa 600
tggcttaaag gtgttattga cggattaagc gaagcgaaag gacacagcgc ttcggcagct 660
gttccagcgg aagctcctgc aggaacttca ccatattcaa gaacaaatcc ttttaaagca 720
gaagtgcttg agaacttaaa cttaaacggc cgcggatcaa ataaagaaac gcgacactta 780
gaactatctc tagaaggttc aggtttgacg tatgaaccag gagacagttt aggtatttat 840
cctgaaaatg acccggagct tgttgatctt cttcttaacg aattcaagtg ggatgcaagt 900
gaaagtgtaa cggttaataa agaaggagaa acgcgtcctc ttagagaagc gctaatctct 960
aattttgaaa ttaccgtttt aacaaagcct cttttaaagc aagcagctga gcttactgga 1020
aacgataagt taaaagcgct tgtagaaaat cgcgaggaat taaaagcata cacacaaggc 1080
cgtgatgtaa ttgacttagt tcgtgacttc ggtccatgga acgtatcggc acaagagttt 1140
gtagccattc tacgtaaaat gccagcgcgt ctttactcga ttgcaagcag cttatcagca 1200
aaccctgatg aagttcatct aacaatcgga gcggtacgct acgaagcgca tggacgggag 1260
cgcaaaggtg tttgttcagt cctttgttca gaacgtttgc agccaggcga tacgattcct 1320
gtataccttc aaagcaataa aaactttaag cttcctcaag atcaagaaac gccaattatt 1380
atggtaggac ctggtacagg tgtggctccg ttccgctcat ttatgcaaga gcgtgaagaa 1440
acaggggcaa aaggcaagtc atggatgttc tttggagatc agcacttcgt aacagacttc 1500
ctttaccaaa cagaatggca aaagtggtta aaagatggcg tactgacaaa aatggacgtg 1560
gcgttttcac gcgatacaga agaaaaagta tacgtacaaa accgtatgct cgaacatagt 1620
aaagaattat tccaatggtt agaagaaggc gcatcttttt atgtgtgcgg agataaaaca 1680
aatatggcac gcgacgtgca caacacgcta gttgaaatta tcgaaacaga aggcaagatg 1740
agccgtgaac aggcggaagg ttaccttgct gaaatgaaga aacaaaaacg ttatcagcgt 1800
gatgtatact ga 1812
<210> 21
<211> 1278
<212> DNA
<213> Bacillus megaterium strain DSM 33296
<400> 21
ttgccggtta tacagggccc ctcgtcgtat aagcttaccg gtcacctgca aaagtttaga 60
gagaacccac tgggtttttt ggaaaacttg actcagtatg gagaaattgc aacatttaga 120
gttgcgcaca aacgctttta tgtaacgaga gaccctcaac ttattaaaga tgtagtcatt 180
acaaacagca aggcgtttca aaaaattaaa ctaacgcata tgtttaaaac gctgctaggc 240
gaagaaatgt tatggacaga tgaagcatta tatatgagcc ccattcaacc ctcacaacta 300
aaacaacatc taacttataa taaggaagca atcgcaaaaa taattgaaaa gcatacggaa 360
acgtgggaag aagggcagct tcgaacgata gtaaaagaca taagacagat agtcgtagct 420
gtactccttc aacttgtatt tggcatttcg attgaggaga aagataaaat tcactatgtt 480
caagcgctta tgagaaaaaa agaaaagtta ggcaaaattt atattcgtct acctttgcac 540
cagcttgact cagatgagca gctagaacaa ctcctttttg aacgcgttca aatgcgtgtt 600
caaaacaaaa ccgaaggaaa tgatttactg cagtatatat tgaattctta cggagaagac 660
agcgatgaaa gagaaatata tgaacagcta aattctatat tcctttcgat gtatgaaatg 720
attacgcacg tatgcagctg gtctattcat ttactgtctc aaaatactag ggagcacctt 780
cagctgtata aagaaattca agcctatgct agcggcgaat cactttcaac caaaaatctg 840
acctatatgc gcaaaataat tgctgaaagc atgaggttgt atccgcctct ttggctattt 900
gggcgtcaag cacgtgaaga tatacaaata gatggctaca gtatcaaaaa aggggagatt 960
atgttaatca gcccttatat gatgcatcgc catgaagatt attttttaga gccaagtgaa 1020
tttttacctg accgttttga aaaaggaggg tccattgatg tcccaagcta tatgtatatg 1080
ccgcttggga ttgagcatca agcggaaagg ggcattaact atatcactga aatagtaacc 1140
atttttctgt cagaaatgac aaagcgcttt ttatttcagc tgactgagcc cgaatctatt 1200
gctccgatgg cgggcgtaat gctgaatatg aaagaagaac tgaaggtgaa tgttcacaaa 1260
gttcacgcgc agtcttga 1278
<210> 22
<211> 1215
<212> DNA
<213> Bacillus megaterium strain DSM 33296
<400> 22
atgaaaaccg aaagagaaaa cggaattgtc cgtcaagtga atacaattca aacaaaagaa 60
gagcgcttta atcctttttc atggtatgaa gagatgagaa acaccgcgcc tgtgcaatgg 120
gatgaagaaa ggcaggtatg ggatgttttt cactatgacg gggttaaaga agtgctagaa 180
caaaagaata ttttttcttc tgatcgaaga cctccacaaa accaaagaca aactgctcta 240
ggaacgagtc taattaatat tgatccgcct aagcatgctg aaatgagagc acttgttaat 300
aaagctttta cgcctaaagc aatgaaagca tgggagccta aaattgcgcg tattacagct 360
gaattattac aagaagttga gcatcttgaa gatattgata tagtcgagca tctgtcctat 420
ccgcttccgg ttatggtaat tgccgatatt ttaggcgtgc cgatagaaga tcagcgtcag 480
tttaaagatt ggtccgatat tatcgtagcc ggtccttcta ataatgaacg tgaaacgctc 540
gaaaaattgc agcaagagaa aatgaaagca aatgatgagc tagaaactta tttttatcga 600
atcattgaag aaaaacgcac gcgtccagga gatgatatta tctccgtgct tcttcaggca 660
aaagaagaag ggaaacagct aacggatgaa gaaatcgtcg gtttttctat tttgctgctg 720
attgctggaa acgaaacaac cacaaattta atttcaaata cgatttattg tttaatggaa 780
gataaaactt cttttgaacg actcaaacga gagaaagaac ttttgccttc tgcgattgaa 840
gaagttcttc gctatcgttc acccgttcag gctcttcacc gaatcgtaaa agaagatgtg 900
actcttgcag gcaagaaact aaaagcgggc gaacacgtgg ttccatggat gggatctgcg 960
catcgagacg cggagtattt tgaagacccg gatgtattta aaatcgatcg aaagccaaat 1020
gtgcacatgg catttggaag aggcattcat ttttgcttag gagcacccct tgctcgaata 1080
gaagcaaaaa ttatgctggc cgagctgatt gaccgctatc cgcagatgga ctggagcccg 1140
tcatttgggt taaacccgat tgaaagcacg tttgtgtacg ggttaaaaga attattgatt 1200
cgtaaaaacg tataa 1215
<210> 23
<211> 1212
<212> DNA
<213> Bacillus megaterium strain DSM 33296
<400> 23
atgaattcaa aagcagtaaa aagagaaaat cgctatgcta acttgattcc tatgcaagaa 60
atcaaatcag ttgaacagca gctttaccca tttgatattt ataacagtct gcgtcaaaag 120
gcacctattc gttacgatga aagccgaaac tgctgggatg tatttgatta tgaaacagta 180
aagtatattt taaaaaaccc gtcgcttttt tcatccaaac gagcaatgga agaacgccaa 240
gaaagtattt taatgatgga ccctccaaaa catacaaagt tacgaaactt agtaaacaaa 300
gcttttacgc caagagctat tcagcactta gagagtcata ttgaagagat tgcagattat 360
ttattagatg aagtaagcag ggaaaaaaag tttgatatag tagaagactt tgctggacca 420
ctgccgatta ttgtaatagc agaattgcta ggagtaccaa tccaagaccg agaactgttt 480
aaaaaatact ccgatgactt agtgagcggt gctgaaaata attcagacga agcttttgcg 540
aaaatgatgc aaaagcgtaa tgaaggcgtg atttttttac aagggtattt taaagaaatt 600
atcgcggagc gtcagcaaaa taaacaagaa gatctcattt cgcttctttt agaagcagaa 660
atcgacggcg agcatttaac agaagaggaa gtgctggggt tttgtatttt attgctagta 720
gcaggtaatg agacaacgac aaacttaatt acgaacggag tccggtatat gacagaagac 780
gtagacgtgc agaatgaagt tcgtcaagac atatcgctag ttccgaacct ggtagaagaa 840
acgcttcgct attatcctcc tattcaagcg attggacgca tagctgctga agatgtagaa 900
cttggagagt gtaagattaa aaaagggcag caggtaatta gctgggcagc aagtgcaaat 960
agagattcag ctaagtttga acggcctgac acttttgtcg tgcatcgtaa aacaaatcct 1020
cacgtgagct ttggattcgg catccatttt tgcttaggag caccgctagc aagaatggaa 1080
gggaaaattg cttttactaa gttactagag aaaggcgagt ttttaaaagt tgagaatcag 1140
tctttaaagc caataggcag cccttttgtt tttggcgtaa aaaaatatga gattactttt 1200
aataaagctt aa 1212
<210> 24
<211> 1233
<212> DNA
<213> Bacillus megaterium strain DSM 33296
<400> 24
atgaacaaag aagtcattcc cgttacagaa attccaaaat tccaatcacg tgcagaagag 60
tttttcccta tccaatggta taaagaaatg ctgaataacc accctgttta ttttcatgaa 120
gaaacaaaca catggaatgt attccaatac gaccatgtta aacaagtctt gagcaactac 180
gaattctttt caagcgatgg gcaaagaacc actatttttg ttggggataa tagtaagaaa 240
aaaagcacat ctccaattac caatcttaca aacttagatc ctcctgacca ccggaaagcg 300
cgatctttgc ttgctgcagc ctttactcct cgcagtttaa agaactggga accgcgaatc 360
aaacaaattg cagcagacct tgtagaagcc atacaaaaga attcaactat taatattgtt 420
gacgatttat cttctccttt tcctagttta gttatagcag atttattcgg tgtaccggta 480
aaagaccaat atcagttcaa aaaatgggta gatattctgt ttcagcctta tgaccaagaa 540
agattagaag agattgaaca agaaaagcag cgtgcaggag ctgaatattt tcaatacctc 600
tacccgattg tcattgaaaa gcgctccaac ctttctgatg atattatctc agacttaatt 660
caagccgaag ttgatggtga aacatttaca gatgaagaaa ttgtacacgc taccatgctg 720
cttttaggtg caggagttga aaccacaagt cacgccattg caaatatgtt ttattctttt 780
ttatatgacg acgagtcgtt atacagcgag ctgagaaaca atagagaatt agctccaaaa 840
gcagtagaag aaatgcttcg atatcggttt cacatctcca gacgagatcg gacggttaaa 900
caagataacg atttattagg cgttaagcta aaaaaaggag atgtcgttat tgcgtggatg 960
agtgcatgta atatggatga gaatatgttt gaaaaccctt tttctgtaga cattcaccgc 1020
caaactaata aaaaacactt aacgtttgga aacggacctc atttttgttt gggcgcccct 1080
cttgcccgac ttgaaatgaa aatcatatta gaagcatttt tagaggcctt ttctcatatc 1140
gaaccatttg aagattttga attagaatcg catttaactt cttcagctac ggggcaatct 1200
ttaacgtatt tgccgatgaa ggtgtacaga taa 1233
<210> 25
<211> 1549
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 25
tcggagagtt tgatcctggc tcaggatgaa cgctggcggc gtgcctaata catgcaagtc 60
gagcgaactg attagaagct tgcttctatg acgttagcgg cggacgggtg agtaacacgt 120
gggcaacctg cctgtaagac tgggataact tcgggaaacc gaagctaata ccggatagga 180
tcttctcctt catgggagat gattgaaaga tggtttcggc tatcacttac agatgggccc 240
gcggtgcatt agctagttgg tgaggtaacg gctcaccaag gcaacgatgc atagccgacc 300
tgagagggtg atcggccaca ctgggactga gacacggccc agactcctac gggaggcagc 360
agtagggaat cttccgcaat ggacgaaagt ctgacggagc aacgccgcgt gagtgatgaa 420
ggctttcggg tcgtaaaact ctgttgttag ggaagaacaa gtacgagagt aactgctcgt 480
accttgacgg tacctaacca gaaagccacg gctaactacg tgccagcagc cgcggtaata 540
cgtaggtggc aagcgttatc cggaattatt gggcgtaaag cgcgcgcagg cggtttctta 600
agtctgatgt gaaagcccac ggctcaaccg tggagggtca ttggaaactg gggaacttga 660
gtgcagaaga gaaaagcgga attccacgtg tagcggtgaa atgcgtagag atgtggagga 720
acaccagtgg cgaaggcggc tttttggtct gtaactgacg ctgaggcgcg aaagcgtggg 780
gagcaaacag gattagatac cctggtagtc cacgccgtaa acgatgagtg ctaagtgtta 840
gagggtttcc gccctttagt gctgcagcta acgcattaag cactccgcct ggggagtacg 900
gtcgcaagac tgaaactcaa aggaattgac gggggcccgc acaagcggtg gagcatgtgg 960
tttaattcga agcaacgcga agaaccttac caggtcttga catcctctga caactctaga 1020
gatagagcgt tccccttcgg gggacagagt gacaggtggt gcatggttgt cgtcagctcg 1080
tgtcgtgaga tgttgggtta agtcccgcaa cgagcgcaac ccttgatctt agttgccagc 1140
atttagttgg gcactctaag gtgactgccg gtgacaaacc ggaggaaggt ggggatgacg 1200
tcaaatcatc atgcccctta tgacctgggc tacacacgtg ctacaatgga tggtacaaag 1260
ggctgcaaga ccgcgaggtc aagccaatcc cataaaacca ttctcagttc ggattgtagg 1320
ctgcaactcg cctacatgaa gctggaatcg ctagtaatcg cggatcagca tgccgcggtg 1380
aatacgttcc cgggccttgt acacaccgcc cgtcacacca cgagagtttg taacacccga 1440
agtcggtgga gtaaccgtaa ggagctagcc gcctaaggtg ggacagatga ttggggtgaa 1500
gtcgtaacaa ggtagccgta tcggaaggtg cggctggatc acctccttt 1549
<210> 26
<211> 1549
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 26
tcggagagtt tgatcctggc tcaggatgaa cgctggcggc gtgcctaata catgcaagtc 60
gagcgaactg attagaagct tgcttctatg acgttagcgg cggacgggtg agtaacacgt 120
gggcaacctg cctgtaagac tgggataact tcgggaaacc gaagctaata ccggatagga 180
tcttctcctt catgggagat gattgaaaga tggtttcggc tatcacttac agatgggccc 240
gcggtgcatt agctagttgg tgaggtaacg gctcaccaag gcaacgatgc atagccgacc 300
tgagagggtg atcggccaca ctgggactga gacacggccc agactcctac gggaggcagc 360
agtagggaat cttccgcaat ggacgaaagt ctgacggagc aacgccgcgt gagtgatgaa 420
ggctttcggg tcgtaaaact ctgttgttag ggaagaacaa gtacgagagt aactgctcgt 480
accttgacgg tacctaacca gaaagccacg gctaactacg tgccagcagc cgcggtaata 540
cgtaggtggc aagcgttatc cggaattatt gggcgtaaag cgcgcgcagg cggtttctta 600
agtctgatgt gaaagcccac ggctcaaccg tggagggtca ttggaaactg gggaacttga 660
gtgcagaaga gaaaagcgga attccacgtg tagcggtgaa atgcgtagag atgtggagga 720
acaccagtgg cgaaggcggc tttttggtct gtaactgacg ctgaggcgcg aaagcgtggg 780
gagcaaacag gattagatac cctggtagtc cacgccgtaa acgatgagtg ctaagtgtta 840
gagggtttcc gccctttagt gctgcagcta acgcattaag cactccgcct ggggagtacg 900
gtcgcaagac tgaaactcaa aggaattgac gggggcccgc acaagcggtg gagcatgtgg 960
tttaattcga agcaacgcga agaaccttac caggtcttga catcctctga caactctaga 1020
gatagagcgt tccccttcgg gggacagagt gacaggtggt gcatggttgt cgtcagctcg 1080
tgtcgtgaga tgttgggtta agtcccgcaa cgagcgcaac ccttgatctt agttgccagc 1140
atttagttgg gcactctaag gtgactgccg gtgacaaacc ggaggaaggt ggggatgacg 1200
tcaaatcatc atgcccctta tgacctgggc tacacacgtg ctacaatgga tggtacaaag 1260
ggctgcaaga ccgcgaggtc aagccaatcc cataaaacca ttctcagttc ggattgtagg 1320
ctgcaactcg cctacatgaa gctggaatcg ctagtaatcg cggatcagca tgccgcggtg 1380
aatacgttcc cgggccttgt acacaccgcc cgtcacacca cgagagtttg taacacccga 1440
agtcggtgga gtaaccgtaa ggagctagcc gcctaaggtg ggacagatga ttggggtgaa 1500
gtcgtaacaa ggtagccgta tcggaaggtg cggctggatc acctccttt 1549
<210> 27
<211> 1188
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 27
atgaagaatg gatggacaaa ctttgttatt ggtaccgtac gtattcgaat tgttggaaaa 60
ggaattgaac gttttttaaa taattgtgtg agacaacaga ttatgatttc gaatgtccat 120
aaagttgacg gtcagctagc gacagcaacg atattattga aagatgtaaa gaaaattcgt 180
atactaattc gcaacgcaga ctgtaaaatt tattttataa gaggtcgagg ttttcctttt 240
ttaacaaaac gagtgatcaa aaatagtggg tttgctttag gttttctttc tttttttatt 300
attcttggtt tgctttccaa catggtgtgg aaagtggaaa ttagcggtgc agaaccacaa 360
acagaacatc aaatgactaa gcagctagcc aaaataggtg taaaaagagg agagtttcaa 420
tttctgttag agagtcctga aaaaattcag cgctatttaa cggataatat gaacaatatt 480
acctgggtgg gagtagaagt gcgcggcact tcttatcact tccaagtggt tgaaaaaaat 540
gagcccaagc ctcagcaaaa aacaccttac caacatttaa ttgctaaaaa gaaagccatt 600
attacgaatt tgtttgtcga aaaaggacaa cctttagtca aggttaacga ttttgtcaat 660
gaaggcgagg tcttagtttc cggtattatt ggaaacgaaa aaaataaaaa agtagtagct 720
gctaaaggga aagtctatgg tgaaacatgg tataagtctg aggtggaagt acctttaaaa 780
actgattttc aggtattaac gggtaatgga tatacgaagc actatttaga ttttaaagct 840
tttaaaatgc ctctttgggc ttttaacaaa gagaaatacg gctcaaaggt gacagaaaaa 900
gtggaacatc cactctattt ttttaaatgg aaattacctc tgtcgtatga gaaagttgct 960
gtacgagaag aacagaactc gcagcgcgtc tattctaaac aagaggcggt ggaaaaagct 1020
ttggaaatcg gtcgaaaaaa attactatca actttaggtg aggatgctaa aataaaaggt 1080
gaaaaagttt tgcaccaaga acaggacaat ggtaaagtta gattatcaat acattaccaa 1140
gttatagaaa atattgcgaa cactcaacca attattcaag gagattga 1188
<210> 28
<211> 1923
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 28
ttgacgatgg aacaaaaaga agtacaagca tatgaagctg atcagataca agtattagaa 60
ggattagaag ctgttcgtaa acgtccgggg atgtatattg gatcgacgag cgctaagggt 120
ttacatcatc ttgtatggga aattgtagat aatagtattg atgaagcgct ggccggctat 180
tgcgatgaaa ttaatgttat tatcgaaaag gataatagta ttacagtcaa agataacggt 240
cgtggaattc cggttggtat tcaagaaaaa atgggcagac ctgctgttga agttatctta 300
acggttcttc atgccggagg taaatttggc ggcggcggct ataaagtatc tggtggatta 360
cacggtgtag gtgcctcagt tgttaacgca ctttctacct ctttggaagt acacgtacat 420
cgtgatggta aagttcatta tcaaaaatat gaacgaggtg taccagctgc tgacttgaaa 480
gtagtcggag aaacagataa aacaggtact gttattcaat tccatccaga cggtgaaatt 540
tttacagaaa cgcttgaata cgattttgat acgttagcta atcgtctgcg tgagttagct 600
ttcttaaatc gcggcattaa aattacgatt gaagacaaac gtgaagaaga taaaagacgt 660
gaatatcact atgaaggcgg aattaagtct tacgttgaac acttaaaccg ttcgaaagaa 720
gtgattcacg aagagccaat ctatatcgaa ggtaatcgag acaacatttc tgtagaaatt 780
gctattcaat ataacgatag ctatacaagt aatttatatt cttttgcaaa caacattcac 840
acatatgaag gtggaacgca cgaagcagga tttaaaacag cgttaacgcg tgtaattaac 900
gactatgcac gtaaaaacag cgtatttaaa gacagtgacg ccaatttaac gggtgaagat 960
gttcgtgaag gaattacagc tatcatctct attaagcacc cagatccgca gttcgaagga 1020
caaacgaaaa caaagctggg aaatagtgaa gcaagaacaa ttactgactc tgtgtttgca 1080
gaacacttag aaacttactt gctagagaac cctattgtgg cgaaaaaggt aattgaaaaa 1140
ggtttaatgg ctgcaagagc aagaatggca gctaaaaaag ctcgtgagct tacaagacgt 1200
aaaagcgcgc ttgaaatttc aaacttaccg ggtaaattag cagattgttc atcaaaagat 1260
ccttctatta gcgaactcta tgtagtagag ggtgactctg ccggcggttc agctaagcag 1320
ggaagaagcc gtcatttcca agctattttg cctttgcgcg gtaaaattat caacgtagag 1380
aaagcgcgtt tagataaaat tttatctaat aacgaaattc gtacaatcat taccgctcta 1440
ggaacgggta ttggtgacga ttttgatatt tcgaaagccc gctaccataa aattgtgatt 1500
atgacagatg cagacgtaga cggtgcgcat attcgtacgc ttcttctaac gttcttctat 1560
cgctatatga gacagattat tgagcacgga tatgtgtaca ttgcccagcc gcctctttac 1620
aaagtttcac aaggtaaaaa agtggagtac gcgtacaacg atcgtcaatt agaagaggta 1680
ttagcttctt tccctgaagg cgcaaaacca aaccttcagc gttacaaagg tttaggagag 1740
atgaatcctg aacaattatg ggaaacaaca atggatccag aattccgtac tcttcttcag 1800
gtgaacttgc aggatgcaat tgaagctgat gagacatttg aaattttaat gggcgacaaa 1860
gtagaaccac gccgtaattt cattgaagaa aatgctcagt acgtaaaaaa tctcgatatt 1920
taa 1923
<210> 29
<211> 3564
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 29
ttgacaggtc aactagttca gtatggacgc caccgccaac gcagaagtta tgctcgtatt 60
agtgaagttt tagagttacc gaacttaatc gagattcaaa cggcttcata ccaatggttt 120
ttagatgaag gtttacgaga aatgttccaa gatatttctc caattgatga ttttacaggt 180
aacttatcac tagaatttat tgattacagc ttaggtgagc caaagtattc agtaggagag 240
tctaaagaac gtgatgtaac ttatgcagca cctcttcgtg ttaaggtgcg gttaattaat 300
aaagaaacag gtgaagtaaa agaccaagat gtgttcatgg gagatttccc attgatgacc 360
gaaacaggta cctttgtaat taatggtgct gagcgtgtta ttgtatcaca gttggttcgt 420
tcaccaagtg tttactatag tggaaagctt gataaaaacg gtaaaaaagg atatacagca 480
actgttatcc ctaaccgtgg tgcatggcta gaatatgaaa ctgatgcaaa agatgtagta 540
tacgtgcgta ttgatcgtac tcgtaaactg ccagtaacag tgctgttacg cgcgctaggt 600
ttcggttctg accaagagat tatcgattta atcggtgata atgaatacat ccgtaatacg 660
cttgaaaaag ataacacgga aacaacggaa aaagcgctat tagaaatcta tgagcgttta 720
cgtccgggtg aaccaccgac agttgagaat gcgaaatctc tattagtatc tcgcttcttt 780
gatccaaaac gatatgactt agcgaacgta ggtcgctata aaattaataa aaagcttcat 840
atcaaacatc gcttatttaa tcaaaaacta gctgaaacat tagttgatcc tgaaacaggt 900
gaaattattg cagaaaaagg cgcaatgatt gaccgacgtc tgctagatcg cttgattccg 960
atgcttgaag gtggagtaaa cttcaaaact tatagtccag ttggtggagt agtagaagac 1020
gatgttacat tacaatctat taagatttat gcgccaaatg atccagaagg tgaaaaagtc 1080
atcactgtat caggtaacgc atatgtaaca gaagaagtta aaaatatcac acctgctgat 1140
attttagcat caatcagtta cttctttaac ttgcttcatc aagtaggaga cacagatgat 1200
atcgaccact taggtaaccg tcgtctgcgt tctgtaggtg aattgttaca aaaccaattc 1260
cgtatcggtt tatctcgtat ggaacgtgtt gttcgtgaaa gaatgtcaat tcaagacacg 1320
aatacaatca cacctcaaca attaattaat attcgtccag ttattgcggc gattaaagag 1380
ttctttggaa gttctcaatt atcacagttc atggatcaaa cgaatccatt aggcgaattg 1440
acgcacaaac gtcgtctttc agctctagga cctggtggtt taacgcgtga gcgcgctggt 1500
ttcgaagtgc gtgacgttca ctactcccac tatggccgta tgtgtccgat tgaaacgcca 1560
gaggggccga atatcgggtt aatcaactca ctttcttctt atgcaaaagt aaacaaattc 1620
ggtttcatcg aaacacctta ccgtcgtatc gatcctgaaa caggtaaagt gacagagcga 1680
attgactact taacagctga tgaagaagat aactatgttg tagcccaagc gaacgctcgt 1740
ctaggtgatg atggttcatt cttagatgaa aatgtcgttg cacgtttccg tggagaaaac 1800
acggttatcc gtcgcgatcg tttagactat atggatgtat caccaaaaca agttgtatct 1860
gccgctacgg catgtatccc attcttagag aacgatgact ctaaccgtgc attaatgggt 1920
gcgaacatgc aacgtcaagc agtaccttta ttaaatcctg aagcaccaat cgtaggtaca 1980
ggtatggaat atgtatctgg taaagactct ggtgcagccg tgatttgtaa ataccctggc 2040
gttgtagagc gcgtagaagc aaaacaaatt tttgttcgcc gctatgaaga agtagacgga 2100
caaaaggtta aaggcaactt agatcaatac aaattattaa aattcgttcg ttctaaccaa 2160
ggtacttgtt acaaccagcg tccaattgtt tcagttggcg acgaagtagt aaaaggtgag 2220
atcttagccg atggtccttc aatggaaaaa ggtgagcttg ctttaggacg aaacgtaatg 2280
gttggtttca tgacatggga tggttacaac tatgaggatg ccatcatcat gagtgaacgc 2340
cttgtgaaag acgatgtata tacgtctgtt catattgaag aatatgaatc tgagtctcgt 2400
gatacgaaac ttggacctga agaaattacg cgtgacattc caaacgtagg tgaagatgcg 2460
cttcgcaact tagatgagcg tggaatcatc cgcattggtg cagaagtaaa agatggagat 2520
cttttagttg gtaaagtaac gccaaaaggt gtaacagaac taacagctga agaacgtctt 2580
ctacacgcta ttttcggtga aaaagcgcgt gaagttcgtg atacttctct tcgtgtaccg 2640
cacggcggcg gtggaattat tcttgatgtt aaagtcttca accgtgaaga tggcgacgaa 2700
ttaccaccag gtgtaaacca attagtccgt gtatatattg ttcagaagcg taaaatttct 2760
gaaggtgaca aaatggccgg tcgtcacggt aacaaaggtg taatttcacg tattttaccg 2820
gaagaagata tgccttacct accagacggt acgccaattg acatcatgtt aaacccatta 2880
ggggtaccat ctcgtatgaa catcggtcag gtgctagagc ttcatttagg tatggctgct 2940
cgtaagcttg gcattcacgt tgcgtctcca gtatttgatg gtgcgcgtga ggaagatgtt 3000
tgggcaacaa tcgaagaagc tggcatgtct cgtgatgcta aaacagttct atatgatggt 3060
cgaacaggtg aaccattcga taaccgtgta tcagtaggaa tcatgtacat gatcaaactt 3120
gctcacatgg tagacgataa acttcacgct cgttctactg gaccatactc acttgttaca 3180
caacaaccac ttggtggtaa agcgcagttc ggtggacagc gttttggtga gatggaggta 3240
tgggcacttg aagcatacgg tgctgcttac acattacaag agatcttaac agtgaaatca 3300
gacgacgtag taggtcgtgt gaaaacatac gaagcaattg ttaaaggtga aaacattcca 3360
gaacctggca tacctgaatc gttcaaagta ttaattaaag aactacaaag tttaggtatg 3420
gatgtgaaga tgctttctgc tgacgagcaa gaaattgata tcatggactc agaagaggac 3480
catgagcaac caacagaatc aattattgca gataacgaag aaagcctttc tgaaggacaa 3540
aaagatcctg tcacaaaaga gtaa 3564
<210> 30
<211> 1632
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 30
atggcaaaag acattaaatt tagcgaagaa gcacgtcgcg caatgctacg tggtgtagat 60
acattagcaa atgctgtaaa agtaacgctt ggaccaaaag gtcgtaacgt tgtattagaa 120
aagaaattcg gttcaccgct tattacaaat gatggtgtaa caattgcaaa agaaatcgaa 180
ttagaagacg catttgaaaa catgggtgct aaattagtag ccgaggttgc tagcaaaaca 240
aacgacgttg ctggtgacgg tacaactact gcaacagttt tagcgcaagc aatgatcaga 300
gaaggtctta aaaacgtaac ggctggtgct aacccaatgg gtatccgtaa aggtatggaa 360
aaagcagtag ctgtagcggt tgaagaacta aaagcaatct ctaaaccaat tcaaggtaaa 420
gattcaattg ctcaagtagc ggctatctca gcagctgacg aagaagtagg tcaattaatt 480
gctgaagcaa tggagcgcgt tggtaacgac ggcgttatca cacttgaaga atcaaaaggt 540
ttcacaactg aattagaagt ggtagaaggt atgcagtttg accgtggata tgcatctcct 600
tatatggtaa ctgattcaga taaaatggaa gctgtattag atgatccata catcttaatc 660
acagacaaaa aaatcggtaa cattcaagaa atcttaccgg tattagagca agttgttcaa 720
caaggcaagc ctctattaat catcgctgaa gacgtagaag gcgaagcttt agcaacatta 780
gttgtgaaca aacttcgtgg tacatttaca gctgtagctg ttaaagctcc tggttttggt 840
gatcgtcgta aagcaatgct acaagacgtt gcgatcttaa caggcggaga agtaatcact 900
gaagagcttg gtcttgactt aaaaacagca ggcatcgatc aattaggtcg cgcttctaaa 960
attgttgtaa caaaagaaaa tacaacagtt gtaaacggtg caggaaacgc agaagatatc 1020
ctagcacgcg taaaccaaat caaagctcag cttgaagaaa caacttcaga gtttgaccgt 1080
gaaaaattac aagagcgctt agcaaaactt gctggtggcg tagctgtaat taaagtgggt 1140
gcggcaactg aaactgagtt aaaagaacgt aaattacgta ttgaagatgc attaaactct 1200
acgcgtgctg cggttgaaga aggtatcgta gctggtggtg gtactgcatt agtaaatatc 1260
tataataaag tagcaagcat cgaagctgac ggtgacactg ctacaggtat caacatcgta 1320
ttacgtgcga tcgaagagcc tgtacgtcaa atcgctcaca atgctggttt agaaggatca 1380
gtaatcgttg agcgtctaaa aggcgaagca gttggaactg gattcaatgc tgcaactggc 1440
gagtgggtaa acatgctaga cactggtatc gttgacccaa caaaagtaac gcgttcagct 1500
cttcaaaatg cttcttctgt agcggctatg ttcttaacaa ctgaagcagt tgttgctgac 1560
aagccagaag aaggcggagc acctgcaatg cctgacatgg gcggcatggg tggaatgggc 1620
ggcatgatgt aa 1632
<210> 31
<211> 3150
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 31
atgacaatta aagaaatgcc tcagccaaaa acgtttggag agcttaaaaa cttaccgtta 60
ttgaacacag acaaaccact tcaaacgctg atgaaaattg cggatgaatt aggggaaatc 120
tttaaatttg aagcgcctgg ccgtgtaacg cgctacttat caagtcagcg tctaattaaa 180
gaagcatgtg atgagtcccg attcgataaa aacttaagtc aagctcttaa atttgtgcgt 240
gattttgcag gagacggttt atttacaagc tggactcatg agaaaaactg gaaaaaagca 300
cacaacatct tacttccaag ctttagccag caggcaatga aaggctatca cgcaatgatg 360
gtcgatatcg ccgtgcagct tattcaaaaa tgggagcgtc taaatgcaga tgagcatatt 420
gaagtaccgg aagacatgac gcgcttaacg cttgacacaa tcggtctttg cggctttaat 480
taccgcttta acagctttta tcgcgatcag ccgcacccgt ttattacaag tatggtccgt 540
gcactggatg aatcgatgaa aaagctgcag cgtgcaaatc cggatgaccc agcttatgat 600
gaaaataagc gccagtttca agaagatgtt aaggtgatga acaacctagt agataaaatt 660
attgcagatc gcaaagcaag cggtgaacaa agtgatgatc tattaacgca tatgctaaac 720
ggaaaagatc cagaaacagg tgagccgctt gatgacgaga acattcgcta tcaaattatt 780
acgttcttaa ttgcgggaca cgaaacaaca agcggtctgt tatcatttgc gctgtatttc 840
ttagtgaaaa atccacatgt attacaaaaa gcagcagcag aagcagcacg agttctagta 900
gatcctgttc caacctacaa acaagtcaaa cagcttaaat atgtgggcat ggtcttaaat 960
gaagcgctgc gcttatggcc gacggctcct gcgttttctc tatatgcaaa agaggatacg 1020
gtgcttggag gagaatatcc gttagaaaaa ggggatgaac tgatggttct gattcctcag 1080
cttcaccgtg ataaaacgat ttggggagac gatgtagaag agttccgccc agagcgtttt 1140
gaaaacccaa gcgcgattcc gcagcatgcg tttaaaccat ttggaaacgg tcagcgcgcg 1200
tgtatcggtc agcagttcgc tcttcatgaa gcaacgcttg tacttggtat gatgctaaaa 1260
cactttgact ttgaagatca tacaaactac gagctagata ttaaagaaac gttaacgtta 1320
aaacctgagg gctttgtggt aaaagcaaaa tcgaaacaaa ttccgcttgg cggcattcct 1380
tcaccaagcc gagagcagtc agctaaaaaa gagcgcaaaa ccgtagaaaa cgctcataat 1440
acgccgctgc ttttgctata cggttcaaat atgggaacag ccgaaggaac ggcgcgggat 1500
ttagcggata ttgcgatgag caaaggattc gcaccgcaag tcgcaacgct tgattcccac 1560
gcaggaaatc ttccgcgtga aggagctgtg ttaattgtaa cagcttcgta taacggacat 1620
ccgcctgata acgcaaagca gtttgtcgag tggttagacc aagcgtctgc tgatgaagtc 1680
aaaggcgttc gctactccgt atttggatgc ggcgataaaa actgggctac tacgtatcaa 1740
aaagtgcctg cttttattga tgaaacgctt gcggctaaag gagcagaaaa catcgctgaa 1800
cgcggcgaag cagatgcaag cgacgacttt gaaggcacat acgaagaatg gcgtgaacac 1860
atgtggagtg acgtagcagc ctactttaac ctcgacattg aaaacagtga agataatcaa 1920
tctacgcttt cacttcaatt tgtcgacagc gctgcggaca tgccgcttgc gaaaatgcac 1980
ggtgcgtttt cagcaaacgt cgtagcgagc aaagaacttc aacagccagg cagtgcacga 2040
agcacgcgac accttgaaat tgaacttcca aaagaagctt cttatcaaga aggagatcat 2100
ttaggtatta ttcctcgcaa ctatgaagga atagtaaatc gtgtaacagc aaggttcgat 2160
gtagatgcat cacagcaaat ccgtctggaa gctgaagaag aaaaattagc gcatttgcca 2220
ctcggtaaaa cagtatcagt agaagagctt ctacaatatg tagagcttca agatcctgtt 2280
acgcgcacgc agcttcgcgc aatggctgct aaaacggtct gcccgccgca taaagtggag 2340
cttgaagcct tgcttgaaaa gcaagcgtac aaagaacaag tactggcaaa acgcttaaca 2400
atgcttgaac tgcttgaaaa atacccggcg tgtgaaatgg aattcagcga atttatcgct 2460
cttcttccaa gcatgcgtcc gcgctattac tcaatttctt catcaccttg cgtcgatgaa 2520
aaacaagcaa gcatcacggt cagcgttgtt tcaggagaag cgtggagcgg atatggagaa 2580
tacaaaggaa ttgcgtcgaa ctatcttgcc gagctgcaag aaggagatac gattacgtgc 2640
tttgtttcca caccgcagtc aggctttacg ctgccaaaag aatctgaaac acctattatc 2700
atggtcggac cgggaacagg cgtcgcgcca tttagaggct ttgtgcaggc tcgcaagcag 2760
ttaaaagaac aaggacagtt gcttggagaa gcgcatttat actttggctg ccgttcacct 2820
catgaagact atctgtatca agaagagctt gaaaacgcac aaaatgaagg tgtcattacg 2880
cttcataccg ctttttcacg cgtaccaaat cagccgaaaa catacgttca gcgcctgatg 2940
gaacaagacg gtatgaaatt gattgaactt cttgatcaag gagcgcattt ctacatttgc 3000
ggagacggaa gccaaatggc acctgacgtt gaagcaacgc ttattaaaag ctatgctgat 3060
gttcataaag taagtgaagc agacgctcgc ttatggctgc agcagctaga agaaaagggc 3120
cgatacgcaa aagacgtgtg ggctgggtaa 3150
<210> 32
<211> 1812
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 32
gtgttgcaac ttaaggtagt aaacagccct tttaatcaag aacaagcaga tttgcttaat 60
cgccttctgc cgacattaac agaagcacaa aaaatgtggt tgagtggtta tttaacagca 120
gctcaatcta cgtctgccga aggaacgcca gccgtttcta cagcagcgcc tgctcaaacg 180
aagcagacag tttcaaaaga tgtaacgatt ctttacggat cacaaacagg aaatgctcaa 240
ggacttgctg aaaatacagg caaaacgctt gaagcaaaag gttttaatgt aactgtatct 300
tctatgaatg atttcaaacc aaataattta aagaaacttg aaaatttatt aattgttgta 360
agtacacatg gagaaggaga gccgcctgat aacgccctgt ctttccacga atttcttcac 420
ggccgtcgag cgccaaaact tgagaatttc cgtttttctg tcttgtcgct tggagacagc 480
tcatacgaat ttttctgtca aaccggaaaa gaatttgatg tgcgcttagc agaacttggc 540
ggtgaaagac tgtatccgcg cgttgactgt gatttagatt ttgaagaacc cgcaaataaa 600
tggcttaaag gtgttattga cggattaagc gaagcgaaag gacacagcgc ttcggcagct 660
gttccggcgg aagctcctgc aggaacttca ccatattcaa gaacaaatcc ttttaaagca 720
gaagtgcttg agaacctaaa cttaaacggc cgcggatcaa ataaagaaac gcgacactta 780
gaactatctc tagaaggttc aggcttgacg tatgaaccag gagacagttt aggtatttat 840
cctgaaaatg acccggagct tgttgatctt cttcttaacg aattcaagtg ggatgcaagt 900
gaaagtgtaa cggttaataa agaaggagaa acgcgtcctc ttagagaagc gctaatctct 960
aattttgaaa ttaccgtttt aacaaaaccg cttttaaagc aagcagctga gcttactgga 1020
aacgataagt taaaagcgct tgtagaaaat cgcgaggaat taaaagcata cacacaaggc 1080
cgtgatgtga ttgacttagt tcgtgacttc ggcccatgga acgtatcggc acaagagttt 1140
gtagccattt tacgtaaaat gccagcgcgc ctttactcga ttgcaagcag tttatcagca 1200
aaccctgatg aagttcatct aacaatcgga gcggtacgct acgaagcgca tggacgcgag 1260
cgtaaaggtg tttgttcagt cctatgttca gaacgtttgc agccaggcga tacgattcct 1320
gtataccttc aaagcaataa aaactttaag cttcctcaag atcaagaaac gccaattatt 1380
atggtaggac ctggtacagg tgtggctccg ttccgctcat ttatgcaaga gcgtgaagaa 1440
acaggagcaa aaggcaagtc atggatgttc tttggagatc agcacttcgt aacagacttc 1500
ctttaccaaa cagaatggca aaagtggtta aaagatggcg tactgacaaa aatggacgtg 1560
gcgttttcac gcgatacaga agaaaaagta tacgtacaaa accgtatgct cgaacatagc 1620
aaagaattat tccagtggtt agaagaaggc gcatcttttt atgtgtgcgg agataaaaca 1680
aatatggcac gcgacgtgca caacacgcta gttgaaatta tcgaaacaga aggcaagatg 1740
agccgtgaac aggcggaagg ttaccttgct gaaatgaaga aacaaaaacg ttatcagcgt 1800
gatgtatact ga 1812
<210> 33
<211> 1278
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 33
ttgccggtta tacagggccc ctcgtcgtat aagcttaccg gtcacctgca aaagtttaga 60
gagaacccac tgggtttttt ggaaaacttg actcagtatg gagaaattgc aacatttaga 120
gttgcgcaca aacgctttta tgtaacgaga gaccctcaac ttattaaaga tgtagtcatt 180
acaaacagca aggcgtttca aaaaattaaa ctaacgcata tgtttaaaac gctgctaggt 240
gaagaaatgt tatggacaga tgaagcatta tacatgagcc ccattcaacc ctcacaactt 300
aaacaacatc taacttataa taaggaagca atcgcaaaaa taattgaaaa gcatatggaa 360
acgtgggaag aagggcagct tcgaacgata gtaaaagata ttagacaaat agtcgtagct 420
gtactccttc aacttgtatt tggcatttcg attgaggata aagataaaat tcactatgtt 480
caagcgctta tgagaaaaaa agaaaagtta ggcaaaattt atattcgtct acctttgcac 540
cagcctgact cagatgagca gctagaacaa ctcctttttg aacgcgttca aatgcgtgtt 600
caaaacaaaa ccgaagaaaa tgatttactg cagtatgtat tacattctca cggggaagac 660
atcgatgaaa gagaaatata tgaacagcta aattctatat tcctttcgat gtatgaaatg 720
attacgcacg tatgcagctg gtctattcat ttactgtctc aaaatactag ggagcacctt 780
cagctgcata aagaaattca agcctatgct agcggtgaat cactttcaac caaaaatctg 840
acctatatgc gcaaaataat tgctgaaagc atgaggctgt atccgcctct ttggctattt 900
gggcgtcaag cacgtgaaga tatacaaata gatggttaca gcattaaaaa aggggagatt 960
atgttaatta gcccttatat gatgcatcgc catgaagatt attttttaga gccaagtgaa 1020
tttttacctg accgttttga aaaaggaggg tccattgatg tcccaagcta tatgtatatg 1080
ccgcttggga ttgagcatca agcggaaaga ggcatggact atatcactga aatagtaact 1140
atttttctgt cagaaatgac aaagcgcttt ttatttcaac tgactaaggc cgagtctatt 1200
gctccgatgg cgggcgttat gctgaatatg aaagaagaac tgaatgtgaa tgttcacaaa 1260
gttcacacgc agtcttga 1278
<210> 34
<211> 1215
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 34
atgaaaaccg aaagagaaaa cggaatcgtc cgtcaagtga atacgattca aacaaaagaa 60
gagcgcttta atccttttac atggtatgaa gagatgagaa acagcgcgcc tgtgcaatgg 120
gatgaagaaa ggcaggtatg ggatgttttt cactatgacg gggtcaaaga agtgctggaa 180
caaaagaata ttttttcttc tgatcgaaga cctccacaaa accaaagaca aactgctcta 240
ggaacgagcc taattaatat tgatccgcct aagcatgctg aaatgagagc gcttgttaat 300
aaagctttta cgcctaaagc aatgaaagca tgggagccta aaattgcgcg tattaccgct 360
gaattattac aagaagttga gcatcttgaa gatattgata tagtcgagca tctttcctat 420
ccgcttccgg ttatggtaat tgccgatatt ttaggcgtgc cgatcgaaga tcagcgtcag 480
tttaaagatt ggtcggatat tatcgtagcg ggtccatcga ataatgaacg tgaaacgctc 540
gaaaaattgc agcaagagaa aatgaaagca aacgatgagt tagaaactta cttttatcga 600
atcattgaag aaaaacggac gcagccagga gatgatatta tttccgtgct tcttcaagca 660
aaagaagaag ggaagcagct aacggatgaa gaaatcgtcg ggttttccat tttgctgctg 720
attgcaggaa acgaaacaac tacgaactta atttcaaata caatttattg tttaatggaa 780
gataaggctt cttttgaaca cctcagacgt gagaaagagc ttttgccttc tgcgatcgaa 840
gaagttcttc gctatcgttc acccgttcag gctcttcacc gaatcgtaaa agaagatgtg 900
actcttgccg gtcagaaact aaaagcgggc gaacacgtcg ttccatggat gggatctgcg 960
catcgagatg ctcagtactt tgaagacccg gatgtattta aaatcgatcg aaagccaaat 1020
gtgcacatgg catttggaag aggcattcat ttttgcttag gagcaccgct tgctcgaata 1080
gaagcaaaaa ttatgctggc tgagctgatt gaccgctatc cgcagatgga ctggagccca 1140
gcatttgagt tgaagccgat tgaaagcacg tttgtgtacg ggttaaaaga attattaatt 1200
cgtaaacatg tataa 1215
<210> 35
<211> 1212
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 35
atgaacccaa aagcagtgaa aagagaaaat cgttatgcta acttaattcc tatgcaagaa 60
attaaatccg ttgaacagca gctttaccca tttgatattt ataacagttt gcgtcaagaa 120
gcacctattc gttacgatga aagccgaaac tgctgggatg tatttgatta tgaaacagta 180
aagtatattt taaaaaaccc gtcgcttttt tcatccaaac gagcaatgaa agaacgccaa 240
gaaagtatct taatgatgga tcctccaaaa catacaaaat tacgaaactt agtgaataaa 300
gcttttacac caagagctat tcagcacttg gagggtcata ttgaagagat tgcagattat 360
ttattagatg aagtaagcag caaaaaaaag tttgatatag tagaggattt tgctggacca 420
ctgccgatta ttgtaatagc agagctactg ggcgtaccca tacaagaccg agcactgttt 480
aaaaagtact ccgatgactt agtgagcggt tctgaaaata attcagacga agcctttgcg 540
aaaatgatgc aaaagcgtaa tgacggtgtg ctttttttac aagggtattt taaagaaatt 600
atcgctaagc gtcagaaaga taaacaagaa gatcttattt cgctgctttt agaagcagaa 660
attgacggcg agcatttaac agaagaggaa gtactggggt tttgtattct attgctagta 720
gcaggcaatg aaacaacaac aaacttaatt acgaacggag tccggtatat gacagaagat 780
gtagacgtgc agaatgaagt tcgtcaagac atatcgctag ttccgaatct cgtggaagaa 840
acgcttcgtt attatcctcc tattcaagcg attggacgca tagccgctga agatgtagaa 900
cttggagagt gtaaaattaa aaaagggcag caggtaatta gctgggcagc aagtgcaaat 960
agagattcag ctaagtttga acggtctaac acttttgtcg tacatcgtaa agcgaatcct 1020
cacgtaagct ttggatttgg cattcatttt tgcttaggag caccgctagc aagaatggaa 1080
gggaaaattg cctttgctaa attactagaa aaaggggaat tttccaaagt tcagaatcag 1140
tctttaaagc caatagacag cccttttgtt tttggtgtaa aaaaatacga aattactttt 1200
aataacgtct ga 1212
<210> 36
<211> 1215
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 36
atggctgtca aaaaagtgat taacttagct ccaataacgc ccatgaaaga attaaataca 60
aaagagaagt attttaatcc gtttccaatc tatgaaatgt ttcgagaaga aaatccggta 120
cgctatgatg aggaaagaaa gtgctgggat atctttttat atgaagatgt agactacgtt 180
cttaaacatc acgagctctt ttcttctcag cagcagcgaa tggtagaagg ggaaaactta 240
ttaagaatgg atcctccccg tcataaacaa atgcgcgatc tcgttaataa agcgtttacg 300
cctagagaaa ttaataatct tgctcctcgt attgaagaaa ttactaatca cttgctgcaa 360
aatgtcatag acaaaggaga aatgaaaatg attcatgact ttgccatgcc gcttccggtc 420
atcgtcatag ctgatttgtt aggcgttccg gccgaggaca gggaaaagtt taaggagtgg 480
tctgatatcc ttgtaaaagg agtaagtgaa aataagcctg aagcgtacga agcagtgaag 540
caggaacagc agattgcccg cgatgagtta aaggaatatc ttcatagaat tgtgcatata 600
agacgtttcg atcctaaaca agatatcata tcagctttac tttcatcaga agttgacgga 660
ggtaagcttg cagacagcga aatattagag ttcagtatgc ttctcttggc tgctggtaat 720
gaaacgacga caaacttaat tacaaatgga gtccgtctgc ttactgaaat accgagtctg 780
caaaaacaag tgaaaaatga tctttcactt gtgccaacta tggtggagga ggttctccgg 840
ttttatccac ctgtacaggc gccttcacgt attgccataa aagacgttga acttagaggt 900
aagacaataa gaaaagggga tgcggtgaca gcctgggtag catcagctaa ccgagatgaa 960
gctaaatttc ctcatgctaa tgtatttcaa gcggatcgta agcccaatca gcatcttact 1020
tttgggaaag gaattcattt ctgcttaggt gctcccttag cccgtctaga agcaaaaatt 1080
gcgtttgaag aaatgctaag taaatgtacg aatcttcaat taaaagaagg ttcattaata 1140
gaacgaactc cggcaccgca aatgtacggt gtggtagaat atcctgttac attttcagtg 1200
agcccttcat tatag 1215
<210> 37
<211> 1233
<212> DNA
<213> Bacillus megaterium strain DSM 33299
<400> 37
atgaacaaag aagtcattcc cgtgacagaa attccaaaat ttcaatcacg tgcagaagag 60
tttttcccta tccaatggta taaagaaatg ttaaacaatt cccccgttta ttttcatgaa 120
gaaacaaaca catggaatgt attccaatac gaacatgtta aacaagtctt gagcaactac 180
gaattttttt caagcgatgg acaaagaacc actatttttg ttggagataa tagcaagaaa 240
aaaagcacat ctccaatcac caaccttaca aacttagatc ctcctgacca ccggaaagcg 300
cgatctttgc ttgctgccgc ctttactcct cgcagtttaa agaactggga gccgcgaatc 360
aaacaaattg cagcagacct tgtagaagag acacaaaaga attcaactat taatattgtt 420
gaagatttgt cttctccttt tcctagttta gttatagcag atttattcgg cgtaccggta 480
aaagaccgat atcagttcaa aaagtgggta gatattcttt ttcagcctta tgaccaggaa 540
agattaaaag agattgaaca agaaaagcaa cgtgcaggag ctgaatattt tcaatatctc 600
tacccgattg tcgttgaaaa gcgctccaac ctttctgatg atattatttc agacttaatt 660
caagcggaag ttgatgggga aacattcaca gatgaagaaa ttgtgcacgc taccatgctg 720
cttttaggtg caggagttga aaccacaagt cacgccattg caaatatgtt ttattctttc 780
ttatatgacg acaagtcgtt atacagcgag ctgagaagca atagagaatt agctccaaaa 840
gcagtagaag aaatgcttcg atatcggttt catatctcca gacgagatcg cacggttaaa 900
caagataacg agctattagg cgttaagcta aaaaaaggag atgtcgtgat tgcgtggatg 960
agtgcatgta atatggatga aaatatgttt gaaaaccctt tttctgtaga cattcatcgt 1020
ccaactaata aaaagcactt aacattcgga aacggacctc atttttgttt gggcgcccct 1080
cttgcccgac ttgaaatgac aattatctta gaagcatttt tagaggcctt ttctcatatc 1140
gaaccatttg aaggttttga attagaaccg catttaacac cttcagctac gggtcaatct 1200
ttaacatact tgcccatgac ggtgtacaaa taa 1233
Claims (17)
- - 바실루스 메가테리움 속에 속하는 적어도 하나의 프로바이오틱 균주, 및
- 에이코사펜타엔산(EPA), 도코사헥사엔산(DHA), 아라키돈산(ARA), 알파 리놀렌산, 스테아리돈산, 에이코사테트라엔산, 도코사펜타엔산, 리놀레산, γ-리놀렌산으로부터 선택된 적어도 하나의 오메가-3 또는 오메가-6 지방산을 포함하는 다중불포화 지방산 성분
을 포함하고
여기서 다중불포화 지방산 성분은 오메가-3 또는 오메가-6 지방산 염을 포함하는 것인 제제. - 제1항에 있어서, 프로바이오틱 균주가 휴면 형태로 또는 영양 세포로서 존재하는 것인 제제.
- 제1항에 있어서, 오메가-3 또는 오메가-6 지방산이 유리 지방산, 염, 천연 트리글리세리드, 어유, 인지질 에스테르 또는 에틸 에스테르의 형태인 제제.
- 제1항 내지 제3항 중 어느 한 항에 있어서, 지방산이 오메가-3 지방산 EPA 및 DHA로부터 선택되거나 또는 오메가-6 지방산 성분이 ARA인 제제.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 5-아미노레불린산을 추가로 포함하는 제제.
- 제1항 내지 제5항 중 어느 한 항에 있어서, 프로바이오틱 균주가 바실루스 메가테리움 DSM 32963, 바실루스 메가테리움 DSM 33296, 또는 바실루스 메가테리움 DSM 33299 중 하나 이상으로부터 선택되는 것인 제제.
- 제1항 내지 제6항 중 어느 한 항에 있어서, 다중불포화 지방산 성분이 오메가-3 지방산 염, 바람직하게는 아미노산 염, 보다 바람직하게는 리신, 아르기닌, 오르니틴, 콜린 및 그의 혼합물로부터 선택된 염기성 아미노산, 가장 바람직하게는 리신으로부터 선택된 것을 포함하는 것인 제제.
- 제1항 내지 제7항 중 어느 한 항에 있어서, 다중불포화 지방산 성분이 적어도 하나의 인지질 및 적어도 하나의 오메가-3 또는 오메가-6 지방산의 분산액을 포함하는 제제를 포함하는 것인 제제.
- 제1항 내지 제8항 중 어느 한 항에 있어서, 지연 방출 또는 장 또는 결장 방출을 위한 코팅을 포함하는 제제.
- 사료 또는 식품 보충제로서의 제1항 내지 제9항 중 어느 한 항에 따른 제제의 용도.
- 제약 제품의 제조를 위한 제1항 내지 제9항 중 어느 한 항에 따른 제제의 용도.
- 제1항 내지 제9항 중 어느 한 항에 따른 제제 및 바람직하게는 단백질, 탄수화물, 지방, 추가의 프로바이오틱스, 프리바이오틱스, 효소, 비타민, 면역 조절제, 우유 대체품, 미네랄, 아미노산, 항 콕시듐증 제제, 산-기재 제품, 의약, 및 그의 조합으로부터 선택된 적어도 하나의 추가의 사료 또는 식품 성분을 함유하는 사료- 또는 식품 조성물.
- 제12항에 있어서, 동물 또는 인간의 건강 상태, 장 건강, 심혈관 건강, 심장-대사 건강, 폐 건강, 관절 건강, 눈 건강, 정신 건강, 구강 건강 또는 면역 건강을 개선시키기 위한 조성물.
- 제13항에 있어서,
- 위장 미생물에 의한 그의 제조를 통해 숙주에서 하기 지질 매개인자의 총량을 증가시키는 것: 17-HDHA, 14-HDHA, 13-HDHA, 7-HDHA, 4-HDHA, 18-HEPE, 15-HEPE, 12-HEPE, 11-HEPE, 5-HEPE, 15-HETE, 12-HETE, 11-HETE, 8-HETE, 5-HETE, 9-HODE, 13-HODE, PDX, PD1, AT-PD1, MaR1, MaR2, LTB4, t-LTB4, RvD1-5, AT-RvD1, RvE1, RvE3, LXA4, LXA5, LXB4, LXB5,
- 숙주에서 EPA의 총량을 증가시키는 것,
- 숙주에서 DHA의 총량을 증가시키는 것
중 하나 이상에 의해 동물 또는 인간의 건강 상태를 개선시키기 위한 조성물. - 적합한 매트릭스 또는 담체를 사용하여 피부, 눈 및 구강 공동 상에 국소 적용하기 위한 제1항 내지 제9항 중 어느 한 항에 따른 제제의 용도.
- 제15항에 있어서, 제제가 나노셀룰로스를 포함하는 사전-합성된 다상 생체물질 상에 및/또는 내에 로딩되며,
여기서 나노셀룰로스는
- 셀룰로스 섬유 또는 나노위스커의 네트워크를 포함하는 박테리아 합성된 나노셀룰로스(BNC),
- 셀룰로스 피브릴의 2개 이상의 상이한 층을 포함하며, 여기서 각각의 층은 상이한 미생물로부터의 또는 상이한 조건 하에 배양된 미생물로부터의 BNC로 이루어진 것인 BNC,
- 2종 이상의 상이한 셀룰로스 네트워크를 포함하는 BNC 또는
- 중합체를 추가로 포함하는 BNC 복합 물질
로부터 선택된 박테리아 합성된 나노셀룰로스(BNC)인 용도. - SPM의 생명공학적 제조를 위한, 하기 특징:
a) 서열식별번호: 1 또는 서열식별번호: 2, 서열식별번호: 13 또는 서열식별번호: 14, 서열식별번호: 25 또는 서열식별번호: 26에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 16S rDNA 서열; 및/또는
b) 서열식별번호: 3, 서열식별번호: 15 또는 서열식별번호: 27에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 yqfD 서열; 및/또는
c) 서열식별번호: 4, 서열식별번호: 16, 서열식별번호: 28에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 gyrB 서열; 및/또는
d) 서열식별번호: 5, 서열식별번호: 17, 서열식별번호: 29에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 rpoB 서열; 및/또는
e) 서열식별번호: 6, 서열식별번호: 18, 서열식별번호: 30에 따른 폴리뉴클레오티드 서열에 대해 적어도 99.5 %, 특히 100 %의 서열 동일성을 갖는 groEL 서열
을 나타내는, 휴면 형태의 또는 영양 세포로서의 바실루스 메가테리움 균주의 용도.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18209509 | 2018-11-30 | ||
EP18209509.1 | 2018-11-30 | ||
PCT/EP2019/082924 WO2020109474A1 (en) | 2018-11-30 | 2019-11-28 | Preparation comprising a probiotic strain of the genus bacillus megaterium and a polyunsaturated fatty acid component |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210099037A true KR20210099037A (ko) | 2021-08-11 |
Family
ID=64745858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020217019791A KR20210099037A (ko) | 2018-11-30 | 2019-11-28 | 바실루스 메가테리움 속의 프로바이오틱 균주 및 다중불포화 지방산 성분을 포함하는 제제 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20210392935A1 (ko) |
EP (1) | EP3886613A1 (ko) |
JP (1) | JP7383023B2 (ko) |
KR (1) | KR20210099037A (ko) |
CN (1) | CN113395908B (ko) |
AU (1) | AU2019387329A1 (ko) |
BR (1) | BR112021010335A2 (ko) |
CA (1) | CA3121033C (ko) |
MX (1) | MX2021006084A (ko) |
WO (1) | WO2020109474A1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022051613A1 (en) * | 2020-09-04 | 2022-03-10 | Dsm Ip Assets B.V. | Production of hydroxylated polyunsaturated fatty acids |
AR128521A1 (es) * | 2022-02-21 | 2024-05-15 | Bioconsortia Inc | Microbios, composiciones microbianas y consorcios beneficiosos para la agricultura |
WO2024068304A1 (en) | 2022-09-30 | 2024-04-04 | Evonik Operations Gmbh | Probiotic strains for the treatment of irritable bowel syndrome and fodmap intolerance |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08298982A (ja) * | 1995-05-02 | 1996-11-19 | Aasu Giken:Kk | 複合微生物製剤 |
US6107334A (en) * | 1998-02-23 | 2000-08-22 | Wake Forest University | Dietary control of arachidonic acid metabolism |
ATE344226T1 (de) * | 2000-02-16 | 2006-11-15 | Brigham & Womens Hospital | Aspirin-ausgelöste lipidmediatoren |
US20020188024A1 (en) * | 2000-08-23 | 2002-12-12 | Chilton Floyd H. | Fatty acid-containing emulsion with increased bioavailability |
DK3236782T3 (da) | 2014-12-23 | 2020-04-27 | Evonik Operations Gmbh | Fremgangsmåde til forøgelse af stabiliteten af en sammensætning, der omfatter flerumættede omega-3-fedtsyrer |
WO2016113400A1 (en) * | 2015-01-15 | 2016-07-21 | JeNaCell GmbH | Multi-phase bacterially-synthesized-nanocellulose biomaterials and method for producing the same |
US10653703B2 (en) | 2015-09-03 | 2020-05-19 | Solutex Na Llc | Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same |
EP3248467A1 (de) | 2016-05-25 | 2017-11-29 | Evonik Technochemie GmbH | Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze |
AU2017319484B2 (en) * | 2016-08-30 | 2022-04-07 | Amvac Chemical Corporation | Defined microbial compositions |
-
2019
- 2019-11-28 MX MX2021006084A patent/MX2021006084A/es unknown
- 2019-11-28 KR KR1020217019791A patent/KR20210099037A/ko unknown
- 2019-11-28 JP JP2021529679A patent/JP7383023B2/ja active Active
- 2019-11-28 CA CA3121033A patent/CA3121033C/en active Active
- 2019-11-28 CN CN201980078589.8A patent/CN113395908B/zh active Active
- 2019-11-28 EP EP19832564.9A patent/EP3886613A1/en active Pending
- 2019-11-28 WO PCT/EP2019/082924 patent/WO2020109474A1/en unknown
- 2019-11-28 US US17/296,465 patent/US20210392935A1/en active Pending
- 2019-11-28 BR BR112021010335A patent/BR112021010335A2/pt unknown
- 2019-11-28 AU AU2019387329A patent/AU2019387329A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN113395908A (zh) | 2021-09-14 |
MX2021006084A (es) | 2021-07-06 |
AU2019387329A1 (en) | 2021-07-15 |
CN113395908B (zh) | 2024-06-11 |
US20210392935A1 (en) | 2021-12-23 |
CA3121033C (en) | 2023-06-13 |
WO2020109474A1 (en) | 2020-06-04 |
JP7383023B2 (ja) | 2023-11-17 |
CA3121033A1 (en) | 2020-06-04 |
JP2022513633A (ja) | 2022-02-09 |
BR112021010335A2 (pt) | 2021-11-16 |
EP3886613A1 (en) | 2021-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210163878A1 (en) | Modulation of tissue fatty acid composition of a host by human gut bacteria | |
CN113395908B (zh) | 包含巨大芽孢杆菌属益生菌菌株和多不饱和脂肪酸组分的制剂 | |
AU2016203427B2 (en) | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof | |
JP5392672B2 (ja) | 新規の乳酸桿菌株及びその使用 | |
JP6062931B2 (ja) | 噴霧乾燥ラクトバチルス株/細胞およびヘリコバクターピロリに対するその使用 | |
JP4565750B2 (ja) | 共役リノール酸エステルの製造法 | |
TW201036554A (en) | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof | |
US20220265749A1 (en) | Preparation comprising omega-3 fatty acid salts and extracts of gum resins from boswellia species | |
JP6456987B2 (ja) | 成長促進のためのビフィドバクテリウム・ブレーベcbt br3菌株及びこれを含む成長促進用機能性食品組成物 | |
WO2014146098A1 (en) | Compositions of crude algal oil | |
US20210393565A1 (en) | Preparation for use to increase the formation of one or more specialized pro-resolving lipid mediators (spm) | |
US20240180978A1 (en) | Preparations comprising probiotic strains and l-tryptophan | |
KR102483912B1 (ko) | 연질캡슐형 건강기능식품의 제조방법 | |
WO2021024872A1 (ja) | ストレス低下用及び/又は体重回復用経口組成物、並びにプラズマローゲン含有組成物の製造方法 | |
US20220312816A1 (en) | Preparation for use in enhancing formation of short-chain fatty acids (scfas) | |
Roux et al. | Overview on biotics development | |
WO2024105265A1 (fr) | Limosilactobacillus mucosae et désordres nécessitant un accroissement du niveau de glp-1 | |
Ribeiro | Novel Microalgae Formulations Comprising Lactic Acid Bacteria for Human Consumption | |
IES20080790A2 (en) | Modulation of tissue fatty acid composition of a host by human gut bacteria | |
IE20080790U1 (en) | Modulation of tissue fatty acid composition of a host by human gut bacteria |